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The five pairs of mouse mammary glands are ectoderm-derived appendages that are 
formed in the embryo. The cellular and molecular mechanisms that regulate embryonic 
mammary gland development are largely unknown. To understand these mechanisms, I 
study the involvement and roles of GLI-Kruppel family member 3 (Gli3) in embryonic 
mammary gland development using the Gli3Xt-J/Xt-J (null) mouse model. Previous studies 
have shown that Gli3Xt-J/Xt-J embryos fail to induce mammary rudiment (MR) pairs 3 and 
5. Here, I show that, in addition, Gli3Xt-J/Xt-J MR2 and MR4 are severely hypoplastic and 
protrude outwardly. In contrast, MR1 is mildly hypoplastic but develops fairly normally.  
In the first part of this study, I sought to determine the cellular mechanisms that 
normally regulate embryonic mammary gland development and the involvement of Gli3 
in regulating these mechanisms. I show that cell migration and cell hypertrophy are the 
primary mechanisms that regulate induction and growth of the MRs during the first two 
days of mammogenesis. These cellular processes are compromised with the loss of 
Gli3, resulting in the lack of induction or hypoplasia of Gli3Xt-J/Xt-J MRs.  
In the second part of the study, I sought to determine the molecular mechanisms 
regulated by Gli3 in embryonic mammary gland development. Building on previous 
observations that Wnt10b is downregulated in the mammary line of Gli3Xt-J/Xt-J embryos, I 
show that WNT/β-catenin signalling is downregulated during the first day of 
mammogenesis in Gli3Xt-J/Xt-J embryos. Reconstitution of WNT/β-catenin signalling using 
an ectoderm-specific stabilized β-catenin transgene rescues the induction of MR3, but 
not MR5, and attenuates the hypoplasia of MR1, MR2, and MR4 in Gli3Xt-J/Xt-J embryos. 
However, proper morphogenesis was not restored in Gli3Xt-J/Xt-J MR2 and MR3. In 
addition, stabilized β-catenin did not rescue the MR phenotype of null mutants for the 
genes encoding fibroblast growth factor 10 (FGF10), or its main receptor FGFR2B which 
 X 
 
have lower basal levels of WNT/β-catenin signalling compared to Gli3Xt-J/Xt-J embryos 
during the first day of mammogenesis. We propose that sufficiently high levels of 
WNT/β-catenin signalling are crucial in mediating MR induction and growth, but not 
morphogenesis.  
In the third part of the study, I perform a meta-analysis of reported mouse genetic 
models that have an embryonic MR phenotype and observed that different genes are 
required for the induction and morphogenesis of each MR pair. This analysis revealed 
that the mammogenic potential along the mammary line is different – MR4 is the most 
resistant to compromised induction caused by single and double gene deletions, while 
the induction of MR3 is frequently compromised by the loss of gene function. The 
differential mammogenic potential could, in part, explain the diversity of mammary gland 
numbers and positions among the mammalian species. 
My MR-specific analyses in this thesis uncovered position-specific roles for Gli3, 
leading to the unexpected notion that different mechanisms are involved in the early 
development of these functionally-identical organs. The utilization of different molecular 
mechanisms represents an ingenious way of safeguarding the mammary glands in the 
event of an inhibitory mutation, and highlights the importance of using mammary gland-
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Organisation of this Thesis 
 
This thesis is composed of 6 chapters. Chapter 1 introduces the mammary gland, 
and provides a comprehensive literature review of the development of the embryonic 
mammary rudiments (MRs) and the involvement of various cellular and molecular 
mechanisms. The role of GLI-Kruppel family member 3 (Gli3) and WNT signalling are 
highlighted in this chapter. Chapter 2, written in the style of an original research article, 
focuses on the role of Gli3 in regulating different cellular mechanisms in the embryonic 
MRs. Chapter 3, also written in the style of an original research article, describes the 
partial rescue of the MR phenotype in Gli3-deficient mice with the reconstitution of 
WNT/β-catenin signalling. Chapter 4 is written in the style of a review article and 
describes the different mammogenic potential of each of the five MR pairs based on a 
meta-analysis of the literature and with original data from mouse genetic mutant studies. 
Chapter 5 is a general discussion of the findings and implications of this thesis beyond 
what is discussed in each of the preceding chapters separately. Finally, this thesis ends 
with Chapter 6 which summarizes the conclusions of this thesis and provides a list of 















1.1 The mammary gland 
 
The mammary gland is the definitive feature of species in the class of Mammalia. 
The term Mammalia, named after the mammary gland itself, was coined by Linnaues in 
1758 (Schiebinger, 1993). The purpose of the mammary gland is to provide the newborn 
with copious amounts of milk, the primary source of nutrients, as well as various 
antimicrobial substances and antibodies (Butler, 1979; Van de Perre, 2003) for 
immunological protection. While certain animals, for example some cichlid fish, pigeons, 
and some insects, are known to produce special secretions to nurture their young, only 
mammals have a particular organ devoted to that function. Furthermore, only in 
mammals has feeding of the young by maternal secretions been brought to such a high 
degree of integration and sophistication (Peaker, 2002). In addition, the relatively long 
periods of parental care and close contact brought about by lactation enables the forging 
of a close and intimate bond between the newborn and its mother. 
The mammary gland is a skin-derived appendage. As the focus of this thesis is on 
the embryonic phase of development, I will only briefly describe key developmental 
aspects of the postnatal mammary gland here. The postnatal mammary gland is made 
up of two distinct compartments namely the epithelium and the mammary fat pad or 
stroma (Fig. 1.1). The bilayered epithelium is organized into a ductal and alveolar 
network that is embedded in the mammary fat pad. The fat pad consists mainly of 
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adipocytes, but also fibroblasts, cells of the hematopoietic system, blood vessels and 
neurons (reviewed in (Richert et al., 2000; Hennighausen and Robinson, 2005)).  
At birth, the mammary gland consists of a rudimentary epithelial tree. Later at 
puberty, club-shaped structures at the distal end of the epithelial branches, termed 
terminal end buds, drive the growth of the mammary epithelium into the fat pad to create 
a ductal network (Fig. 1.1 A). When the terminal end buds reach the end of the fat pad 
they regress, and the epithelial network becomes static with only small, estrus-related 
structural changes. 
During pregnancy and lactation, the epithelium remodels to form alveolar structures, 
which are further organized into lobules (Fig. 1.1 A, B). Epithelial cells lining the lumen of 
the alveoli undergo functional differentiation to become milk-producing secretory cells. 
The luminal cells are enveloped by contractile myoepithelial cells that facilitate the 
delivery of milk from the alveolar units into the lumen, from which milk is drained into a 
lactiferous ductal system connected to the nipple (Fig. 1.1 E, F).  As the newborn begins 
to suckle, an oxytocin-mediated reflex ensues and the mother's milk is secreted into the 
newborn's mouth (reviewed in (Richert et al., 2000)). 
Upon weaning of the newborns, the mammary gland goes though involution (Fig. 1.1 
A, B), which encompasses both apoptosis and remodelling (Fig. 1.1 C). This process of 
involution takes approximately two weeks to complete, after which, the gland is ready to 
initiate another cycle of pregnancy, lactation, and involution. 
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Fig. 1.1. Postnatal mammary gland development. 
(A) Schematic illustrating the development of the mouse mammary gland. Each stage of 
the schematic is accompanied by (B) matched timepoints of mammary glands in 
Carmine-red stained wholemount preparations and (C) histological sections. Insets in 
the histological panels show (from left to right) examples of immunohistochemistry for α 
smooth muscle actin to highlight the cap cells of a terminal end bud (puberty), PCNA to 
illustrate rapid growth (pregnant) and TUNEL to illustrate regulated cell death 
(involution). Reproduced from (Andrechek et al., 2008), with permission from The 
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1.2 Variation in the number of mammary glands 
 
The number of mammary glands varies among different mammals. In general, the 
number of mammary glands seem to be proportional to the number of offspring resulting 
from a given pregnancy ((Aristotle, 350B.C.E.), cited in (Diamond, 1987)). By 
assembling mammary gland numbers from 266 rodent species, Gilbert established that 
mean litter size is typically half the number of available mammary glands, while 
maximum litter size approximates mammary gland number (Gilbert, 1986). Interestingly, 
high incidences of supernumerary nipples, correlating with a high rate of twinning have 
been reported in Formosan macaques at Mount Longetivity, Taiwan (Hsu et al., 2000), 
supporting the hypothesis that mammary gland number is proportional to offspring 
number.  
However, there are notable exceptions to this relationship. There is no correlation 
between teat and litter size number in the golden hamster (Anderson and Sinha, 1972). 
Other examples include the cow, Bos taurus, which has four teats and generally only 
one offspring, and the chinchilla, Chinchilla lanigera, which has six teats and usually two 
or three offspring (Long, 1969). In the other extreme, the guinea pig, Cavia porcellus, 
which has only two teats, may have as many as six pigs per pregnancy (Anderson and 
Sinha, 1972). One of the most exceptional examples recorded is the marsupial, 
Dasyurus, which has only six to eight teats and up to 24 young (Cockrum, 1962). An 
explanation that could account for these exceptions is the different volume of milk 
produced per gland. Thus, a small number of mammary glands would suffice even for a 
large litter size if the mammary glands produce a large volume of milk.  
The mammary glands are usually formed as bilaterally symmetrical pairs but the 
opossum (with 13), pouchless Chilean rat opossum (with five), and Philander (with 
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seven) are three marsupials which usually possess odd numbers ((Grass, 1955; 
Cockrum, 1962),  cited in (Long, 1969) ). 
How is the variation in the number of mammary glands in different species achieved? 
In humans, supernumerary breasts (polymastia) and supernumerary nipples (polythelia) 
occur in 1% to 2% of the general population (Grossl, 2000). These supernumerary 
breasts are typically located between the axilla and groin or even on the vulva on each 
side of the body. When these locations are connected by artificial lines, two bilaterally 
symmetrical lines along the antero-posterior body axis are formed (Fig. 1.2). These lines 
are reminiscent of the mammary lines (MLs) formed in the embryo at five to six weeks of 
gestation; therefore the supernumerary breasts are thought to have an embryonic origin 
(Grossl, 2000). In the embryo, the mammary glands are formed on ectoderm-derived 
bilaterally symmetrical MLs that extend from the forelimb to the hindlimb. The MLs 
represent an initial broad band of potential on which mammary glands can be formed. In 
different species, different areas of the MLs continue to form mammary glands, while 
areas of the ML that do form mammary glands will revert to the ectoderm fate. The 
differential number of induced mammary glands along the ML would then give rise to the 
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Fig. 1.2. Supernumerary mammary glands may have an embryonic origin.  
(A) Cartoon showing the locations of supernumerary breasts or nipples in the human. 
When lines are drawn to connect the different positions from the thoracic to inguinal 
region on each body side, the lines are reminiscent of the MLs that are formed in the 
embryo at Carnegie stage 15 (37-42 days old; as seen in B), suggesting that the 
formation of supernumerary mammary glands may be due to variable induction events 
on the ML in the embryo. Arrows in (B) indicate the extent of the mammary line. (A)  
Reproduced from (Dixon and Mansel, 1995) with permission from BMJ Publishing group. 
(B) Reproduced from the Kyoto Collection of Human Embryos, with permission from Dr 




1.3 Variation in the position of mammary glands 
 
Besides the difference in numbers, the locations at which the mammary glands form 
differ among species. Even between species with the same number of mammary glands, 
the mammary glands can be formed in different locations on the body. For example, 
goats and primates both have one pair of mammary glands, but in the former, the glands 
are located in the inguinal region, while in the latter, mammary glands are located in the 
thoracic region (Table 1.1). The monotreme, Echidna, has an abdominal, nippleless pair 
of mammary glands consisting of about 100 to 150 separate gland tubes but lacking a 
centralized duct (Bresslau, 1920). Often, in marsupials, four teats are confined to an 
abdominal pouch. The opossum Didelphis has between 13 and 15 mammary glands, 
 A B 
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with six or seven pairs arranged in a semi-circular pattern surrounding one central gland 
inside a pouch (Renfree et al., 1990). If MLs are present in a given species, and when 
more than one pair of mammary glands form, rather than being clustered at a given 
location, the mammary glands tend to form at different regions on the body (Long, 1969).  
For example, the rat has three pairs of thoracic, a pair of abdominal and two pairs of 











Number of mammary glands 
Total Reference 













Elephant,   
primates 
2 0 0 2 (Hurley, 2010) 
Monotreme 
(Echidna) 




0 4 0 4 (Hurley, 2010) 
Cat 4 4 0 8 (Hurley, 2010) 
Dog 4 4 2 8 -12 (Hurley, 2010) 
Mouse 6 0 4 10 (Hurley, 2010) 
Rat 6 2 4 12 (Hurley, 2010) 
Opossum 
(Didelphis) 
0 13-15 0 13-15 
(Renfree et al., 
1990) 
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1.4 Theories of the evolutionary origin of the mammary gland 
 
The evolutionary origin of the mammary glands has been difficult to establish, as the 
soft tissue of the glands make fossilization of the glands and other intermediate 
structures nearly impossible (McClellan et al., 2008). Several theories on the origin of 
the mammary glands have been proposed based on studies of the anatomy of the 
mammary glands of primitive mammals, the comparison of the mammary glands with 
other skin appendages and on the properties and origin of milk proteins, as described 
below.   
Based on the assumption that the phylogenetic history of the mammary glands may 
be inferred from the developmental stages of the mammary glands of primitive 
mammals, Klaatsch proposed that the mammary glands may have arisen from 
structures akin to the slits in the abdominal panniculus muscle in the adult of the 
monotreme Echidna. The slits in the panniculus muscle will deepen over time to produce 
mammary pouches and form the ancestral mammary gland, termed the incubatorium 
(Bresslau, 1920). However, Bresslau observed the presence of the primary mammary 
gland primordia in the Echidna embryo, dispelling Klaatsch‘s view that the abdominal slit 
is the earliest developmental stage of the mammary gland. This indicated to Bresslau 
that the primary primordia, rather than the slits, should be considered the most primitive  
and ancestral structure of the mammary gland (Bresslau, 1920). Based on this, Bresslau 
proposed that since the primary primordia resemble the brooding spots in birds in terms 
of their location and rich vascular supply, with the shortening of the brooding period, the 
vascular supply would somehow favour the development of a tubular gland that 
possesses stronger secretory abilities compared to other skin glands (Bresslau, 1920).  
The separate ancestral line of synapsids, which would one day produce mammals, 
was first found in fossils of the mid-Pennsylvanian, about 310 million years ago. It has 
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been proposed that the mammary glands evolved from simple cutaneous glands, 
namely sebaceous, sweat, or apocrine glands in early synapsids (Oftedal, 2002). A brief 
analysis of the different candidates is discussed below: 
Sebaceous glands secrete the oily, waxy substance called sebum and are closely 
associated with hair follicles. Sebaceous glands bear little resemblance to mammary 
glands: they are highly specialized for holocrine secretion, while the mammary glands 
are specialized for merocrine secretion. Secretory structures in mammary and other 
cutaneous glands are lined with bilayered epithelium; this contrasts with the lining of 
sebaceous glands that accumulate multiple layers of basal, differentiating, and necrosing 
cells, and lack myoepithelial cells. As individual lobules of the sebaceous glands become 
exhausted, they are replaced by new lobules (Oftedal, 2002). 
The ontogeny of mammary glands resembles that of eccrine sweat glands. This is 
particularly the case in the monotremes, which have branched, tubular mammary glands 
(Bresslau, 1920). Thus, sweat glands are a more probable ancestral structure of the 
mammary gland compared to sebaceous glands. Moreover, as with mammary glands, 
eccrine sweat glands secrete by exocytosis. This process is mediated by myoepithelial 
cells which expel luminal contents to the surface. However, eccrine sweat glands are 
rarely profusely distributed in mammals. In humans and some other primates sweat 
glands are abundant over the general body surface. Yet, in other mammals, sweat 
glands are usually restricted to areas of the skin that make regular surface contact, such 
as the palmar surfaces and the underside of a prehensile tail in monkeys such as 
Cebidae, and on the beak of the platypus, Ornithorhynchus anatinus. Thus, by their 
frequency of occurence and location in mammals, it is improbable that sweat glands are 
an ancestral mammary gland structure. Furthermore, their simple dilute secretions for 
evaporative cooling have little organic material compared to milk produced by the 
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mammary glands. Lastly, sweat glands, unlike the mammary glands, develop 
independently of sexual maturity (Oftedal, 2002). 
Oftedal therefore argued that the most likely precursor of the mammary gland is the 
apocrine gland, which bears far more similarities to the mammary gland than sweat and 
sebaceous glands. In both apocrine and mammary glands, a single layer of secretory 
epithelial cells is underlain by a single layer of myoepithelial cells and the volume of 
secretory cells changes little during secretion. Furthermore, during embryonic 
development, apocrine glands develop in close association with hair follicles as is in the 
case of the mammary glands of monotremes and marsupials. At least some specialized 
apocrine glands resemble mammary glands in being able to synthesize and secrete 
lipids and other complex organic molecules (Oftedal, 2002).  
Although mammary glands possess some overlapping characteristics with other 
cutaneous glands, it has also been argued that the mammary glands are not similar or 
convincingly suggestive of any particular ancestral type. Blackburn argued that 
mammary glands share features with multiple gland types and could have evolved as a 
novel mosaic structure incorporating features of multiple types of skin glands, rather than 
evolving from a single population of glands (Blackburn, 1991). As the mesenchyme can 
direct the differentiation of the epithelium (see also section 1.7.3.2 ―Epithelial-
mesenchymal interactions‖ below), variation in the timing and nature of reciprocal 
signals between epithelium and mesenchyme may have led to a novel mosaic structure 
that shares many similarities with other skin glands.  
Besides the similarities of the mammary glands with other skin appendages 
discussed above, another school of thought about the evolutionary origin or phylogeny of 
the mammary gland arose from the properties of the secreted milk. Both the 
immunological and the strong nutritional value of milk are largely due to unique 
evolutionary contributions of the two antimicrobial enzymes xanthine oxidoreductase and 
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lysozyme, that are expressed in and secreted from the lactating mammary epithelium. 
Thus, it has been proposed that milk from the mammary glands evolved from a mucus-
secreting epithelial gland. This epithelial gland is suggested to have been part of the 
innate immune system providing the first-line of defence against microbes and other 
infectious agents. Antibacterial skin and skin gland secretions are well-described in other 
animal species, such as salamanders, fish epidermis, or frogs. Thus, lactation is 
proposed to be analogous to the inflammatory response (Vorbach et al., 2006). Ancient 
mammary glands presumably had no nipples and milk flowed onto the ventral fur as in 
the monotreme platypus. 
Can the origin of lactation in mammals be linked to the gradual shift of nourishment 
source from the yolk to milk? Brawand et al. showed that the transition from 
yolk-dependent nourishment toward alternative resources namely lactation and 
placentation coincide with the loss of a functional vitellogenin gene, required to transport 
nutrients that make up the yolk into the egg. Furthermore, their analyses showed that 
caseins, which encode for major milk proteins, first appeared in the mammalian 
ancestor. Thus, lactation is suggested to be the driving force behind the reduction of 
nutritional content within the egg (Brawand et al., 2008).  
 
1.5 Ontogeny of the mammary gland 
 
The mammary gland is of ectodermal origin, as indicated from tissue recombination 
studies in which the epithelium and mesenchyme from different species are combined 
and cultured. Cunha and Hom showed that by combining the mesenchyme from the 
mouse with mid-ventral and dorsal epidermis from the rat, a functional mammary gland 
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can be induced. Moreover, the mammary gland is derived entirely from the latter tissue 
(Cunha and Hom, 1996).  
Two different types of mesenchyme are critically involved in guiding embryonic 
mammary gland development. The first kind, termed the mammary mesenchyme, 
consists of condensed fibroblastic cells that surround the embryonic mammary rudiment 
(MR) at embryonic day (E) 12.5.  The origin of the mammary mesenchyme is unclear — 
it may be the result of mesenchymal cell differentiation adjacent to the mammary 
epithelium, or the result of cells migrating from other regions. The other mesenchymal 
tissue is the fat pad precursor cells, consisting of preadipocytes, which appear 
separately posterior to the MR at E14.5 (Sakakura et al., 1982). The origin of this tissue 
is also unclear, but as it is a mixed population of adipocytes, vasculature and nerve cells, 
the possible source may be either general or specialized fibroblasts, the 
reticuloendothelial cells, or neuroectodermal cells (Sakakura, 1991; Veltmaat et al., 
2003). 
 
1.6 The mouse as a model for the study of the embryonic mammary glands 
 
Various considerations make the mouse the ideal model organism for this thesis 
project. As the mammary gland is the focus of this thesis project, the choice of model 
organism is confined to mammals, and further confined to a species with a short 
generation time and large litter size. Large litter sizes increase the frequency of 
obtaining, within a litter, at least one wildtype and mutant pair of embryos for analysis. 
Furthermore, the relative ease in genetically manipulating the mouse genome has 
resulted in the availability of a large collection of mouse genetic mutants that facilitates 
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the identification and understanding of the roles of various genes, and how these genes 
may interact to regulate embryonic mammary gland development.   
In the mouse, three pairs of mammary glands are located in the thoracic region while 
two pairs develop in the inguinal region. The anterior-most pair is, by convention, 
referred to as mammary gland pair 1, while the posterior-most corresponds to mammary 
gland pair 5 (Fig. 1.3). As one of the aims of this study is to determine the cellular and 
molecular regulation of induction and growth, the number of mammary glands in the 
mouse is sufficiently large to facilitate the identification and quantitation of absent and 
extra mammary glands in different genetic mutants, and to determine the cellular and 
molecular mechanisms underlying these defects.  Moreover, as there is sufficient space 
between the glands to potentially form more glands, the cellular and molecular regulation 
of induction and growth at various locations on the body may be studied and compared.  
 
 
Fig. 1.3. Locations of the five pairs of mammary glands in the mouse.  
Cartoon depicting the ventral (left) and lateral (right) views of an adult female mouse. 
Three pairs of glands are formed at the thoracic region, while two pairs are formed 
inguinally. Note the area between mammary gland (MG) 3 and MG4 which contains 
sufficient space for the formation of supernumerary mammary glands. Shaded area 
depicts the extent of the mammary fat pad. Modified from (Murphy, 1966).  
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1.7 Development of the murine embryonic mammary gland 
 
1.7.1 From mammary line to ductal tree 
 
Development of the mammary glands starts in the embryo with the formation of the 
mammary line (ML). For many years, the presence of a ML in the mouse was doubted 
as no obvious anatomical structure, such as that in the rabbit, was observed (Fig. 1.4 A-
C, 1.4 D-F). However, by screening the expression of several WNT ligands, Veltmaat et 
al. showed that Wnt10b distinguishes 3 mammary crests at E10.5, which later fuse into 
one continuous line at around E11.5 (45-somite stage) (Fig. 1.4 G-I, (Veltmaat et al., 
2004)). By histological analysis, it was observed that this ML comprises enlarged, 
columnar epithelial cells that begin to form a multilayer, while the dorsal ectoderm 
consists of single-layered cuboidal epithelium (Fig. 1.4 J) and the ventral ectoderm 
consists of squamous cells (Veltmaat et al., 2004). Within one day, the expression of 
Wnt10b becomes restricted to five distinct regions, corresponding to each of the MRs, 
while along the rest of the ML, if still existing as an anatomical structure, Wnt10b 
expression has disappeared (Fig. 1.4 I).  
The first distinct and localized region showing high expression of Wnt10b along the 
ML corresponds to the prospective MR3. By E11.75, all five MR pairs are present as 
disk-shaped, multi-layered placodal structures. The placodes will then grow and acquire 
a hillock, bud and bulb morphology (Fig. 1.5 B). At around E12.5, a subset of 
mesenchymal cells near the mammary epithelial compartment undergoes differentiation 
((Durnberger and Kratochwil, 1980; Sakakura et al., 1982) and this thesis)). These cells, 
which collectively make up the mammary mesenchyme will elongate, condense, and 
orient their long axis along concentric circles around the developing epithelial buds, first 
around MR3, and later around the other MRs. Besides being histologically distinct from 
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the surrounding dermal mesenchyme, the mammary mesenchyme is also characterized 
by the expression of markers, such as the receptors for androgen and estrogen 
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Fig. 1.4. The mammary line is anatomically different between the rabbit and the 
mouse.  
(Continued on next page) 
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 (A) Scanning electron micrograph of an E13.5 rabbit embryo, showing the mammary 
line (ML) in the rabbit as an elevated ectodermal ridge located between the fore (fl) and 
hindlimb (hl). (B) High magnification of the box shown in A. (C) As the mammary 
rudiments (MRs) are formed, the ML receeds in the rabbit embryo. (D) Scanning 
electron micrograph of an E11 mouse embryo, which is developmentally equivalent to 
the rabbit at E13.5, showing no anatomically distinct structure such as seen in the rabbit 
embryo. (E, F) The MRs are slightly elevated as they are forming. P: mammary placode, 
B: mammary bud (G) Wnt10b expression marks the mammary line at E11 and E11.5 in 
the mouse embryo and the expression domain becomes progressively restricted to the 
MRs as they are formed. dl: dorsal line (H, I). (J) Histological section through the mouse 
ML at E11.75, showing multilayering of ectodermal cells. d: dermal mesenchyme, e: 
ectoderm. (A-F) Reprinted from (Veltmaat et al., 2003) with permission from Elsevier. 




At around E14.5, development of the mammary glands diverges between the two 
genders. In the female, development proceeds with the enlargement of the bud which 
subsides into the mesenchyme. By E16.5, the bud transforms into a sprout which 
penetrates a second stromal compartment, termed the mammary fat pad (Sakakura et 
al., 1987). The embryonic fat pad consists of a loose collection of preadipocytes that 
starts with mesenchymal condensation at E14 and is essential in guiding ductal 
branching ((Sakakura et al., 1982),  Fig. 1.5)). At E16.5, the epidermis adjacent to the 
mammary ducts undergoes differentiation to form the nipple sheath. This involves a 
thickening of the epidermis, the suppression of hair follicle development and the 
invagination of a concentric ring of keratinocytes to form the nipple sheath surrounding 
the origin of the primary duct where it connects to the surface (Foley et al., 2001). At 
E18.5, just prior to birth, the MRs exhibit a rudimentary ductal tree structure of 10 to 15 
branches, embedded in the mammary fat pad. In this tree, a primary branch connects to 
the nipple and numerous secondary and tertiary branches emanate from the primary 
branch. This rudimentary duct system forms the scaffold on which further development 
during puberty and pregnancy will eventually produce the mature milk-producing glands 
found during lactation in the adult.  
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In males, under the influence of androgenic hormones, the mammary epithelium 
connecting the ectoderm to the bud constricts at around E14.5 and the mammary 
epithelium regresses with time. However, the regression is not complete as some 
remnant epithelium, particularly the thoracic glands, can still be observed underneath the 
male epidermis at E18.5 (M.Y. Lee, J.M. Veltmaat, unpublished observations). 
Regardless of whether or not some epithelium remains, male mice do not form nipples.  
 
                      
Fig. 1.5. Mammary gland development in the mouse embryo.  
Cartoon showing the development of MRs from E11.5 to E18.5. The mammary placode, 
formed as the result of localized ectodermal thickening, will enlarge and form a bud at 
E12.5 and subsequently a bulb at E13.5. Interactions between the epithelium and 
mesenchyme cause the condensation of mesenchymal cells that orient themselves 
concentrically to the bud. While MRs start to regress in males around this time, in 
females, the bud forms a sprout which will penetrate the underlying fat pad precursor. 
The sprout forms branches prior to the birth of the embryo at E18.5. Ec: ectoderm, dm: 
dermal mesenchyme, mm: mammary mesenchyme, fpp: fat pad precursor, ns: nipple 
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1.7.2 Growth asynchrony 
 
The five pairs of MRs in the mouse do not form at once, but asynchronously. 
Discrepancies exist, however, in the exact order of formation found in different studies 
and are reviewed here:  
Balinsky showed that MRs do not arise simultaneously, and that amongst the MRs, 
MR3 is the first to form (Balinsky, 1950). Based on the pattern dynamics of lymphoid 
enhancer binding factor 1 (Lef1) expression and scanning electron microscopy (SEM), 
Mailleux et al.  showed that MR3 is the first to form, followed by MR4,  MR1 and MR5, 
and finally MR2 (Mailleux et al., 2002). This order of MR appearance concurs with the 
order determined by Wnt10b expression (Veltmaat et al., 2004).  
The temporal expression patterns of T-box transcription factor Tbx3, dual specificity 
phosphatase 6 (Dusp6 or Pyst1) and Lef1 suggest that the order of MR initiation is MR3, 
MR4, MR1, MR2 and MR5 (Eblaghie et al., 2004). The same order of MR formation is 
observed by monitoring the temporal expression of neuregulin 3 (Nrg3) within the MRs 
(Howard et al., 2005).  
By histological analysis, I have determined that MR3 is the first to emerge, followed 
by MR4, MR1, MR5, and lastly MR2. In some cases, MR4 seem to emerge after MR1, 
which may be caused by the flat morphology of MR4, obscuring its appearance. The 
same is true for the order of MR1 and MR5, the latter is very flat initially while the former 
has a bud shape (Chapter 2).  
Thus, gene expression data from several studies points to MR3, MR4, MR1 as the 
order of induction of the first three rudiments, with discrepancies over the timing of 
induction of MR2 and MR5. However, more weight should be given to evidence from 
histological and SEM analyses, which detect the structure of the MR. Therefore, in this 
thesis,  MR induction is in the order of MR3, MR4, MR1, MR5, and lastly MR2.  
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The order in which the MRs emerge is intriguing as it appears to be random, as 
compared to it being organised along the antero-posterior axis, which would suggest a 
MR1, MR2, MR3, MR4, MR5 (or vice-versa) order, or along the dorso-ventral axis, which 
would suggest a MR3, MR2 and MR4, and MR1 and MR5 (or vice-versa) order. 
 
 
1.7.3 Mechanisms of development of the embryonic mammary glands 
 
1.7.3.1 Cellular mechanisms 
 
Numerous hypotheses have been put forward with regards to the cellular 
mechanisms that regulate MR growth. It was suggested that the MRs may have 
developed as a result of a local elevation of cell proliferation (Raynaud, 1961). Balinsky 
compared the proliferative activity between cells of the mammary epithelium and the 
surrounding ectoderm in both mouse (Balinsky, 1950) and rabbit  embryos (Balinsky, 
1949-1950). He identified mitotic cells by their lack of nuclear membrane and observed 
significantly fewer numbers of such cells in the MRs than in the surrounding ectoderm in 
a pool of E11 to E14 mouse embryos (Balinsky, 1950). Similarly the mitotic activity in 
MR1 of E13 rabbit embryos, and MR4 and MR5 of E14 rabbit embryos was lower 
compared to the adjacent regions of the mammary line (Balinsky, 1949-1950) . 
Propper observed loosely-associated, amoeboid-like cells along the elevated 
mammary ridge in the rabbit, which led him to also hypothesize that these cells may 
migrate along the line to form the mammary placodes (Propper, 1978). Furthermore, 
charcoal particles placed on top of the mammary ridge were incorporated into the MR as 
the rudiments were being formed, showing that MR-cells are derived from the mammary 
ridge (Propper, 1973). 
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The idea of cell migration as the mechanism of MR formation is also suggested by 
results from DiI-labeling of flank cells of E10 mouse embryos in culture (Cho et al., 
2006). However, there are caveats and limitations to the interpretation of the findings 
using this approach: it is important to note that this experiment was performed at a time-
point prior to the formation of the ML, as opposed to Propper‘s experiment described 
previously. At 72 hours post-labeling, the labeled cell domain posterior to the forelimb 
bud showed an expansion in the ventral and posterior directions, suggesting a 
dorso-ventral direction of migration of cells, leading to the formation of the ML. However, 
these data are suggestive of cell migration at best as intermediate time points are not 
documented. Moreover, the growth distortion of embryonic flanks caused by prolonged 
culture periods may lead to the same observation, without the involvement of cell 
migration. Furthermore, it is unclear to what extent ectodermal cell proliferation plays a 
role in the expansion of the labeled domain towards the ventral and posterior direction 
given that many cells were labeled simultaneously and the labelled cells were observed 
after a long time post-labeling. Lastly, as there was only one site of injection, it remains 
unclear whether cell migration contributes to the formation of all the MRs, or is exclusive 
to a subset of MRs. The latter is of significant consideration as from studies of various 
murine genetic models (see section 1.7.3.3 ―Molecular mechanisms‖ below), each MR 
pair is uniquely induced by different genes, which may translate into unique cellular 
mechanisms of induction and growth.  
It has been proposed that cell migration, mediated by somitic gradients of fibroblast 
growth factor 10 (FGF10) may be a mechanism of MR3 formation (Veltmaat et al., 
2006). As the thoracic somites elongate in the dorso-ventral direction from E10 to E11.5, 
ectodermal cells may, by chemoattraction, migrate along to form MR3. This 
chemoattraction is postulated to be mediated by delaminated somitic cells that transport 
FGF10 across the mesenchyme to the overlying ectoderm which expresses FGFR2B, 
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the main receptor for FGF10. Cell migration could optionally be mediated by FGF10 
which diffuses from the somites to the ectoderm (Veltmaat et al., 2006).  
In summary, while many hypotheses have been proposed, the cellular mechanisms 
that are involved in the induction and growth of the murine MRs remain largely unclear.  
 
 
1.7.3.2 Epithelial-mesenchymal interactions 
 
The mesenchyme is instructive for the development of the MRs from the overlying 
ectoderm. Classical experiments using heterotypic recombination of tissues from various 
organs have shown that mesenchymal factors largely govern the morphology of glands, 
while biosynthetic functions are determined by the epithelial tissue of origin. Thus, 
isografts of heterotypic recombinants of embryonic mammary epithelium and salivary 
mesenchyme acquire a salivary gland morphology (Kratochwil, 1969; Sakakura et al., 
1976). However, the epithelial cells will differentiate into functional mammary epithelial 
cells which responds to hormonal stimulation and produces milk proteins (Sakakura et 
al., 1976).   
Epithelial-mesenchymal interactions that begin in the embryonic mammary gland 
continue into adulthood. Indeed, these interactions are responsible for rapid epithelial 
growth and the distinctive pattern of ductal branching morphogenesis characteristic of 
the mammary gland (Sakakura et al., 1976). 
The tissues regulating functional differentiation started to be unraveled from the late 
1960s onwards. However, molecules orchestrating induction and morphogenesis, 
especially in the murine embryo were not determined until the1970s, starting with the 
identification of the androgen receptor (Kratochwil and Schwartz, 1976), and later the 
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parathyroid hormone-related protein (PTHrP) (Wysolmerski et al., 1998; Dunbar et al., 
1999; Foley et al., 2001) and FGF proteins (Mailleux et al., 2002).  
 
 
1.7.3.3 Molecular mechanisms 
 
 
Various mouse genetic models have revealed the molecular players and 
mechanisms that govern MR induction and morphogenesis. These functionally important 
molecular factors will be reviewed according to their signalling pathways or gene families 
as they pertain to mammogenesis (summarized in Fig. 1.6). 
 
 
Androgen receptor (AR) 
 
AR is expressed in the mammary mesenchyme from E12.5, first in MR3 and in other 
MRs as they develop (M.Y. Lee, J.M. Veltmaat, unpublished observations and Chapter 
5). In male embryos at E13.5, AR binds to circulating testosterone and mediates 
mesenchymal condensation around the mammary epithelium, thus halting further 
mammary gland development. The preceding conclusion was drawn from observations 
in male testicular feminization (Tfm) embyos in which the lack of functional AR 
expression in the mammary mesenchyme results in non-responsiveness to circulating 
testosterone, the lack of AR ultimately results in the lack of mesenchymal condensation 
and the development of the mammary glands following the female morphogenetic 
programme (Kratochwil and Schwartz, 1976).  
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Bone morphogenetic protein (BMP) signalling 
 
BMPs constitute a large family of secreted growth factors that are involved in many 
aspects of development ((reviewed in (Chen et al., 2004)). Binding of BMPs to their 
cognate receptors induces phosphorylation of members of the receptor-regulated 
mothers against decapentaplegic homolog (SMAD) family. Bmp2 is expressed in the 
mammary epithelium at E13.5 (Phippard et al., 1996). As Bmp2 homozygous-null 
mutants die before the onset of mammogenesis, the function of Bmp2 in mammogenesis 
remains undetermined. From E11.5 to E14.5 Bmp4 is expressed in the mesenchyme, 
and to a lesser extent in the mammary epithelium (Phippard et al., 1996; Hens et al., 
2007). Bmp4 is involved in the positioning of the mammary line along the dorso-ventral 
axis at E11.5 (Cho et al., 2006), and ductal outgrowth (Hens et al., 2007).  
 
 
Ectodysplasin (EDA) signalling  
 
EDA is a member of the tumour necrosis factor (TNF) ligand superfamily, and 
functions with its receptor, EDAR, in a variety of ectodermal appendages. Edar is 
expressed within the MRs at E12 (Pispa et al., 2003). However, Eda expression is 
undetermined. While Eda-/- (Tabby) mutants have normal numbers of mammary glands 
(Mustonen et al, 2003), overexpression of the Eda isoform, Eda-A1 under the keratin 
(Krt) 14 promoter promotes supernumerary MR formation between MR3 and MR4 
(Mustonen et al., 2004). These supernumerary MRs eventually develop into mature 
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Fibroblast growth factor (FGF) signalling 
 
The fibroblast growth factor (FGF) family comprises at least 22 members that are 
involved in various aspects of vertebrate development (reviewed in (Pownall and Isaacs, 
2010)). In particular, FGF10 and its main receptor, FGFR2B (FGF2IIIB) are involved in 
epithelial-mesenchymal interactions. Fgf10 expression is found in the ventral part of the 
thoracic somites at E10.5 (Mailleux et al., 2002; Veltmaat et al., 2006). At E11 to E12, 
Fgfr2b is expressed in the mammary epithelium (Spencer-Dene et al., 2001; Mailleux et 
al., 2002). These complementary expression domains strongly suggest a role for this 
ligand-receptor couple in embryonic mammary gland development.  
Fgf10-/- embryos fail to induce all MRs with the exception of MR4 (Mailleux et al., 
2002; Veltmaat et al., 2006). At E18.5, MR4 of Fgf10-/- embryos consists only of a sprout 
connected to the nipple, showing the requirement of Fgf10 for branching 
morphogenesis. Tissue recombination experiments reveal that mesenchymal Fgf10 is 
required for proper branching morphogenesis of MR4 (Mailleux et al., 2002). Fgf10mlcv/- 
(Fgf10 hypomorph) embryos fail to induce MR3, showing that high levels of FGF10 are 
required for the induction of MR3 (Veltmaat et al., 2006). Similar to the phenotype of 
Fgf10-/- embryos, Fgfr2b-/- embryos fail to induce all MRs except MR4 (Veltmaat et al., 
2006). Moreover, in Fgfr2b-/- embryos, MR4 develops only transiently, and regresses by 
E13 due to the apoptosis of the mammary epithelial cells (Mailleux et al., 2002).    
The expression of other known ligands of FGFR2B, namely Fgf1, Fgf3, and Fgf7 
have also been assessed in the MRs. While Fgf1 and Fgf3 are not expressed, Fgf7 is 
expressed at E12.5 in the mesenchyme, prior to the formation of the mammary 
mesenchyme. Thus, FGF7 may act redundantly with FGF10 to activate FGFR2B, 
required which is for the maintenance of MR4. By E15.5, Fgf7 expression decreases and 
extends into the adjacent fat pad precursor (Mailleux et al., 2002).  





GATA3 is a zinc finger transcription factor. GATA family members bind to a 
consensus DNA sequence (A/T)GATA(A/G) in the promoters of genes, from which they 
derive their name, to directly activate or repress the expression of target genes 
((reviewed in (Chou et al., 2009)). GATA3 is expressed in the MR and ectoderm at 
E12.5 (Asselin-Labat et al., 2007). Conditional deletion of Gata3 in the ectoderm and 
MRs under the Krt14 promoter resulted in the loss of placodes and hypoplasia in a 




Homeobox transcription factors 
 
Homeotic (Hox) genes encode the prototypic homeobox transcription factors that are 
master regulators for developmental programs - switches that initiate unique 
developmental cascades (reviewed in (Carroll, 1995)). The role of Hox genes in 
specifiying regional differences along the antero-posterior body axis is reflected in their 
sequential, partly overlapping expression domains along that axis. These expression 
patterns also correspond to the relative positions of the Hox genes on the chromosome 
(reviewed in (Morgan, 1997)).  
Several homeobox factors have been implicated in embryonic mammary gland 
development: Hoxc6-/- mouse embryos form hypoplastic thoracic MRs at E12.5, while 
inguinal MRs develop normally (Garcia-Gasca and Spyropoulos, 2000). The observed 
phenotype is consistent with the expression of Hoxc6 normally in the anterior thoracic 
somites underlying the thoracic MRs, and the absence of Hoxc6 expression in the more 
posterior somites underlying the inguinal MRs. Hoxb9 and Hoxd9 are expressed in the 
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mammary mesenchyme at E12.5 (Chen and Capecchi, 1999), although no functional 
roles have been attributed to these genes in embryonic mammary gland development. 
However, the ectopic expression of Hox genes, associated with the development of 
structures out of place and time has been proposed to be a cause of supernumerary 
mammary gland formation (Schmidt, 1998). 
The Msx genes belong to a small family of homeobox-containing transcription factors 
related to the Drosophila muscle segment homeobox gene, msh (reviewed in (Davidson, 
1995)). Msx1 and Msx2 are expressed in the MRs at E13.5 (Phippard et al., 1996). 
While Msx1-/- mutants do not exhibit any abnormal MR phenotype (Phippard et al., 
1996), Msx1-/-;Msx2-/- mutants display a hypoplastic, protruded MR4 coinciding with 
defective mammary mesenchyme formation at E15.5 (Satokata et al., 2000). 
Furthermore, the phenotype of Msx1-/-;Msx2-/- MR4 is associated with the loss of 
mammary epithelial and mesenchymal Lef1 expression. As Lef-/- MRs show a similar 
protruding morphology, this suggests that Msx1, Msx2 and Lef1 may act in the same 
genetic hierarchy to mediate invagination.  
The paired-box homeobox gene 3 (Pax3) is expressed in the somites at E11.5 
(Veltmaat et al., 2006). Pax3ILZ/ILZ (null) mouse embryos, which do not form hypaxial 
buds of the somites, show delayed induction of MR3 (Veltmaat et al., 2006). This 
strongly suggests the involvement of the somites in the induction of MR3 (Veltmaat et 
al., 2006).  
 
 
Neuregulin 3 (NRG3) 
 
NRG3 is a ligand for the receptor tyrosine kinase erythroblastic leukemia viral 
oncogene homolog 4 (ERBB4) (Zhang et al., 1997). Nrg3 is expressed in the dermal 
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mesenchyme adjacent to the sites where the mammary placodes will form as well as at 
the presumptive mammary region at E11 (Howard et al., 2005). Nrg3 expression is 
maintained in the epithelium as the MRs form. This expression of Nrg3 prior to the 
morphological appearance of the MRs suggests that Nrg3 is involved in early induction 
events. Similar to the expression of Nrg3, at E11.5, Erbb4 is expressed in the dermal 
mesenchyme underlying the area where MR3 and MR4 will form. Subsequently, at 
E12.5 and E13, Erbb4 expression can be detected in the mammary epithelium and 
ectoderm (Howard et al., 2005).  
Mice harbouring the scaramanga (ska) mutation, a hypomorphic allele of Nrg3 
(Nrg3Ska), often fail to form MR3, and ectopic MRs are often observed adjacent to the 
site of MR4. Moreover, recombinant NRG3 induces ectopic MRs along the mammary 
line (Howard et al., 2005). Consistent with this, Nrg3 overexpression using the ectoderm- 
and MR-specific Krt14 promoter induces extra placodes along the mammary line 
(Panchal et al., 2007).  
 
 
P190b RhoGTPase activating protein (P190B RHOGAP), insulin receptor substrate 
(IRS), and insulin-like growth factor 1 receptor (IGF-1R) signalling 
 
P190B is a member of the RhoGAP family, which function as negative regulators of 
Rho activity (Burbelo et al., 1995). At E12.5, p190B transcripts are detected throughout 
the mammary epithelial bud. At E14.5, expression of p190B is present in the epithelium 
and at a lower level in the surrounding mesenchyme of wild type embryonic mammary 
buds (Heckman et al., 2007) .  
P190b-/- embryos have small mammary buds with disorganized mammary 
mesenchyme that fails to express androgen receptor (Heckman et al., 2007). Earlier 
work showed that the P190B RHOGAP pathway intersects with IGF1 signalling for 
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ductal morphogenesis during postnatal mammary gland development (Chakravarty et 
al., 2003), Heckman et al. further examined this cross-talk, and identified a function for 
IRS1, IRS2, and IGF1R in embryonic mammary development. IRS1 and IRS2 are 
expressed in the mammary epithelium and mesenchyme.  Irs1-/-;Irs2-/- embryos 
phenocopy p190b-/- embryos in their smaller MR size and the lack of mammary 
mesenchyme differentiation (Heckman et al., 2007). Moreover, Igf1r-/- embryos also 
show smaller MRs at E14.5. This indicates that cross-talk between the P190B RHOGAP 
and IGF signalling pathways is required to specify MR size and maturation of the 





The p63 gene, a homologue of the tumour suppressor p53, is highly expressed in the 
basal or progenitor layers of many epithelial tissues. Deletion of p63 resulted in the 
failure of induction of all MRs and all other ectodermal appendages (Mills et al., 1999; 
Yang et al., 1999).  
 
 
Parathyroid hormone-related protein (PTHrP) signalling 
 
The Pthrp gene is expressed by mammary epithelial cells from the placodal stage 
through birth, whereas its type I receptor Pth/Pthrp (Pthr1) is expressed broadly in the 
mammary and dermal mesenchyme (Wysolmerski et al., 1998). The complementary 
expression pattern of PTHrP and its receptor, in the epithelium and the mesenchyme, 
respectively, suggests a key role of these molecules in mediating epithelial-
mesenchymal interactions. Indeed, disruption of either gene results in a similar 
Chapter 1: Introduction 
30 
 
phenotype, the formation of relatively normal appearing mammary buds, but a failure of 
nipple formation and further development (Wysolmerski et al., 1998)  
In addition, Pthrp is necessary for the full differentiation of the mammary 
mesenchyme; in its absence, mesenchymal cells condense around the epithelial bud, 
but do not express markers typical of the dense mammary mesenchyme such as AR 
and tenascin C (Wysolmerski et al. 1998; Dunbar et al. 1999). The absence of AR 
expression explains why the MRs of Pthrp-/- and Pthr1-/- male embryos are resistant to 
androgen-mediated destruction (Dunbar et al., 1999). On the other hand, overexpression 
of Pthrp under the Krt14 promoter results in inappropriate mammary mesenchyme 
differentiation and ectopic nipple formation in the ventral epidermis (Foley et al., 2001).  
In addition, Pthrp upregulates Bmpr1a expression in the mammary mesenchyme to 
enable BMP4 responses in the mesenchyme. The rescue of the lack of ductal outgrowth 
by BMP4 in Pthrp-/- MRs shows that BMP signalling in the mesenchyme is critical for the 
further development of the MRs after the bud stage (Hens et al., 2007). This 
development may also implicate Msx2 in the mesenchyme, as its expression levels are 
dependent on Pthrp (Hens et al, 2007).  
 
 
T-box transcription factors 
 
The T-box family of transcription factors (TBX) are characterized by a highly 
conserved T-box DNA binding domain and can function as transcriptional activators or 
repressors (reviewed in (Wilson and Conlon, 2002)). Tbx2 is expressed in the mammary 
mesenchyme at E11.5 while Tbx3 is expressed in the mammary epithelium between 
E11.5 and E12.5 (Chapman et al., 1996; Eblaghie et al., 2004). Tbx3+/- mice form 
mammary placodes but some thoracic buds are not maintained. Moreover, nipple 
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formation and ductal branching are impaired at E18.5 (Jerome-Majewska et al., 2005). 
Tbx3-/- embryos have a more severe phenotype, failing to develop most MRs all together 
(Davenport et al., 2003). Tbx2+/-;Tbx3+/- embryos show fewer nipple and ductal tree 
formation at E18.5 (Jerome-Majewska et al., 2005). Restriction of Tbx3 expression to the 
dorsal domain by ventrally expressed Bmp4 determines the dorso-ventral boundary, and 





Activation of WNT signalling (see also section 1.9 ―WNT signalling‖ below) is 
associated with various aspects of mammary gland development both in the embryonic 
and postnatal stages (reviewed in (Brennan and Brown, 2004)). By screening a variety 
of WNT signalling members, it was demonstrated that many members of the pathway 
are expressed in the MRs (Chu et al., 2004; Veltmaat et al., 2004). Strikingly, inhibition 
of the pathway by the over-expression of the WNT inhibitor dickkopf 1 (Dkk1) resulted in 
the absence of all MRs, showing the absolute requirement of this pathway for MR 
induction (Chu et al., 2004).  
Deletion of various pathway members leads to overt MR phenotype in the embryo. 
Deletion of the WNT co-receptors, low density lipoprotein receptor-related protein 5 and 
6 (Lrp5 and Lrp6) leads to the formation of hypoplastic MRs (Lindvall et al., 2006; 
Lindvall et al., 2009). LEF1 is a co-activator of the canonical WNT signalling pathway 
and associates with β-catenin to mediate gene transcription. At E10.5, Lef1 is expressed 
as a broad domain on the flank (Cho et al., 2006) and later within the ectoderm and 
developing MRs (Foley et al., 2001; Mailleux et al., 2002; Veltmaat et al., 2003). By 
E13.5 to E14, LEF1 expression expands to the mammary mesenchyme ((Foley et al., 
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2001) Chapter 5). All MRs in Lef1-/- embryos regress before E15.5; MR2 and MR3 being 
the first to regress after induction ((Kratochwil K., personal communication; (van 
Genderen et al., 1994; Boras-Granic et al., 2006)). 
Another more recently identified WNT pathway member that participates in the 
transcription of canonical WNT signalling target genes is the pygopus (PYGO) family of 
proteins. PYGO proteins contain a highly conserved C-terminal plant homeodomain 
(PHD) often found in chromatin regulatory factors (Belenkaya et al., 2002; Thompson et 
al., 2002). Thus, it has been proposed that the transcriptional control mediated by 
PYGO2 is primarily via chromatin remodelling. Indeed, PYGO2 can associate with 
histone acetyltransferase (HAT) to promote lysine (K) 9/14 hyperacetylation of histone 
H3 thereby compacting the DNA and inhibiting gene transcription in male germ cells 
(Nair et al., 2008). Moreover, in mammary progenitor cells, PYGO2 promotes gene 
activation by facilitating K4 trimethylation of histone H3, both globally and at 
WNT/β-catenin target loci, via the recruitment of histone H3 K4 methyltransferase 
complexes leading to cell expansion (Gu et al., 2009). Also, PYGO, together with B-cell 
lymphoma 9/legless (BCL9/LGL) has been shown to target β-catenin to the nucleus and 
promote the transcriptional co-activator function of β-catenin, thereby facilitating Wnt-
target gene transcription (Townsley et al., 2004).  PYGO2 is expressed in the embryonic 
MRs and also the basal ectodermal cells at E12.5 and E13.5 (Chapter 3). By E15.5, 
expression of PYGO2 is found within the mammary epithelium and mesenchyme (Gu et 
al., 2009). Loss of Pygo2 leads to a variety of MR phenotypes ranging from failure of 
induction, arrest at bud or sprout stages, or reduced or absent ductal branching (Gu et 
al., 2009).  
Conversely, activation of the WNT signalling pathway, done by culturing embryos in 
the presence of the WNT ligand, WNT3A, or the GSK3β inhibitor, lithium chloride (LiCl) 
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results in the formation of larger MRs (Chu et al., 2004). In summary, the activation of 
WNT signalling is crucial in the induction and growth of the MRs.  
 
 
GLI-Kruppel family member 3 (GLI3) 
 
The GLI-Kruppel family member 3 (GLI3) is a transcription factor most commonly 
associated with the Hedgehog (HH) signalling pathway. During embryonic mammary 
gland development, Gli3 is expressed in the somites at E11.5, and the expression 
domain shifts to the mammary epithelium and ectoderm at E12.5 (Chapter 2, 5). GLI3 is 
required to transcriptionally repress HH target genes (Hatsell and Cowin, 2006) for the 
induction of MR3 and MR5.  
Thus, the loss of Gli3 results in the failure of MR3 and MR5 induction (Veltmaat et al, 
2006; Hatsell and Cowin, 2006). The failure of MR3 induction occurs due to the 
downregulation of Fgf10 expression in response to an absence of Gli3 expression within 
the thoracic somites (Veltmaat et al., 2006). The loss of Gli3 also results in impaired 
mammary line formation, and a smaller domain of the expression of the LEF/TCF-
mediated transcription reporter, TOPGAL, along the flank. The smaller domain of 
TOPGAL expression strongly suggests that canonical WNT signalling activity is 
downregulated along the mammary line in Gli3-deficient embryos (Veltmaat et al., 2006).  




Fig. 1.6. Molecular mechanisms in embryonic mammary gland development.  
(Continued on next page) 
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(A) Expression profiles of molecules, molecular interactions and signalling pathways 
involved in mammary line specification and MR3 induction. Cartoon showing a 
transversal cross-section of the mammary placode at E11.5. Signals originating from the 
mesenchyme (for example, FGF10) instruct the ectoderm to differentiate and adopt a 
mammary epithelial fate. The definition of the mammary line involves ventrally-
expressed Bmp4 which restricts dorsal Tbx3 expression to establish a dorso-ventral 
boundary. Refer to text for more information. (B) Expression profiles of molecular 
regulators, molecular interactions and signalling pathways in the bud stage of MR 
development. Cartoon showing a transversal section of a MR at approximately E12 to 
E13.5. Interactions depicted here represent data obtained from all MR pairs. Ligand-
receptor interactions are depicted by green arrows while transcriptional interactions and 
signalling pathway cross-talks are depicted by pink arrows. Inhibitory relationships are 






As discussed previously, the Veltmaat lab and others (Hatsell and Cowin, 2006; 
Veltmaat et al., 2006) have shown that a severe and differential embryonic mammary 
gland phenotype results in the absence of Gli3. This thesis aims to build our 
understanding of the cellular and molecular mechanisms that are mediated by Gli3 in 
embryonic mammary gland development. Thus, Gli3 will be discussed in the following 
sections. 
 
1.8 The transcription factor GLI3 
 
1.8.1 Structure and function of GLI3 
 
GLI3 encodes a protein of 1,596 amino acids and an apparent molecular mass of 
190 kiloDaltons (kDa) (Ruppert et al., 1990). Structurally, it is a sequence-specific DNA-
binding protein containing five zinc fingers (Ruppert et al., 1990). 
GLI3 is mostly known for its role as a transcription factor of the HH signalling 
pathway (Fig. 1.7). As HH signalling activity is normally turned-off during embryonic 
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mammary gland development (Hatsell and Cowin, 2006), and null-mutants of HH ligands 
do not present with abnormal embryonic mammary gland phenotypes (Gallego et al., 
2002; Michno et al., 2003), I will only discuss key steps in the pathway as follows:  
In the Drosophila, HH signalling is mediated by the transcription factor, cubitus 
interruptus (CI), while in vertebrates, HH signalling is mediated by the zinc-finger 
transcription factors, GLI1, GLI2 and GLI3. In the absence of HH, GLI1 is not expressed, 
while CI, GLI2 and GLI3 are expressed and are proteolytically cleaved to produce 
N-terminal gene repressor forms (Fig. 1.7, 8, reviewed in (Ruiz i Altaba et al., 2007; 
Jiang and Hui, 2008)).  
The molecular mechanisms of CI and GLI processing implicate the same set of 
kinases, including protein kinase A (PKA), casein kinase 1 (CK1), and glycogen 
synthase kinase  3β (GSK3β) (Fig. 1.8). These kinases form a complex and 
phosphorylate GLI in a sequential manner. In Drosophila, costal 2 (COS2) forms a 
scaffold for kinases to mediate CI phosphorylation. PKA phosphorylations prime 
subsequent GSK3β and CK1 phosphorylations. Phosphorylation targets GLI2 and GLI3 
for ubiquitination and limited processing by the proteasome into an N-terminal repressor 
fragment. The transcriptional repressor function of GLI3 is mediated by the N-terminal 
portion of the protein and the minimal repressor has been mapped to residues 106 to 
236 (Tsanev et al., 2009). Interestingly, this repressor domain does not utilize histone 
deacetylases (HDACs) to achieve repression (Tsanev et al., 2009), despite the presence 
of a putative ski sarcoma viral oncogene homolog (ski) binding site on GLI3. SKI can 
recruit HDACs to mediate transcriptional repression (Fig. 1.9). A repressor form of GLI1 
cannot be generated.   
HH pathway activity is triggered by the binding of a dually lipidated HH ligand, 
secreted by the HH producing cell, to patched (PTCH), a 12-span transmembrane 
transporter-like protein located at the cilium. Upon HH binding, the suppression of PTCH 
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on the 7-span transmembrane protein smoothened (SMO) is lifted (reviewed in (Wang et 
al., 2007), Fig. 1.7). Subsequently, the inhibition of SMO on the suppressor of fused 
(SUFU) is released. This is followed by the inhibition of phosphorylation and proteolytic 
processing of CI or GLI proteins. The inhibition of proteolysis results in the accumulation 
of full-length transcription factors that function as transcriptional activators, which leads 





Fig. 1.7. Simplified model of the vertebrate Hedgehog signalling pathway.  
(Continued on next page) 
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Hedgehog (HH) proteins are synthesized as 45 kDa precursor proteins that are 
palmitoylated (blue jagged line) at the N-terminus by skinny hedgehog (SKN), and 
concomitantly auto-catalytically cleaved and cholesterol-modified at the C-terminus to 
yield a 19 kDa, dually lipidated, N-terminal signalling protein (black C: cholesterol). HH 
proteins are then trafficked to the cell surface and released from cells as lipoprotein 
associated oligomers in a process mediated by the 12-transmembrane-pass protein 
dispatched (DISP). These HH oligomers travel from HH-producing cells to HH-
responding cells via interactions with glypicans. The cilium is the signalling center for HH 
signalling. In the HH-recipient cell (right), PTCH1 inhibits SMO activity in the absence of 
HH ligand, or activates SMO in the presence of HH ligand.  HH interacts with a complex 
of PTCH1 and CDO/BOC, resulting in derepression of SMO and activation of the HH 
signalling cascade. HH ligands also interact with HIP1, PTCH2 and GAS1 to regulate the 
range and level of HH signalling. Derepression of SMO activates downstream pathways 
such as the release of SUFU inhibition, accumulation of Gli activators (GLIA) and 
reduced production of GLI repressors (GLIR). Gli-dependent transcriptional read-outs 
result in activation of positive targets both directly via GLI binding, and indirectly, 
possibly via transcriptional regulation of other factors. Importantly, SMO, GLI activators 
and SUFU all localize to the tips of cilia. SUFU plays an essential role as a negative 
regulator between SMO and GLI. In vertebrates, FU homolog is not required for HH 
signalling, and the involvement of COS2 homologs, is uncertain. Refer also to text. 
Modified from (Wang et al., 2007; Jiang and Hui, 2008), with permission from Elsevier.  
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Fig. 1.8. Proteolytic CI/GLI processing and degradation.  
In the absence of HH signalling, CI and GLI proteins are phosphorylated initially by PKA 
and subsequently by GSK3β and CK1. Hyperphosphorylation of Drosophila CI confers 
binding to the F-box protein Slimb, while hyperphosphorylated GLI proteins bind the 
vertebrate homolog of Slimb, β-TrCP. Subsequently CI or GLI proteins are 
polyubiquitinated and recruited to the proteasome (Note: while this model shows 
ubiquitination at the C-terminus, the exact sites of CI/GLI ubiquitination are not known. 
The number and sites of phosphorylated residues are also not known) In the 
proteasome, CI and GLI3 are mainly converted into repressors, while nearly all GLI2 
undergo complete degradation. A minor portion of GLI2, however, does appear to be 
converted into a repressor. Gli1 is not transcribed in the absence of HH, and a repressor 
form of GLI1 cannot be generated Modified from (Wang et al., 2007) with permission 
from Elsevier.  




Fig. 1.9. Schematic alignment of GLI1, GLI2 and GLI3 in the N-terminal half. 
The suggested repressor domain (Rep) is only found in GLI2 and GLI3. The sequences 
for the Sufu binding site and DegronN  is found in all three GLI proteins.  Degron N is a 
specific sequence of amino acids in a protein that directs the starting place of 
degradation positioned in the N-terminal region (Huang et al., 1998). The black line 
above GLI3 indicates the presumed SKI binding region. Both SKI and SUFU are not 
likely to recruit HDACs and induce transcriptional termination by this mechanism. 
Modified from (Tsanev et al., 2009), with permission from Elsevier. 
 
 
1.8.2 Gli3 in disease 
 
In humans, mutations in GLI3 lead to several syndromes including Greig's 
cephalopolysyndactyly (GCPS) (Greig, 1926), Pallister-Hall syndrome (PHS) (Hall et al., 
1980), postaxial polysyndactyly type A (PAP-A) and preaxial polydactyly type-IV 
(PPD-IV) (reviewed in (Biesecker, 1997; Naruse et al., 2010)). GCPS, PHS, PAP-A and 
PPD-IV are autosomal dominant syndromes characterized by polydactyly of hands and 
feet. In addition, GCPS patients are also characterized by craniofacial defects.  
The different syndromes are associated with the different types of mutations in the 
various functional domains of the GLI3 gene (reviewed in (Naruse et al., 2010)). For 
example, GCPS is caused by deletions and/or mutations in the 5‘ open reading frame, 
which includes the zinc finger DNA-binding domain. By contrast, most of the mutations 
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responsible for PHS occur on the protease cleavage site and also in the open reading 
frame encompassing the transactivation domain (TA) and CREB-binding protein (CBP) 
binding site. Furthermore, PAP-A is known to be induced by the mutation in the post-zinc 
finger region, but before the TA/CBP binding site. Lastly, PPD-IV is caused by mutations 
further downstream of the zinc finger region, such as in region of the TA2 domain 
(reviewed in (Naruse et al., 2010)). Collectively, the above syndromes show that a large 
area spanning the GLI3 gene, and in particular, its zinc finger domain, and the protease 
cleavage site which is essential for the processing of GLI3A to GLI3R, are critical for 
proper GLI3 function.  
 
 
1.8.3 The Gli3Xt-J/Xt-J model  
 
We use the mouse Gli3Xt-J/Xt-J (Xt: extra-toes) model to study the role of Gli3 in the 
embryonic mammary glands. The Xt-J deletion maps to a region of 51.5 kilo base pairs  
(kbp), starting from the first zinc finger motif in the Gli3 gene located in chromosome 13 
(Maynard et al., 2002). No other genes are known to be within this 51.5 kbp region. The 
deletion results in a non-functional fusion transcript of Gli3 that lacks the sequence 
encoding for the zinc finger motifs which are DNA-binding elements required for its 
normal activity (Buscher et al., 1998). Mutations at the murine Xt locus have arisen 
spontaneously several times, and the Xt-J allele which was originally identified at the 
Jackson Laboratory (Sweet, 1993), is one of the most widely studied allelic variants.  
In addition to the embryonic mammary gland defects described earlier (see section 
1.7.3.3 ―Molecular mechanisms‖), Gli3Xt-J/Xt-J embryos have severe developmental 
anomalies including polydactyly, craniofacial malformations, brain anomalies including 
an absence of the olfactory bulb, and defects in the lungs ((Franz, 1994; Grindley et al., 
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1997; LaMantia, 1999), Fig. 1.10). The severity of these malformations leads to lethality 
either in utero, or if Gli3Xt-J/Xt-J embryos are born, neonates succumb shortly after birth to 
asphyxia due to abnormal lung development. The involvement of the Gli3 gene, and the 
overlapping phenotypes of the Gli3Xt-J/Xt-J embryos in GCPS patients make the Gli3Xt-J/Xt-J 
a frequently used model for GCPS (Hui and Joyner, 1993). Breast anomalies, 
suggestive of the mammary gland defect in Gli3Xt-J/Xt-J embryos, have not been reported 
in GCPS patients. The lack of a reported breast phenotype could be due to 
heterozygosity of the GLI3 mutation in GPCS patients, as the mammary gland defect is 
only present with homozygous deletion of the gene in mouse embryos.  
The defects observed in Gli3Xt-J/+ mice are less severe; there are milder 




 Fig. 1.10 Gli3Xt-J/Xt-J embryos have severe developmental anomalies.  
(Continued on next page) 
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(A-B) Limb of Gli3Xt-J/+ and Gli3Xt-J/Xt-J embryos at E18.5, showing polydactyly in the 
Gli3Xt-J/Xt-J embryo, from which the name extra-toes is derived. (C-D) View of the heads 
of E12.5 wild type and Gli3Xt-J/Xt-J embryos expressing TOPGAL (blue). The Gli3Xt-J/Xt-J 
embryo has severe craniofacial malformations. Note also the absence of eye pigment in 






The observed downregulation of the transgenic TOPGAL reporter for Wnt signalling 
suggested a reduction of WNT/β-catenin/TCF signaling within the mammary line of 
Gli3Xt-J/Xt-J (null) embryos (Veltmaat et al., 2006). Building on this observation, the 
interaction of Gli3 with the canonical WNT/β-catenin signalling pathway in embryonic 
mammary gland development will be one of the focus points of this thesis. Thus, I will 
discuss WNT signalling in added detail in the subsequent sections.  
 
 
1.9 WNT signalling  
 
The name ‗WNT‘ is derived from a combination of wingless and integration site-1 
(Int1). The Int1 gene was originally identified as an oncogene which, upon insertional 
activation by the mouse mammary tumour virus (MMTV), contributed to the formation of 
mammary carcinomas (Nusse and Varmus, 1982). WNT proteins undergo a series of 
modification events in the WNT producing cell prior to being secreted (reviewed in 
(Hausmann et al., 2007). 
There are 19 known WNTs in mammals, which generally fall into two classes. 
Classical WNTs (WNT1, WNT3A, WNT8 and WNT8B) activate signalling through the 
canonical pathway involving β-catenin. Non-classical WNTs (WNT4, WNT5A and 
WNT11) activate the non-canonical WNT/calcium pathway. Still other WNTs have been 
shown to signal through other downstream signalling pathways.  
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WNT ligands bind to frizzled (FZD) receptors on the cell surface (Yang-Snyder et al., 
1996). Signalling through the FZD receptors requires the function of the LRP5/LRP6 




1.9.1 Canonical WNT/β-catenin pathway 
 
The regulation of cytosolic levels of β-catenin is the essence of the canonical WNT/ 
β-catenin pathway. In the absence of WNT, β-catenin is targeted to a multimeric protein 
complex called destruction complex for its phosphorylation (Fig. 1.11). β-catenin is 
phosphorylated by CK1 at Ser45, followed by Ser33, Ser37, and at Thr41 
phosphorylation by GSK3β. These phosphorylation events are coordinated by the 
scaffolding protein, AXIN, which interacts with GSK3β and CK1 (Kimelman and Xu, 
2006). Upon phosphorylation, β-catenin is targeted for ubiquitination by the E3 ubiquitin 
ligase β-TrCP and subsequently degraded by the proteasome. Protein phosphatases 
also regulate β-catenin stability. Protein phosphatase 2A (PP2A), for example, is 
required for the WNT-dependent elevation of β-catenin levels (Yang et al., 2003) and 
can bind AXIN (Hsu et al. 1999), suggesting that it might function to dephosphorylate 
GSK3β substrates. In the absence of WNT as well, LEF/TCF transcription factors bind to 
WNT response elements, facilitating the recruitment of co-repressors such as Groucho 
and HDACs to the particular genomic region to promote histone deacetylation and 
chromatin compaction (Fig. 1.11). The transcription of WNT-target genes is thus 
inhibited. 
In the presence of WNT however, β-catenin accumulates and is imported into the 
nucleus. Within the nucleus, β-catenin binds to LEF/TCF, thereby replacing 
transcriptional repressors and recruiting additional transcriptional coactivators, in 
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particular members of the switch/sucrose non-fermentable (SWI/SNF) family of 
chromatin remodelling complexes, such as bhrama-related gene 1 (BRG1), and the 
histone acetyltransferases (HATs) such as p300/CREB-binding protein (CBP). These 
complexes are brought to the TCF/β-catenin complex by BCL9/LGL and pygopus 
(PYGO).  As the chromatin becomes less compacted as a result of remodelling, the 







Fig. 1.11. Canonical WNT/β-catenin signalling.  
(Continued on next page) 
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In the absence of WNT, cytoplasmic β-catenin forms a complex with AXIN, APC, GSK3β 
and CK1, and is phosphorylated by CK1 (orange) and subsequently by GSK3 (beige). 
Phosphorylated β-catenin is recognized by the E3 ubiquitin ligase β-TrCP, which targets 
β-catenin for proteasomal degradation. WNT target genes are repressed by TCF-
TLE/Groucho and histone deacetylases (HDAC). In the presence of WNT ligand, a 
receptor complex forms between FZD and LRP5/6. DVL recruitment by FZD leads to 
LRP5/6 phosphorylation, and AXIN recruitment. This disrupts AXIN-mediated 
phosphorylation and degradation of β-catenin, allowing β-catenin to accumulate in the 
nucleus where it serves as a co-activator for TCF to activate WNT target genes. 






1.9.2 Non-canonical WNT/planar cell polarity pathway 
 
In the non-canonical planar cell polarity pathway, the WNT signal is thought to be 
mediated through FZD, independent from the LRP5/6 co-receptor (reviewed in (Komiya 
and Habas, 2008; Rao and Kuhl, 2010)). The signal is then transduced to dishevelled 
(DVL), leading to its activation. The PDZ and DEP domains of DVL are both utilized to 
activate two parallel pathways that, in turn, activate the small GTPases, RHO and RAC. 
For activation of the RHO branch of signaling, WNT signaling induces the activation of a 
Dvl-Dvl associated activator of morphogenesis 1 (DAAM1) complex, which in turn 
activates RhoGTPase. RhoGTPase, in turn, stimulates the activation of Rho-associated 
kinase (ROCK) and myosin, which leads to modification and rearrangement of the actin 
cytoskeleton (Fig 1.12 A). 
The second branch of signaling requires the DEP domain of DVL and activation of 
the RACGTPase. This activation is independent of DAAM1, with activated RAC 
stimulating c-Jun N-terminal kinase (JNK) activity. The defining feature of this pathway is 
its regulation of the actin cytoskeleton for such polarized organization of structures and 
directed migration. These functions are also mediated by several other components of 
the pathway such as vangl/strabismus, the flamingo-related mouse Celsr (CELSR), 
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prickle, or the tyrosine-protein kinase-like 7 (PTK7). Moreover, this pathway appears to 
function independently of transcription. 
In addition to FZD receptors, WNT ligands are also thought to interact with members 
of the receptor-like tyrosine kinase (RYK) and receptor tyrosine kinase-like orphan 
receptor 2 (ROR2) which are single-span transmembrane receptors with an intracellular 
tyrosine kinase domain. Signaling events from these receptors remain poorly 
understood: ROR2 has been placed upstream of small RHO-GTPases and JNK, 
whereas SRC is involved in RYK signaling (reviewed in (Rao and Kuhl, 2010)). 
 
 
1.9.3 Non-canonical WNT/calcium pathway 
 
The WNT/Ca2+ pathway was discovered with the finding that some WNT ligands and 
FZD receptors can stimulate intracellular  Ca2+ release from the endoplasmic reticulum 
and is dependent on G-proteins (reviewed in (Brennan and Brown, 2004; Komiya and 
Habas, 2008; Rao and Kuhl, 2010)).  
WNT signaling through the receptor FZD mediates activation of DVL via activation of 
G-proteins. DVL then activates the phosphodiesterase which inhibits protein kinase G 
(PKG) and in turn inhibits Ca2+ release. DVL, acting through PLC leads to release of 
intracellular Ca2+; this, in turn, activates Ca2+/calmodulin-dependent protein kinase II 
(CAMKII) and calcineurin. Calcineurin stimulates other factors to regulate ventral cell 
fates whereas CAMK11 inhibit β-catenin/TCF function to negatively regulate dorsal axis 
formation. Finally, pathway activation through PKC, activates CDC42 to mediate tissue 
separation and cell movements during gastrulation (Fig. 1.12 B).  




Fig. 1.12. Non-canonical WNT signalling pathways.  
(A) A schematic representation of the Planar Cell Polarity signal transduction cascade. 
WNT signalling is transduced through FZD independent of LRP5/6 leading to the 
activation of DVL. DVL through DAAM1 mediates activation of RHO which in turn 
activates ROCK. DAAM1 also mediates actin polymerization through the actin binding 
protein profilin.  DVL mediates activation of RAC, which in turn activates JNK. The 
signalling from ROCK, JNK and profilin are integrated for cytoskeletal changes for cell 
polarization and motility during gastrulation. (B) Schematic representation of the 
WNT/Ca2+ signal transduction cascade. WNT signalling via FZD mediates activation of 
DVL via activation of G-proteins. DVL activates phosphodiesterase which inhibits PKG 
and in turn inhibits Ca2+ release. Dvl through PLC leads to the release of intracellular 
Ca2+, which in turn activates CAMK11 and calcineurin. Calcineurin activates NF-AT to 
regulate ventral cell fates. CAMK11 acting through other factors, inhibit β-catenin/TCF 
function to negatively regulate dorsal axis formation. Lastly, pathway activation through 
PKC activates CDC42 to mediate tissue separation and cell movements during 
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1.10 Aims of this thesis project 
 
To determine the cellular processes underlying the formation of the embryonic 
MRs. Early studies in the mouse and rabbit embryo have alluded to the lack of 
contribution of cell proliferation in mediating the growth of the epithelial compartment 
(Balinsky, 1949-1950; Balinsky, 1950). While the contribution of cell migration has been 
demonstrated in the rabbit (Propper, 1973), anatomical differences caution the 
extrapolation of this finding to the mouse. After establishing the contribution of the 
various cellular processes to mammary gland induction and early growth, I will then 
evaluate the cell behaviours that are causal to the mammary gland phenotype in 
Gli3Xt-J/Xt-J embryos. 
To determine the role of WNT/β-catenin signalling that underlie the MR defect 
of Gli3Xt-J/Xt-J embryos. My mentor, Dr Veltmaat, has previously reported that Gli3Xt-J/Xt-J 
embryos show a downregulation of canonical WNT signalling (Veltmaat et al., 2006). 
This project will uncover the role of WNT signalling in regulating various aspects of 
mammary gland development such as induction and morphogenesis, downstream of 
Gli3.  
To determine the unique nature of each mammary gland pair in the mouse and 
the implications these findings have on future research.  Unexpectedly, the 
induction and morphogenesis of each mammary gland pair in the embryo are governed 
by a varied repertoire of genes. This project will dissect the unique aspects of each 
mammary gland pair for its mammogenic potential. Understanding the unique 
characteristics of the embryonic mammary glands has a bearing on the choice of 
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The cellular processes governing formation and early growth of the five pairs of 
murine mammary rudiment (MR) pairs within the ectoderm are largely unknown. Here, 
we identified these processes in our aim to understand the non-induction of MR3 and 
MR5 at embryonic day (E) 11.5, and the 20% to 50% smaller size of MR1 respectively 
MR2 and MR4, and outward protrusion of MR2 and MR4 at E13.5 in Gli3Xt-J/Xt-J embryos. 
BrdU-labeling shows a mean 5.5-fold lower proliferation rate within wild type (wt) MRs 
compared to adjacent ectoderm, decreasing from 4.5 2.4% to 3.3 1.5% between E12.5 
and E13.5 despite an increased MR growth rate, and not accounting for MR growth 
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during that day. Seemingly contradictory to their smaller size, Gli3Xt-J/Xt-J MRs display a 
2-fold higher epithelial proliferation rate than their wt counterparts, and an absence of 
apoptosis that occurs at the apex of E12.5 wt MRs. Tracing of cells 24 hours after their 
BrdU-incorporation shows that ectodermal cells from outside the mammary line 
accumulate in all MRs between E11.5 and E13.5. While the influx is normal in Gli3Xt-J/Xt-J 
MR1, it is 2-fold reduced in Gli3Xt-J/Xt-J MR2 and MR4, indicating compromised 
ectodermal influx as a cause for the initial growth defect in these MRs. A failure of cells 
in Gli3Xt-J/Xt-J MR2 and MR4 to undergo hypertrophy between E12.5 and E13.5 
aggravates the growth defect of these MRs. Taken together, each MR pair grows by 
distinct dynamics of cell proliferation, hypertrophic differentiation, apoptosis and 





In mouse embryos, the MRs arise asynchronously between E11 and E12 along a 
histologically and molecularly distinct ‗mammary line‘ (ML) of ectoderm at the ventro-
lateral boundary of each flank (Veltmaat et al., 2004). Initially disk-shaped multilayered 
placodes, they transform via a hillock-shape into large bud-shaped entities within 2 days 
(Veltmaat et al., 2003). Tissue recombination experiments have demonstrated the 
ectodermal origin of MRs (Cunha et al., 1995). However, the cellular mechanisms 
orchestrating the formation of MRs from the ectoderm and their growth remain ill-
understood.  
Balinsky determined the mitotic index as the ratio of cells without nuclear membrane 
among all cells. Pooled E11-E14 murine MRs had a significant 3.5-fold lower mitotic 
index than pooled ectoderm (Balinsky, 1950). Balinsky suggested the MRs do not grow 
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by cell proliferation, but by recruitment of ectodermal cells instead (Balinsky, 1949-
1950), without investigating whether their lower mitotic index might just explain his 
finding of their negatively allometric growth with the embryo. Using E13 rabbit embryos, 
Propper showed that charcoal distributed on, but not adjacent to the ridge-like ML, is 
incorporated into the emerging MRs in the course of 24-48 hours (Propper, 1973). He 
also identified spindle-like, thus supposedly migratory, cells aligned along the length of 
the mammary ridge in fixed specimens (Propper, 1978). He therefore concluded that 
MRs grow by influx of cells, which migrate along the antero-posterior axis of the rabbit‘s 
mammary ridge. This conclusion is on occasion extrapolated to mouse, for example, by 
the comparison of the lacZ reporter for lymphoid enhancer binding factor 1/T-cell factor 
(LEF/TCF)-mediated transcription TOPGAL-expressing cells along the surface of the 
murine ML to Propper‘s apparently motile spindle-like cells (Chu et al., 2004).  
However, such extrapolation may not be justified, because the murine ML is much 
thinner than the rabbit‘s mammary ridge. Moreover, the murine ML becomes 
histologically and molecularly distinct almost simultaneously with the appearance of the 
MRs (Veltmaat et al., 2004) - instead of prior to them as occurs in rabbit (Balinsky, 1949-
1950) - and disappears relatively early compared to developmental stage of the MRs 
(Propper, 1973; Veltmaat et al., 2006). Thus, the murine ML may not be able to provide 
sufficient cells for the MRs. Besides, it is unknown how the mammary line or ridge itself 
is formed. Having demonstrated that hypaxial signals of the thoracic and lumbar somites 
determine the position of the ML along the dorso-ventral axis of the mouse embryo, we 
proposed that these ventrally elongating somites may pull ectodermal cells along and 
accumulate them at the ML, and MR2, MR3, and MR4 (Veltmaat et al., 2006). DiI-
labeled ectoderm posterior to the forelimb bud of a cultured E10 mouse embryonic flank 
expanded in ventro-posterior direction over 72 hours (Cho et al., 2006). However, since 
no time-lapse video-analysis was performed, it is unclear whether this expansion 
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resulted from ectodermal cell migration in antero-posterior and dorso-ventral direction, or 
from cell proliferation and distortion of flanks during such long-term culture.  
Furthermore, Balinsky, Propper, and Cho did not investigate whether the 
mechanisms contributing to MR formation and growth vary per MR, or over time. We 
suggested previously that different molecular requirements for mammary induction may 
exist along the ML (Veltmaat et al., 2003). This suggestion is supported by the regional 
instead of global effects along the ML of at least 10 mutated genes (Davenport et al., 
2003; Mustonen et al., 2004; Howard et al., 2005; Jerome-Majewska et al., 2005; Boras-
Granic et al., 2006; Veltmaat et al., 2006; Asselin-Labat et al., 2007). For example, 
Gli3Xt-J/Xt-J null mutants of the transcription factor GLI3 (Johnson, 1969; Maynard et al., 
2002) fail to induce only MR3 and MR5 (Mailleux et al., 2002; Hatsell and Cowin, 2006; 
Veltmaat et al., 2006). Such different molecular requirements of the individual MRs may 
translate into different cellular mechanisms driving their induction and early growth. The 
mouse embryonic MRs change morphogenetic stage roughly every day (Veltmaat et al., 
2003), and we find growth defects associated with sequential stages in the individual 
Gli3Xt-J/Xt-J MRs. Hence, in this further study of the role of Gli3 in early mammary gland 
development, we considered each MR pair as a separate entity, at discrete days of early 
development. 
To determine the cause of stunted growth of Gli3Xt-J/Xt-J MR1, MR2, and MR4, we 
considered that organs may emerge and grow by cell hypertrophy, proliferation, 
recruitment of cells from adjacent regions, prevention of cell death, or a combination of 
these events. We developed image analysis algorithms to quantify the early growth rates 
and proliferation rate by bromo-deoxyuridine (BrdU)-incorporation, and to generate 3D-
reconstructions of the individual MRs. While facing experimental obstacles to assay cell 
migration via time-lapse video-analysis, our finding of a very low proliferation rate, i.e. 
 4.5% BrdU-incorporation within 2 hours in the growing MRs, enabled us to use 
Chapter 2: Gli3 and cell migration in mammogenesis  
54 
 
incorporated BrdU as a cell tracer 24 hours after labeling. We detected that ectodermal 
cells, recruited mostly if not all from outside the ML, contribute significantly to growth of 
MRs during the first day of MR development. Cell hypertrophy plays a major role in 
growth during the second day. We identified a role for Gli3 in cell proliferation, survival, 
migration, and hypertrophy, and differences therein among the MRs themselves and in 
their adjacent tissues. Such MR-specific molecular regulation of cellular mechanisms 
provides a beginning to the understanding of how mammary epithelium is patterned 
within the ectoderm, and may have to be taken into consideration in studies of postnatal 
mammary gland development and tumourigenesis. 
 
2.3 Materials and Methods 
 
2.3.1 Mice  
 
Gli3Xt-J/+ mice on a C57BL/6J background (Jackson Laboratories, stock 000026) were 
maintained per IACUC guidelines. Gli3Xt-J/Xt-J embryos from timed Gli3Xt-J/+ intercrosses, 
with noon of the day of vaginal plug appearance considered as E0.5, were genotyped as 




2.3.2 Section in situ hybridization 
 
4% PFA-fixed embryos were paraffin embedded (=PFPE) and transversally 
sectioned at 8 μm thickness for in situ hybridization with a 35S-labeled Gli3 antisense 
probe as described (Spencer-Dene et al., 2006).  
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2.3.3 Micro-array analysis  
 
Embryos were harvested in RNAlater (Ambion). Ectoderm and mammary epithelium 
were separated from the mesenchyme by microsurgical techniques (Sun et al., 
submitted). Minimal tissue cross-contamination was confirmed by analysis of tissue-
specific transcripts. We generated five E12.5 and two E13.5 independent pools of the 
five mammary rudiment (MR) pairs, ectoderm and mesenchyme respectively of at least 
five embryos. Per pool, 10 ng of high-quality RNA, extracted with the RNeasy Micro Plus 
Kit (Qiagen), was amplified with WT-Ovation™ Pico System to produce labeled cDNA 
(NuGene Technologies, Inc.) for hybridization to Affymetrix Mouse Gene 1.0 ST micro-
array chips. Data were analyzed with Partek Genomics Suite.  
 
 
2.3.4 Immunohistochemical detection of BrdU incorporation 
 
Day 11.5 to 13.5 pregnant mice were injected intraperitoneally with 1 ml/100 g 
bodyweight BrdU (Amersham). Embryos were harvested at 2 or 24 hours post-injection, 
methanol-Carnoy‘s (60% MeOH/ 30% HCl3/ 10% HAc) fixed, paraffin embedded 
(=MCFPE), and transversally sectioned at 5 or 6 μm thickness. BrdU-incorporation was 
detected with mouse anti-BrdU (1:100, Amersham), goat anti-mouse HRP (1:500, 
Jackson), and the substrate diaminobenzidine. Substrate conversion was stopped at 
saturation, but before background signal developed. Slides were counter-stained with 
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2.3.5 Apoptotic cell detection 
 
TUNEL assays were performed on 5 or 6 μm sections of PFPE or MCFPE embryos 




2.3.6 Quantitation of BrdU incorporation  
 
We developed algorithms in Matlab R2008b (Mathworks) to quantify BrdU-labeling in 
digital images loaded into Metamorph 7.5.1 (Molecular Devices Corp.). First, digital 
images were segmented with manually drawn contours along the basement membrane 
of the ectoderm, around the MR, and its neck if present. An automatic active contour 
(Chan and Vese, 2001; Lankton, 2008) further segmented the ectoderm from the 
background. The MR-contour was automatically congruently dilated, and in the central 
sections also eroded (Gonzalez and Woods, 1992) with empirically determined 
parameters: A 15 µm dilation included the mammary mesenchyme; and erosion to yield 
a 1:3 area ratio coincides with histological and immuno-chemical differences between 
cuboidal core cells and larger columnar peripheral cells at budstage. A manually drawn 
line segmented the mammary mesenchyme of Gli3Xt-J/Xt-J MR2. Two automatically placed 
lines parallel to the ectoderm -one through the center of the MR and the other 65 µm 
below it were empirically determined to include dermal mesenchyme while excluding the 
somites and some laterally extending mammary mesenchyme around the top half of 
each MR at E13.5. Manual color thresholding segmented BrdU+ve nuclei and all nuclei 
within the image. The algorithms generated quality control images displaying all 
segmentation boundaries (Fig. 2.2 Z), for validation of the numerical output of segments 
via visual inspection of segmentation. 
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2.3.7 MR volume measurements  
 
Using our abovementioned software, the area (in µm2) of mammary epithelium was 
quantified in consecutive sections through entire MRs of MCFPE embryos. We 
developed a software in C programming language on CentOS 5.3 
(http://www.centos.org) to plot values against cumulative section thickness, apply 
Levenberg-Marquardt curve-fitting (Lourakis, 2004) to reduce errors created by lost 
sections, and then determine the MR volume as the area under the fitted curve.  
 
 
2.3.8 Statistical analysis 
 
Unless indicated otherwise, MRs of one or both flanks of at least 3 wt and 3 
Gli3Xt-J/Xt-J littermates from different litters were used per age-group. Data are 
represented as mean   standard deviation. Asterisks in figure panels indicate a 
significant difference (p<0.05) between samples connected by a horizontal bracket, as 
tested with Student‘s t-test if BrdU-exposure conditions were different (e.g. comparing 2h 
and 24h post labeling), or a paired Student‘s t-test if BrdU-exposure conditions were the 
same (e.g comparing littermates, or tissues within specimens). Significance of 
differences among all MRs was tested with ANOVA.  
 
 
2.3.9 3D-reconstruction of the MRs 
 
We manually segmented (labeled) the ectoderm and MR in each image using 
segmentation editor in Fiji (http://pacific.mpi-cbg.de/wiki/index.php/Fiji). We developed 
algorithms in Matlab R2008b and R2010b (Mathworks) to determine two transformation 
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control points in the ectoderm in addition to the MR-center for alignment of consecutive 
images with the first image of the stack via non-reflective similarity transformation 
(Goshtasby, 1986). The aligned original image-stacks were converted to inverted 
grayscale from 0 to 1.0, after which the black (BrdU+ve) pixels were segmented from the 
background using an empirically determined fixed threshold value of 0.65. With à priori 
knowledge of the approximate nuclear size, we eliminated noise or artifacts. Touching 
nuclei were split using the Evolving Generalized Voronoi Diagram (EGVD) algorithm (Yu 
et al., 2010). Aligned labeled images and segmented original images served to generate 
3D iso-surfaces of ectoderm, MR, and BrdU+ve nuclei, in different superimposed 
transparent colours.  
 
2.4 Results  
 
2.4.1 Individual MR pairs in Gli3Xt-J/Xt-J mutants differ in their growth defects 
 
We previously reported that Gli3Xt-J/Xt-J mutants fail to induce MR3 and MR5 at E11.5 
(Mailleux et al., 2002; Veltmaat et al., 2006). Current analysis revealed that at E13.5, 
Gli3Xt-J/Xt-J MR1, and MR2 and MR4 more obviously, are smaller than their wild type (wt) 
or heterozygous counterparts (Fig. 2.1 A-H). At E12.5, Gli3Xt-J/Xt-J MR2 and MR4 look like 
placodes, instead of hillocks (Fig. 2.2 H, U). Both MRs show defective invagination into 
the underlying dermis by E13.5, most severely for MR2 (Fig. 2.1 B,D,G,H, 2.2 M,O,X,Y, 
7G): By E15.5, MR4 has invaginated, forming an ectodermal indentation preceding 
formation of an outlet of the milk canal (not shown), whereas MR2 continues to grow 
outwardly without forming an outlet (Fig. 2.1 I, J). Nonetheless, Gli3Xt-J/Xt-J MR2 
undergoes nipple formation, sprouting and branching morphogenesis before E18.5, as 
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do MR4 (Fig. 2.1 K-N) and MR1 (not shown). In conclusion, each of the developing 
Gli3Xt-J/Xt-J MRs has a distinct phenotype. 
In serial histological sections, we measured MR size between E11.75 - when all wt 
MRs except MR5 can be accurately segmented from the ectoderm - and E13.5 - when 
the main growth defect has occurred. At E11.75, wt MRs vary in size between 
6.2×104 μm3 (MR2) and 13×104 μm3 (MR3) in accordance with MR3 emerging before 
MR2 (Mailleux et al., 2002; Veltmaat et al., 2004). All MRs grow at different rates (Fig. 
2.1 O); during the first day slightly negatively allometric with the increase in total 
bodyweight, while isometric or positively allometric during the second day, to attain a 
size of 2.6-4.0×105  μm3 by E13.5 (Table 2.1 columns 4-6). The developing Gli3Xt-J/Xt-J 
MRs are about ¼ day delayed in their onset, but MR4 is initially so flat that it can only be 
reliably segmented from the ectoderm from E12.5 onwards. MR1 grows normally, but 
does not compensate for the delayed start and remains about 20% smaller than in wt. 
Gli3Xt-J/Xt-J MR2 and MR4 grow slowly, such that by E13.5 they are ~50% smaller than in 
wt, and even smaller than E12.5 wt MRs (Fig. 2.1 O).   
By in situ hybridization, Gli3 expression is undetectable in the ectoderm or the 
emerging epithelium of mammary line (ML) and placodes at around E11.5, but high in 
the thoracic and lumbar somites and delaminating dermal mesenchyme (Veltmaat et al., 
2006). Thus, the initial growth defect of the Gli3Xt-J/Xt-J MR1, MR2 and MR4 is likely due to 
loss of Gli3 in the mesenchyme, disturbing mesenchymal-ectodermal interactions. 
However, by E12.5 and E13.5, Gli3 is detectable in situ in the (prospective) mammary 
mesenchyme, ectoderm, and mammary epithelium (Fig. 2.1 P-U‘) and by micro-array 
analysis  (Fig. 2.1 V), consistent with previously shown Gli3 protein expression profile in 
these tissues at E13.5 (Hatsell and Cowin, 2006). Thus, the initial growth defects of 
Gli3Xt-J/Xt-J MR2 and MR4 at E11.5 could subsequently be compounded by the lack of 
Gli3 in any of the tissue compartments. 
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Fig. 2.1. Relationship between Gli3 expression and MR growth in mouse embryos.  
(A-H) Hematoxylin/eosin stained transversal histological sections through the center of 
each MR in E13.5 Gli3Xt-J/+ and Gli3Xt-J/Xt-J embryos. Black contours in (B) exemplify the 
boundary of the MR (solid) and mammary mesenchyme (dotted). Scale bar in A-H: 
100 μm. (I-J) Scanning electron micrographs of the external view on epidermis and 
MR2, showing the outlet of the prospective milk-canal in a wt, and the outwardly 
protruding mammary rudiment in a Gli3Xt-J/Xt-J embryo at E15.5. (K-N) Carmine red-
stained skins with MR2 and MR4 at E18.5. White arrowheads indicate some end buds of 
the branched mammary rudiment in wt and Gli3Xt-J/Xt-J embryos. Black arrowheads 
indicate the nipple. (O) Volumetric growth of each MR in wt and Gli3Xt-J/Xt-J embryos 
between E11.75 and E13.5. Error bars represent (one-sided) standard deviations. (P-U’) 
Radioactive section in situ hybridization of wt MRs with a Gli3 mRNA probe. (P-U) 
Brightfield images visualizing the MRs. (P’-U’) Darkfield images of the same sections, 
with white grains indicating hybridization of the probe. (V) Quantification of Gli3 
expression in micro-array data of each of the individual MRs, ectoderm and 
mesenchyme at E12.5 (n=5, solid error bars indicate standard deviation) and E13.5 
(n=2, dashed error bars extend between the two measured values). Asterisks indicate a 




































Table 2.1:  Growth comparison of E11.5-E13.5 mouse embryos and their MRs 
 
ND: not determined, V: volume
1 2 3 4 5 6 7 
 
VolumeE11.75 
(× 104 μm3 ) 
VolumeE12.5 
(× 104 μm3 ) 
VolumeE13.5 
(× 104 μm3 ) 
VE12.5/VE11.75 VE13.5/VE12.5 VE13.5/VE11.75 
MR 1 
9.8 ± 0.8 
(n=4) 
22.1 ± 5.1 
(n=16) 
33.6 ± 8.1 
(n=13) 
2.3 1.5 3.4 
MR 2 
6.2 ± 1.9 
(n=2) 
15.5 ± 3.6 
(n=14) 
32.1 ± 6.4 
(n=14) 
2.5 2.1 5.2 
MR 3 
13.1 ± 3.5 
(n=8) 
20.2 ± 5.5 
(n=14) 
34.5 ± 10.2 
(n=13) 
1.5 1.7 2.6 
MR 4 
9.6 ± 3.7 
(n=6) 
19.1 ± 7.9 
(n=17) 
40.2 ± 8.3 
(n=14) 
2.0 2.1 4.2 
MR 5 ND 
16.4 ± 5.2 
(n=15) 
26.5 ± 7.4 
(n=14) 
ND 1.6 ND 











WE12.5/WE11.5 WE13.5/WE12.5 WE13.5/WE11.5 
Embryo 
30.6 ± 6.3 
(n=6) 
82.8 ± 13.3 
(n=5) 
134.6 ± 12.9 
(n=14) 
2.7 1.6 4.4 




Table 2.2: Fold difference of ectodermal over mammary epithelial proliferation rate 
















Note: Numbers represent the mean ratios (Ectoderm/MR) as derived from the statistics 





2.4.2 Peripheral cells in Gli3Xt-J/Xt-J MR2 and MR4 fail to differentiate into large 
columnar cells 
 
Slightly before E12.5, many peripheral cells within wt MR1, wt MR3 and Gli3Xt-J/Xt-J 
MR1 undergo hypertrophy and become columnar (Fig. 2.2 G, I, T), associated with 
altered protein expression levels (not shown), while cells in the ectoderm and core of 
these MRs remain cuboidal. Between E12.5 and E13.5, hypertrophy occurs also in 
peripheral cells of the other wt MRs, but not of Gli3Xt-J/Xt-J MR2 and MR4 (Fig. 2.1 A-E, 
2.2 L-P). We could not quantify the volume increase by hypertrophy, but can estimate it 
by approximating a MR as a sphere with a realistic radius r of 5 cell-diameters and with 
the outer cell doubling its diameter in 1 day (thus r = 6 cell diameters). Then the sphere‘s 
volume V=  
  
 
    would increase  
  
 
   /   
  
 
    ≈ 1.7 fold, which corresponds 
reasonably well with the observed growth between E12.5 and E13.5 (Table 2.1). Given 
the observed shape changes of the MRs between E12.5 and E13.5 (Fig. 2.2), this 
 


































Mean 3.2 5.5 
10.7 
(7.1 without MR2) 
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calculation probably yields an overestimation, but indicates nonetheless that hypertrophy 
into columnar cells may contribute considerably to MR growth between E12.5 and 
E13.5. Hence, the lack of hypertrophic differentiation in Gli3Xt-J/Xt-J MR2 and MR4 by 
E13.5 (Fig. 2.1 G, H, 2.2 X, Y) may explain, at least partly, the reduced growth of these 
MRs between E12.5 and E13.5.  
 
 
2.4.3 Emergence and growth of the MRs is not mediated by enhanced cell 
proliferation 
 
Notably, Gli3Xt-J/Xt-J MR2 and MR4 are already too small at E12.5, before hypertrophy 
should occur. Histological examination readily visualizes that their smaller size is mainly 
due to a reduced cell number, or hypoplasia (Fig. 2.2 H, U; 2.2 J, V). To address 
whether this reflects a proliferation defect, we labeled cells in S-phase with BrdU. 
Transversal sections of E11.25 (or 42 somite-stage) to E13.5 embryos reveal that the 
ML and MRs contain strikingly few BrdU+ve cells compared to their flanking ectoderm 
(Fig. 2.2 A-Y). Thus, ectodermal multilayering during ML formation and subsequent MR 
formation are not consequences of locally enhanced cell proliferation.  
Could the lower proliferation rate in wildtype MRs compared to the ectoderm be 
consistent with their initially negatively allometric growth compared to the entire embryo? 
To address that question, we developed image analysis algorithms to segment images 
of histological sections in MRs (with neck, periphery and core), ectoderm, dermal and 
mammary mesenchyme (Fig. 2.2 Z), and in BrdU+ve and hematoxylin+ve areas. The ratio 
of BrdU+ve 5 pixels among all nuclear (BrdU+ve + hematoxylin+ve) pixels serves as a 
proxy for 6 proliferation rate. The average proliferation rate seems relatively constant in 
wt MRs 7 larger than 10×104 μm3 (Fig. 2.2 AA), i.e. E12 and older (Fig. 2.1 O), as is the 
case in Gli3Xt-J/Xt-J 8 MRs at all volumes (Fig. 2.2 AB). We therefore excluded a need to 
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correct for differences in developmental stage of the MR at any chronological age of 
embryos, and henceforth grouped the data by chronological age. At E11.5-E11.75, MRs 
incorporate less BrdU than the ectoderm, but we could not quantify the difference due to 
segmentation problems at these ages (Fig. 2.2 AC). The wt MRs vary significantly in 
their proliferation rate at E12.5 and E13.5 (p=0.0002 respectively p=0.0007). Between 
E12.5 and E13.5, the proliferation rate within the wt MRs declines from 4.5%±2.4 to 
3.3%±1.5% (Fig. 2.2 AD, AE), contrary to the steady or increased growth rate of MRs 
during this day (Fig. 2.1 O). Thus the proliferative activity is insufficient to account for all 
MR growth. This conclusion is affirmed by the lower proliferation rate in MR2, MR4 and 
MR5 (Fig. 2.2 AD, AE) despite their faster growth than MR1 and MR3 (Fig. 2.1 O). 
Notably, between E12.5 and E13.5, the mean proliferation rate within MRs decreases 
from 5.5 to 10.7-fold lower (p=<0.0001) than the constant rate of 22%±5% (t-test, 
p>0.09) in the adjacent ectoderm (Table 2.2). As the surface ectoderm of the trunk 
remains single-layered before E13.5, its proliferative activity must be approximately 
isometric with growth of the entire embryo. With e.g. MR2 also growing almost 
isometrically with the embryo  (Table 2.1 column 5), but its cells having a 5.9-fold lower 
proliferation rate than the ectoderm (Table 2.2), proliferation may account for (
   
   
/5.9) 
~18% to (
   
   
/24.8) ~3% of the 27 growth of this MR between E12.5 and E13.5. Similarly, 
we estimate the contribution of 28 proliferation to MR growth may decline from ~15%-
44% to ~3%-19% over 2 days in a MR-specific manner. While these numbers are only 
rough estimates, we can conclude that indeed MRs do not grow entirely, or primarily, by 
cell proliferation, and that cell proliferation contributes progressively less to MR growth 
between E11.5 and E13.5. 
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2.4.4 Hypoplasia of Gli3Xt-J/Xt-J MRs is not due to defective epithelial proliferation, 
and coincides with failure to downregulate mesenchymal proliferation 
 
Interestingly, Gli3Xt-J/Xt-J MRs display hypoplasia despite their normal or increased 
proliferation rate at E12.5 (p=0.012 for MR2), or at E13.5 (Fig. 2.2 AD, AE). As Balinsky 
had suggested that the MRs grow due to cell aggregation from the adjacent ectoderm 
(Balinsky, 1949-1950), we assessed whether the Gli3Xt-J/Xt-J ectoderm proliferates fast 
enough to provide cells for the MRs. Indeed it does, as shown by the equal to perhaps 
increased ectodermal proliferation rate in E11.75 Gli3Xt-J/Xt-J embryos compared to wt 
embryos (Fig. 2.2 AC), and a rate similar to wt at E12.5 and E13.5 near all MRs (Fig. 2.2 
AD, AE), whereby the statistically significant difference near MR2 at E12.5 (p=0.025) is 
considered biologically insignificant.  
Of interest, the ectoderm between the limbs tends to have a higher proliferation rate 
dorsally of the MRs, i.e. near MR2, MR3 and MR4, yet ventrally at the level of the 
forelimb (MR1) and hindlimb (MR5) in wt (Fig. 2.2 AF). The higher proliferation rate at 
the ventral ectoderm seems to neutralize or switch towards a higher dorsal proliferation 
rate by E13.5. However, few of these differences are significant, giving no hint as to 
whether one side may contribute more cells to the MRs than the other. Furthermore, the 
tendency is not different in the Gli3Xt-J/Xt-J ectoderm. 
Between E12.5 and E13.5, a few layers of dermal mesenchyme directly adjacent to 
the MR condense and express the androgen receptor (AR), marking their differentiation 
into mammary mesenchyme (Heuberger et al., 1982). Given the mesenchymal Gli3 
expression (Fig. 2.1 P-V), we also assessed the mesenchymal proliferation rate. In 
E11.75 and E12.5 wt embryos, mesenchymal cells proliferate at a rate similar to 
ectodermal cells (Fig. 2.2 AC, AD, AG, AH), with no biologically and statistically 
significant differences between dermal and ‗pre‘mammary mesenchyme except near 
MR5 at E12.5 (p=0.014) (Fig. 2.2 AG, AH). By E13.5, the dermal mesenchyme reduces 
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its proliferation rate more than the mammary mesenchyme such that the former is 
significantly less proliferative than the latter near MR1, MR2 and MR3 (p=0.035, 0.038 
and 0.012 respectively) (Fig. 2.2 AI). The most prominent difference in Gli3Xt-J/Xt-J 
embryos is the significantly higher proliferation rate of dermal mesenchyme than in wt 
near MR2 (p=0.035) and MR4 (p=0.011) due to a failure to slow down proliferation 
between E12.5 and E13.5.  
In conclusion, the hypoplasia of Gli3Xt-J/Xt-J MR2 and MR4 exists despite an initially 
higher proliferation rate than in wt, particularly in MR2. Furthermore, the loss of Gli3 
changes cell proliferation in the mammary epithelium and mesenchyme, as well as the 
adjacent ectoderm and dermal mesenchyme in a tissue-, location-, and time-specific 
manner. 
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Fig. 2.2. Proliferative activity in wt and Gli3Xt-J/Xt-J MRs and adjacent tissues. 
(Continued on next page) 
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 (A-Y) Representative transversal sections through the center of the mammary rudiment 
wt and Gli3Xt-J/Xt-J embryos between ~E11.5 (42 somite-stage (C) and 49 somite-stage 
(A,B,D-F)) and E13.5, stained for BrdU-incorporation (black) and counterstained with 
hematoxylin (blue). Pregnant mothers were injected with BrdU 2 hours prior to embryo 
dissection, thus black nuclei indicate proliferative activity around the time of dissection. 
Dashed yellow lines outline the mammary rudiment. The ventral ectoderm is always at 
the left, sometimes indicated with an asterisk. Scale bar in A represents 100 μm in all 
panels. (Z-AI) Quantification of BrdU incorporation in wt and Gli3Xt-J/Xt-J samples 
represented in (A-Y). The BrdU+ve pixels were calculated as a ratio of all nuclear pixels in 
all consecutive sections through entire MRs and their adjacent tissues, as a measure of 
proliferative activity. Bars and error bars represent the average and standard deviation of 
1 or 2 (left and right) MRs (or adjacent tissue) of at least 3 embryos per stage per 
genotype, while asterisks indicate a significant difference (p<0.05) between two samples 
connected by the horizontal brackets, as calculated with a paired Student‘s t-test. See 
main text for additional statistically significant variation among the MRs. Error bars are 
missing at around E11.75, as some MRs are not present yet or their boundaries with the 
ectoderm were sufficiently distinct for segmentation in only 1 or 2 embryos. (Z) Quality 
control image as generated with our software. Colored outlines demarcate dorsal 
ectoderm (d. ect., green), ventral ectoderm (v. ect., yellow), MR core (c, orange), MR 
periphery (p, red), MR neck (n, purple), mammary mesenchyme (m.m., turquoise), and 
dermal mesenchyme (d.m., blue). (AA-AB) Graphs displaying the relationship between 
volumetric size and BrdU-incorporation in wt (AA) and Gli3Xt-J/Xt-J (AB) MRs between ± 
E11.75 and E13.5. (AC-AE) The ratio of BrdU+ve pixels in each MR and its adjacent 
ectoderm at ± E11.75, E12.5 and E13.5. (AF) Differences in BrdU-incorporation between 
the ventral and dorsal ectoderm (ratio in dorsal side subtracted from ratio in ventral side 
per embryo) at E12.5 and E13.5. Asterisks denote a significantly higher proliferation rate 
(p<0.05) at that side. (AG-AI) The ratio of BrdU+ve pixels in the few layers of 
mesenchyme directly adjacent to the mammary rudiment (‗pre‘mammary mesenchyme 
at E11.75 and E12.5, mammary mesenchyme at E13.5) and the more distant dermal 






2.4.5 Hypoplasia of Gli3Xt-J/Xt-J MR1, MR2 and MR4 is not caused by apoptosis 
 
We then assessed whether the hypoplasia of Gli3Xt-J/Xt-J MRs could be due to cell 
apoptosis. TUNEL-assays performed on E12.5 MRs show a high number of apoptotic 
cells in the periderm above but not within wt MR2 and MR4, as well as in the apex of 
MR3, but few in MR1, and a more random distribution within MR5 (Fig. 2.3 A-E). The 
surrounding ectoderm and mesenchyme are virtually devoid of apoptotic cells. By E13.5, 
apoptosis is still observed in a few cells in the periderm above MR5, but not in wt MR1-4 
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or their surrounding tissues (Fig. 2.3 F-J). Apoptosis is strikingly less prominent to 
absent in the Gli3Xt-J/Xt-J MRs at both ages (Fig. 2.3 K-P). Thus, the marked hypoplasia of 
the Gli3Xt-J/Xt-J MRs by E13.5 is not due to apoptosis within the ectoderm or mammary 
epithelium, but occurs despite the prevention of apoptosis in the overlying periderm. By 
contrast, while wt mammary and dermal mesenchyme are virtually devoid of apoptotic 
cells, the dermal mesenchyme near E12.5 MR4 in Gli3Xt-J/Xt-J mutants contains apoptotic 
cells. Given this effect of loss of Gli3 on the dermal mesenchyme, it remains possible 
that mesenchymal interactions with the mammary epithelium are disturbed, affecting the 















































































































Chapter 2: Gli3 and cell migration in mammogenesis  
71 
 
A-P: Transversal sections through the center of each MR in E12.5 and E13.5 wt and 
Gli3Xt-J/Xt-J embryos, TUNEL-stained to detect apoptotic cells (green) and counterstained 
with DAPI to detect all nuclei (blue). Dashed white lines demarcate the MRs. Red boxed 
insets: magnification of the apical area of the mammary epithelium. White boxed insets: 
magnification of a region in the mammary mesenchyme, in cases where this 
mesenchyme contains TUNEL+ve cells. The ventral ectoderm is always at the left, as 





2.4.6 Influx of ectodermal cells from outside the ML contributes to MR formation 
and growth 
 
Next we asked whether the MRs grow due to recruitment of cells from the ectoderm. 
Unfortunately, the focal instability of flank cultures rendered time-lapse video-analysis of 
deposited dyes like DiI, or of conversion of the fluorescent substrate DDAOG visualizing 
expression of the mammary epithelial marker TOPGAL, fruitless for answering this 
question. However, the low and declining proliferation rate (4.5% to 3.3%) of cells in the 
MRs between E11.75 and E13.5 allowed us to BrdU-label embryos 24 hours before 
harvest and determine whether the percentage of BrdU+ve cells in the MRs was higher 
than that in embryos harvested 2 hours after labeling due to an influx of cells. In 
accordance with BrdU being taken up by cells quickly or otherwise degraded within 10 to 
60 minutes (Kriss and Revesz, 1961), we did not observe a significant increase in 
absolute number or ratio of BrdU+ve pixels in all tissues combined between 2 hour and 24 
hour post-labeling (Fig. 2.4 Q, R). Thus, postponed harvest did not prolong BrdU-
labeling time. 
Given that we observed no histologically and biochemically different subpopulations 
of cells within the MRs before E12.5 (MR1 and MR3) or E13.5 (MR2, MR4 and MR5), 
we may likely assume that at least until then, all MR-cells have an equal cell cycle 
duration. Because of saturation of the immuno-precipitate, two daughters of a 
symmetrically dividing BrdU+ve cell each generate an equal number of BrdU+ve pixels as 
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their mother, despite inheriting only half the amount of BrdU. Thus, if the MRs would 
grow by cell proliferation only, the ratio of BrdU+ve pixels within the MRs at 24 hours post-
labeling should fluctuate around the ratio at 2 hours post-labeling, and never reach twice 
that ratio, because unlabeled cells in M and G2 will divide prior to the cells labeled in 
S-phase.  
We observed a 2 to 4-fold higher ratio of BrdU+ve cells in MRs harvested 24 hours 
compared to 2 hours after their labeling at E11.5 (p≤0.012) (Fig. 2.4 S). The absolute 
number of BrdU+ve pixels increased about 4-fold, varying per MR (p≤0.003) (Fig. 2.4 U). 
If this increase were only due to mitosis of cells within the MRs, the MR volume should 
increase 4-fold as well, especially for MR2 and MR4 that hardly experience any cell 
apoptosis within them. Since these MRs only double their size in that day, these data 
provide another indication that MRs do not grow by cell proliferation only. 
We infer that the increase of BrdU+ve pixels is at least partly due to an extensive 
influx of cells. Given the ectodermal origin of mammary epithelium (Cunha et al., 1995), 
the influxing cells must come from the more densely labeled ectoderm. A mathematical 
approach (Table 2.3) suggests that growth is approximately entirely due to an influx of 
ectoderm. Since the ML connecting the prospective MR2, MR3 and MR4 in mouse 
embryos at around E11.5 is almost completely devoid of BrdU+ve cells, any influx of cells 
from along the ML into those MRs would not be detected with our method. 
Consequently, the observed BrdU+ve influx suggests that most of the ectodermal cells 
recruited into the MRs by E12.5, were still located outside the ML at E11.5.  
Between E12.5 and E13.5 the ratio of labeled pixels in wt MR4 (p=0.004) and MR5 
(p=0.03) and the absolute number of BrdU+ve pixels in all wt rudiments still increases, but 
to a lesser extent (Fig. 2.4 T, V). Subdivision of the MRs into a core, periphery and 
potential neck (i.e. in MR1-MR4 by E13.5), along with 3D-renderings of MRs show that  
BrdU+ve cells labeled at E12.5 are predominantly located in the proximal region, i.e. neck 
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if present, of the MRs by E13.5 (Fig. 2.4 F‘-J‘, 2.5 A, B, G). In the absence of such 
preferential proximal location at the time of labeling at E12.5 (Fig. 2.2 G-P, 2.5 G), these 
data strongly suggest that the increase of BrdU+ve cells is caused by a continued 




2.4.7 Ectodermal influx is decreased in Gli3Xt-J/Xt-J MR2 and MR4 
 
In Gli3Xt-J/Xt-J MR1, the change in ratio, absolute number, and location of BrdU+ve 
pixels is similar to that in wt between E11.5 and E13.5 (Fig. 2.2 A, G, Q ,T; 2.4 A, F, K, 
N, S-V; 2.5 A-F), indicating no perturbation of migration, and being consistent with a 
similar growth rate and morphogenesis as wt MR1. By contrast, the ratio of BrdU+ve 
pixels in E12.5 Gli3Xt-J/Xt-J MR2 and MR4 labeled at E11.5 is almost as high as in wt (Fig. 
2.4 S), but their absolute increase in pixels over 24 hours is at least 2-fold less than in wt 
(Fig. 2.4 U) despite an ectodermal labeling density similar to that in wt (Fig. 2.2 AC, AD). 
This indicates a strongly reduced influx of ectodermal cells in Gli3Xt-J/Xt-J MR2 and MR4 
(Fig. 2.4 L, M), which accounts primarily for their hypoplasia seen at E12.5.  
Between E12.5 and E13.5, the absolute number of BrdU+ve pixels increases slightly 
in these MRs (Fig. 2.4 T). Added to the minimal growth of these MRs (Fig. 2.1 O) and 
their lack of neck formation or proximal accumulation of BrdU+ve cells (Fig. 2.4 O, P; 2.5 
G), this may suggest that ectodermal influx remains compromised. Thus, continued 
compromised ectodermal influx contributes to the persistent hypoplasia of Gli3Xt-J/Xt-J 
MR2 and MR4. 
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Fig. 2.4. Using BrdU as a cell-tracker reveals ectodermal cell migration into all MR 
pairs and perturbation of migration into Gli3Xt-J/Xt-J MR2 and MR4.  
(Continued on next page) 
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(A-P) Representative transversal sections through the center of the mammary rudiment 
wt and Gli3Xt-J/Xt-J embryos at E12.5 and E13.5, stained for BrdU-incorporation (black) 
and counterstained with hematoxylin (blue). Pregnant mothers were injected with BrdU 
24 hours prior to embryo dissection, thus black nuclei represent cells that were BrdU-
labeled at around the time of injection. The higher proportion of black cells compared to 
labeling seen in Fig. 2.2 represents primarily an influx of cells from the ectoderm. Panels 
(F-J) and (F’-J’) show two different types of distribution (random versus primarily in the 
proximal half) of labeled cells observed in 60% and 40% of the wt MRs respectively. 
Dashed yellow lines outline the mammary rudiment. The ventral ectoderm is always at 
the left, sometimes indicated with an asterisk. Scale bar in A represents 100 μm in all 
panels. (Q-X) Quantification of BrdU-labeling in wt and Gli3Xt-J/Xt-J samples represented in 
A-P. The BrdU+ve pixels were calculated as a ratio of all nuclear pixels (graphs 
R,S,T,W,X) or as an absolute number of pixels (graphs R,S,U) in all consecutive 
sections through entire MRs and their adjacent tissues, as a measure for proliferative 
activity (in samples harvested 2 hours after labeling) or cell displacement (in samples 
harvested 24 hours after labeling). Bars and error bars represent the average and 
standard deviation of 1 or 2 (left and right) MRs and/or their adjacent tissues of at least 3 
embryos per stage per genotype. Asterisks indicate a significant difference (p<0.05) 
between two samples connected by the horizontal brackets, as calculated with an 
unpaired Student‘s t-test. See main text for additional statistically significant variation 
among the MRs. Error bars are missing at 2 hours post-BrdU injection at around E11.75, 
as some MRs are not present yet or their boundaries with the ectoderm are insufficiently 
distinct for segmentation of the image. (Q,R) Comparison of the total number (Q) or ratio 
(R) of BrdU+ve pixels in all segmented tissues combined, between 2 and 24 hours post-
labeling, when labeled at E12.5. S,T: Comparison of the ratio of BrdU+ve pixels in the 
MRs between 2 and 24 hours post-labeling, when labeled at E11.5 (S) or E12.5 (T). 
(U,V) Comparison of the absolute number of BrdU+ve pixels in the MRs between 2 and 
24 hours post-labeling, when labeled at E11.5 (U) or E12.5 (V). (W,X) Comparison of the 
ratio of BrdU-labeling between the ventral (right of central axis) and dorsal ectoderm (left 
of central axis) between 2 hours and 24 hours post-labeling, when labeled at E11.5 (W) 
or E12.5 (X).  
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Fig. 2.5. Unique compartmentalization of BrdU+ve cells among individual MRs at 
E13.5.  
(Continued on next page) 
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(A-F) Ratio of BrdU+ve pixels per MR (y-axis), subdivided proportionally by distribution 
over   core, periphery, and neck if present. (G) 3D-reconstruction of MRs based on serial 
sections stained for BrdU as in Figs. 2.2 and 2.5. Ectoderm/epidermis in green, with 






2.5.1 Relative contributions of ectodermal influx, proliferation, apoptosis, and 
differentiation into hypertrophic columnar cells, to MR growth 
 
In this study, we determined which cellular mechanisms govern the initial stages of 
MR development, and which of these mechanisms is regulated by Gli3. Previously, 
Balinsky had addressed the question of  cellular mechanisms of early mammary growth 
in the mouse embryo (Balinsky, 1950). Based on the low index of mitotic cells in pooled 
E11-E14 MRs, he suggested that MRs do not arise or grow by locally enhanced cell 
proliferation (Balinsky, 1949-1950), yet he did not fully address whether the lower 
proliferation rate in MRs simply reflected the negatively allometric growth of the MR that 
he found in comparison to the ectoderm or entire embryo between E11 and E14. To our 
knowledge, alternative growth mechanisms of the early MR have also not been studied 
in sufficient detail or at all.   
Due to Balinsky‘s pooling of data of specimens between E11 and E14, differences in 
proliferative activity and the contribution of proliferation to MR growth on consecutive 
days or between individual MRs were obscured. As we analyzed proliferative activity by 
counting cells in S-phase instead of mitosis, the higher percentages of positive cells 
allowed us to perform statistical analysis on separate MRs at discrete days of 
development. We discovered that the individual MRs differ in their proliferation rate from 
each other at any day, and their proliferative activity declines between E11.5 and E13.5.  
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We provide three independent lines of evidence that indicate that MRs do not grow 
entirely, and not even primarily, by cell proliferation between E11.5 and E13.5: 1) the 
proliferation rate declines contrary to the constant or increasing growth rate of the MRs, 
2) the much lower proliferation rate of cells within MRs compared to the ectoderm is 
inconsistent with the only slightly negative or even positive allometric growth of the MRs 
with the embryo between E11.5 and E13.5, and 3) the fold increase of BrdU+ve cells at 
24 hours compared to 2 hours post-labeling at E11.5 is much greater than the fold 
increase in MR volume in that time period. We estimate that cell proliferation contributes 
initially  15%-44% to MR growth, and declines to  3%-19% between E12.5 and E13.5, 
all in a rudiment-specific manner. Cell proliferation may take on a more important role in 
MR growth between E14.5 and E15.5 (Heckman et al., 2007). 
We provide evidence for Balinsky‘s suggestion that MRs grow by an influx of 
ectodermal cells (Balinsky, 1949-1950). This influx is large during the first day, 
accounting for all growth that is not mediated by cell proliferation within the MRs. We 
show that the influx decreases, such that we estimate it to contribute 22%-39% of MR 
growth between E12.5 and E13.5, again in a rudiment-specific manner (see Table 2.3, 
     
     
). Such migration may continue for one more day, as we had previously observed 
similar proximally located labeled cells in E14.5 MRs in cultured flanks, labeled with [3H]-





































   Table 2.3:  Estimation of volume increase of MRs due to ectodermal influx 
Note: *Vobs > Vexp due to hypertrophy of peripheral cells within all MRs? 
Abbreviations: exp: expected, mt: mutant, wt: wild type, h: hours. incr: increase, obs: observed, pix: pixels, t=time 
1 2 3 4  5  6  7 8 9 10  11 
 
Fold increase in absolute number 
































)   
BrdU+ve 
pix  t=2h 
)   
  
  ( Vt=24h   Vt=2h )  Vt=2h    
E11.5  wt 1 (( 103804   18340 )   18340 )   0.13   3.6E-2   1.29 ( 220554   97777 )  97777    1.26 
E11.5  wt 3 (( 87785   18659 )   18659 )   0.17   3.1 E-2   0.66 ( 201646   131174 )  131174    0.54 
E11.5  wt 4 (( 199576   27841 )   27841 )   0.16   6.5 E-2   2.50 ( 191118   95857 )  95857    0.99 
E11.5  mt 1 (( 73650   11775 )   11775 )   0.17   3.4 E-2   1.06 ( 148758   74470 )  74470    1.00 
E11.5  mt 2 (( 97784   3074 )   3074 )   0.24   5.2 E-2   6.58 ( 115751   14155 )  14155    7.18 
E12.5  wt 1 (( 74388   44606 )   44606 )   0.26   5.9 E-2   0.15 ( 336218   220554 )  220554    0.52* 
E12.5  wt 2 (( 47805   19050 )   19050 )   0.20   3.4 E-2   0.26 ( 320787   154765 )  154765    1.07* 
E12.5  wt 3 (( 71186   34501 )   34501 )   0.27   6.9 E-2   0.27 ( 345423   201646 )  201646    0.71* 
E12.5  wt 4 (( 68000   21156 )   21156 )   0.21   2.3 E-2   0.24 ( 401653   191118 )  191118    1.10* 
E12.5  wt 5 (( 62825   31123 )   31123 )   0.17   4.0 E-2   0.24 ( 265012   163703 )  163703    0.62* 
E12.5  mt 1 (( 99624   56019 )   56019 )   0.18 
  
9.4 E-2   0.41 ( 274814   148758 )  148758    0.85* 
E12.5 mt 2 (( 71708   51318 )   51318 )   0.18   6.3 E-2   0.14 ( 147332   115751 )  115751    0.27 
E12.5  mt 4 (( 85049   62714 )   62714 )   0.21   8.4 E-2   0.14 ( 192489   131015 )  131015    0.47 




Explanation of calculations: 
 See main text for arguments why ectodermal influx should be considered as 
a contributor to MR growth. 
 The increase in BrdU+ve cells correlates linearly with the increase   in BrdU+ve 
pixels between 2 hours and 24 hours: 
(  
                                                   
                     
   
 If no (BrdU+ve) cells within the MR would undergo mitosis, then   would be 
entirely due to cell influx from the ectoderm. Unlabeled cells and labeled cells 
from the ectoderm have an equal chance of entering the MR, their ratio 
inversely correlating to the labeled fraction of the ectoderm. Hence, to obtain 
the total number of influxing ectodermal pixels,   has to be divided by the 
labeled fraction of the ectoderm (column 5). 
 To calculate the expected increase of rudiment volume ( VExp) created by cell 
influx, bear in mind that the number of BrdU+ve pixels (or cells) in column 4 
constitutes the fraction of all cells in MR (i.e fraction of MR volume) as given 
in column 6. Thus, the fold increase of pixels calculated from columns 2-5, 
multiplied by the fraction in column 6 yields  VExp if all additional pixels came 
from ectodermal influx. 
 The observed increase in MR volume ( VObs) is very similar to  VExp between 
E11.5 and E12.5. Thus this calculation gives support for ectodermal influx 
being the main contributor to MR growth in that time period. The slightly 
smaller values for  VObs could be due to experimental variation, a small 
contribution of MR-cell proliferation to MR growth, and/or apoptosis occurring 
in the periderm above and within some MRs.  
 Between E12.5 and E13.5  VExp<  VObs, indicating a much smaller 
contribution of ectodermal influx to MR growth. Histological observations 







Our current results indicate that most if not all of these influxing cells were located 
outside the ML between E11.5 and E12.5, prior to their incorporation in the emerging 
MRs in the course of 24 hours. This doesn‘t exclude the possibility that, cells first line up 
along the ML and subsequently migrate towards the prospective MR within 24 hours. 
Such a sequence would be in agreement with our previous suggestion that at least in 
between the forelimb and hindlimb, ectodermal cells may be pulled along in dorso-
ventral direction with signals from the ventrally elongating somites to form the ML 
(Veltmaat et al., 2006). It would also be in agreement with Balinsky‘s suggestion of 




ectodermal cells aggregating in a centripetal manner toward the MR positions (Balinsky, 
1949-1950). Such centripetal migration may be evoked by hypaxial somitic signals near 
the end of hypaxial elongation. For example, highly expressed hypaxial somitic FGF10 
may evoke chemotaxis in the overlying ectoderm, leading to formation of MR3 (Veltmaat 
et al., 2006). In any case, our data may suggest that if cells migrate towards the 
prospective MRs via the ML, then ectoderm continues to contribute to the ML while the 
MRs are being formed from ML cells. This contrasts with the apparent temporal 
separation of formation of the mammary ridge from cell migration towards the 
prospective MRs in the rabbit embryo, as inferred from Propper‘s results from charcoal-
deposition experiments (Propper, 1973; Propper, 1978). It remains experimentally 
challenging to determine the exact extent, and optional spatial and temporal differences 
in directionality of ectodermal influx into the MRs. 
How do the MRs maintain or even increase their growth rate between E12.5 and 
E13.5 if both cell proliferative activity within the MRs and ectodermal influx are 
declining? We show here a previously unidentified mechanism of MR growth, namely by 
hypertrophy of their peripheral cells between E12.5 and E13.5. We estimated that 
hypertrophy could explain perhaps a 1.7 fold increase in MR-volume, which would equal 
80%-100% of growth in that day in a rudiment-specific manner. All estimations together 
(i.e  3%-19% proliferation + 22%-39% cell migration + 80%-100% hypertrophy) add up 
to more than 100% of the growth between E12.5 and E13.5, which may be partly 
explained by the fact that they are estimations, and partly by the need of these 
mechanisms to compensate for the loss of cells by apoptosis occurring to different 
extents among the MRs within themselves and/or in their covering periderm at around 
E12.5.  




Figure 2.6 shows a model of the contribution of all four abovementioned mechanisms 
to MR growth. These mechanisms contribute to different extents and occur 
asynchronously among all MRs. These differences may simply reflect the asynchronous 
emergence of the MRs (Veltmaat et al., 2004). Alternatively, they may reflect molecular 
differences among the MRs, as demonstrated by the variation in phenotype among MRs 
in Gli3Xt-J/Xt-J embryos.   
 
 
Fig. 2.6 A model of the role of Gli3 in regulating MR induction and early growth. 















 All MRs arise and grow initially primarily by an influx from ectodermal cells (blue) with 
little contribution of cell proliferation (orange). Later, the ectodermal influx diminishes but 
remains present, while hypertrophy of peripheral cells within the MRs (green) 
complements further growth. Consistent with the asynchronous emergence of MRs, MRs 
also transition from cell influx to hypertrophy asynchronously. Hence the x-axis does not 
reflect the embryonic age, but the age of the MR. At around the onset of the second day, 
apoptosis (light burgundy) occurs during a short period in the periderm and for some 
MRs also within the MRs themselves, negatively affecting growth. Gli3 promotes 
ectodermal cell migration into the MRs, apoptosis and hypertrophic differentiation, while 
it decreases mammary epithelial cell proliferation. All four processes are active to a 
similar extent in all MRs. However, the role of Gli3 in these processes varies among the 
MRs, as indicated next to the each of the arrows. MR3 and MR5 are not induced in the 
absence of Gli3, hence no role for Gli3 is indicated for the other cellular processes in 
these MRs. The remaining MRs emerge with a slight delay. While MR2 and MR4 
experience a severe growth defect in the absence of Gli3, MR1 develops almost as 







2.5.2 MR-specific roles of Gli3 in cellular processes governing MR growth 
 
We identified that the five MRs in the mouse embryo display differential responses to 
the absence of Gli3: While MR3 and MR5 are not induced at all, MR1, MR2 and MR4 
are about ¼ day delayed in the onset of their formation. Once induced, MR1 follows a 
normal growth rate and morphogenesis, but MR2 and MR4 experience a slow growth 
until at least E13.5. Moreover, MR2 develops as an outward instead of subsided 
protrusion. This protrusion remains unexplained mechanistically, but may be related to 
the higher proliferation rate in the dermal and mammary mesenchyme at E13.5. We 
could attribute the stunted growth of both rudiments largely to a defect in ectodermal 
influx between E11.5 and E12.5, complemented by a failure of peripheral cells to 
differentiate into hypertrophic, columnar cells between E12.5 and E13.5.  
How would GLI3 regulate these cell fate decisions? In general, high levels of 
Hedgehog (HH) signalling maintain GLI3 in a full length transcriptional activator form 
(GLI3A). In the absence of HH signalling, GLI3 is cleaved and becomes a transcriptional 




repressor (GLI3R). While Hh signalling and activator forms of GLI family members have 
migration promoting effects on e.g. enteric nerves, pancreatic stellar cells and 
endothelial cells (Fu et al., 2004; Shinozaki et al., 2008; Renault et al., 2009), it is very 
unlikely Gli3 regulates ectodermal cell migration cell-autonomously at the time of ML and 
MR induction, as by then these cells do not yet express Hh and Gli proteins (Lewis and 
Veltmaat, 2004; Hatsell and Cowin, 2006; Veltmaat et al., 2006). Instead, the migration 
defect during formation and early growth of MR2 and MR4 is likely the consequence of 
perturbed mesenchymal-ectodermal interactions due to a lack of GLI3 function in the 
somites or other mesenchymal tissue (Veltmaat et al., 2006). We speculate this would 
be a GLIR function, similar to the requirement of formation of MR3 and MR5 for GLI3R  
(Hatsell and Cowin, 2006), if we assume that this failure to form MR3 and MR5 is 
perhaps also due to a more severe defect in ectodermal cell migration. But between 
E12.5 and E13.5, GLI3 is also expressed in the ectoderm, and may cell-intrinsically 
contribute to ectodermal migration into MR2 and MR4 as GLI3A. 
The absence of expression of the targets and mediators of HH signalling, patched 
(Ptch1) and Gli1 within the MRs at respectively E13.5 and E14.5 (Hatsell and Cowin, 
2006) strongly suggest the mammary epithelium proper expresses GLI3 in its GLIR-
form. As such, our observed reduction of mammary epithelial cell proliferation in MR2 
and MR4, and apoptosis in MR2-MR5 in the presence of GLI3 would be consistent with 
high GLI3R activity repressing cell cycle progression and promoting cell apoptosis cell-
autonomously in neural progenitor cells (Ulloa and Briscoe, 2007). Finally, the 
differentiation of the peripheral cells into larger columnar cells in MR2 and MR4 could 
depend cell-autonomously on epithelial GLI3, or non-autonomously on GLI3-mediated 
communicative signals emitted by the mesenchyme.  
 




2.6 Summary and implications 
 
We have answered the long-standing question of which cellular mechanisms drive 
the onset of formation and early growth of MRs in the mouse. Gli3 plays a role in all 
processes involved, i.e. proliferation, migration and differentiation into hypertrophic 
columnar cells, as well as apoptosis, apparently regulating the choice between the 
different fates a cell can have. Gli3 remains expressed in the adult mammary gland 
(Hatsell and Cowin, 2006). It may then perhaps likewise regulate the balance between 
normal homeostasis and tumour growth, as supported by the recent identification of Gli3 
in a primary breast tumour expression dataset (Mosca et al., 2009), and similar to what 
has recently been reviewed for several other genes (Howard and Ashworth, 2006; 
Robinson, 2007; Cowin and Wysolmerski, 2010). Of note, despite the similarities among 
MRs regarding the cellular mechanisms regulating their early growth, the function of Gli3 
in these mechanisms differs among the MRs, indicating MRs are not mere copies of the 
same structure, but distinct entities as we have suggested previously (Veltmaat et al., 
2003). Such differential molecular involvement among the various mammary glands may 
provide a beginning to an explanation how differences in numbers and positions of 
mammary glands are created among mammals, and simultaneously raises the question 
whether all five pairs of murine mammary glands can be considered equally appropriate 
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In embryonic day (E) 11.5 mouse embryos, five pairs of mammary rudiments (MRs) 
develop on and from two mammary lines (MLs). In Gli3Xt-J/Xt-J (null) embryos, MR pairs 3 
and MR5 fail to form, while MR2 and MR4 are hypoplastic. In addition, MR2 protrudes 
outwardly. As WNT/β-catenin signalling is required for MR formation, we monitored the 
status of this signalling in Gli3Xt-J/Xt-J embryos using the expression of the WNT/β-catenin 
reporter transgene TOPGAL as readout. At E11.5, Gli3Xt-J/Xt-J;TOPGAL embryos show 
reduced TOPGAL expression along the ML compared to wild type embyos. This 
suggests that WNT/β-catenin signalling activity along the ML is downregulated. We 
reintroduced WNT/β-catenin signalling with transgenic N-terminal truncated stabilized 
β-catenin (Ctnnb1Tg∆N57) under the ectoderm-specific keratin 5 (Krt5) promoter in 
Gli3Xt-J/Xt-J embryos. Formation of MR3, was restored in 44% (n=9) and in 62% (n=13) of 
Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 embryos at E12.5 and E13.5 respectively, while 
MR5 never was. In addition, Ctnnb1Tg∆N57 attenuated the hypoplasia of Gli3Xt-J/Xt-J MR2 
and MR4. We have previously shown that FGF10/FGFR2B signalling acts downstream 
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of Gli3, but upstream of WNT/β-catenin signalling in the formation of MR3. Now, to 
examine if Ctnnb1Tg∆N57can restore the formation of MR3 and perhaps other missing 
MRs in Fgf10-/- and Fgfr2b-/- mutants, we generated Fgf10-/-;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 
and Fgfr2b-/-;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 embryos. Ctnnb1Tg∆N57 is not sufficient to 
rescue the MR defects in these embryos. We propose that sufficiently high levels of 
WNT/β-catenin signalling are required for MR3 induction and the enlargement of MR 
size. Additionally, these observations reveal that the formation and morphogenesis of 





Mammary gland development starts in the embryo at E11.5 with the formation of two 
anatomically- and molecularly-distinct lines in the surface ectoderm; so-called mammary 
lines (ML) that run along both flanks of the embryo (Veltmaat et al 2004). The mammary 
glands are ectoderm-derived appendages that are formed at five bilaterally symmetrical 
locations along the antero-posterior axis in the mouse. However, the molecular 
mechanisms that determine induction and morphogenesis of the MRs at these different 
locations of the ectoderm are largely unknown.  
We and others have previously reported that Gli3Xt-J/Xt-J embryos, containing a non-
functional fusion transcript of the GLI-Kruppel family member 3 (Gli3)  (Buscher et al., 
1998) are impaired in ML formation, fail to induce MR3 (Veltmaat et al., 2006) and MR5 
(Mailleux et al., 2002; Hatsell and Cowin, 2006), while MR2 and MR4 are severely 
hypoplastic and delayed in their growth (Chapter 2). MR1 is mildly hypoplastic but 
develops fairly normally (Chapter 2). Furthermore, MR2 develops with an aberrant 
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morphology as the mammary epithelium protrudes outwardly above the ectoderm at 
E13.5 (Chapter 2).  
The failure of MR3 induction in Gli3Xt-J/Xt-J embryos is due to lowered Fgf10 levels 
within the thoracic somites leading to reduced FGF10/FGFR2B signalling (Veltmaat et 
al., 2006). In addition, we have previously shown that the impaired ML in Gli3Xt-J/Xt-J 
embryos presents with reduced expression of the mammary epithelial markers Wnt10b 
and TOPGAL (Veltmaat et al., 2006), the latter being a lacZ reporter for lymphoid 
enhancer binding factor/T-cell factor (LEF/TCF)-mediated transcription, and widely 
regarded as a canonical WNT/β-catenin signalling reporter (DasGupta and Fuchs, 
1999). It is becoming increasingly clear that WNT signalling play essential roles during 
early mammogenesis as inhibition of this pathway at various levels interferes with the 
induction, growth or maintenance of the MRs. For example, expression of the secreted 
WNT inhibitor, dickkopf 1 (Dkk1) under the ectoderm- and MR-specific Krt5 promoter 
inhibits the induction of all MRs (Chu et al., 2004). In addition, all MRs in Lef1-/- embryos 
regress before E15.5, MR2 and MR3 being the first shortly after induction ((Kratochwil 
K., personal communication; (van Genderen et al., 1994; Boras-Granic et al., 2006)). 
Embryos null for the WNT co-receptors Lrp5 and Lrp6 form smaller buds, with Lrp6-/- 
embryos displaying additional defects in branching morphogenesis (Lindvall et al., 2006; 
Lindvall et al., 2009). Finally, embryos null for the WNT transcriptional co-activator 
Pygo2 show impaired development of the MRs during induction, sprouting and branching 
stages differentially amongst the five MR pairs (Gu et al., 2009).  Therefore, we 
hypothesized based on the reduction of TOPGAL expression in the mammary region in 
Gli3Xt-J/Xt-J embryos that the various MR defects in these embryos are caused by the 
downregulation of the WNT signalling pathway. 
To test this hypothesis, we elevated ectodermal WNT/β-catenin signalling with 
transgenic N-terminal truncated stabilized β-catenin (Ctnnb1Tg∆N57) under the Krt5 
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promoter in Gli3Xt-J/Xt-J embryos. We show that Ctnnb1Tg∆N57by itself can induce 
supernumerary MRs and provides a differential rescue of the MR defects in Gli3Xt-J/Xt-J 
embryos. However, Ctnnb1Tg∆N57did not rescue the MR induction defects in Fgf10-/- and 
Fgfr2b-/- embryos, both of which form a weaker ML, as assessed by TOPGAL 
expression, compared to Gli3Xt-J/Xt-J embryos. This shows that WNT/β-catenin signalling 
activity must be sufficiently high for MR3 induction and MR size determination. The 
differential rescue contributed by Ctnnb1Tg∆N57 in Gli3Xt-J/Xt-J MRs further shows the 
differential requirement of WNT/β-catenin in mediating different developmental aspects, 
namely induction and morphogenesis in each MR. We provide evidence that the MR 
pairs are not merely copies of each other, but unique structures governed by unique 
signalling networks. 
 




Gli3Xt-J/+ mice were maintained on C57BL/6J background (Jackson Laboratories, 
stock 000026) and were genotyped as described (Maynard et al., 2002). Tg(Krt5-
Ctnnb1ΔN57)#Gluk mice (Ctnnb1Tg∆N57) were maintained on a C57BL/6J×DBA/2J 
background and genotyped as described (Teuliere et al., 2005). Fgf10+/– mice were on a 
C57BL/6N background and genotyped as described (Sekine et al., 1999). Fgfr2b+/– mice 
were maintained on a mixed C57BL/6×GK129 background and genotyped as described 
(De Moerlooze et al., 2000). Tg(Fos-lacZ)34Efu (TOPGAL) mice (DasGupta and Fuchs, 
1999) were maintained on a CD1 background and backcrossed for three or four 
generations with C57BL/6J mice. TOPGAL mice were identified by PCR amplification of 
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the lacZ gene, or by 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) staining 
(see below) of tail biopsies (see also Appendix Table A.1 for primer sequences). For 
timed matings, noon of the day of vaginal plug formation was considered E0.5. All 
animals were kept under normal day-night cycle, with food and water ad libitum, and 





3.3.2 X-gal staining 
 
Embryos obtained from Gli3Xt-J/+;TOPGAL, Gli3Xt-J/+;TOPGAL;Ctnnb1Tg∆N57, 
Fgf10+/-;TOPGAL;Ctnnb1Tg∆N57 and Fgfr2b+/-;TOPGAL;Ctnnb1Tg∆N57 respective 
intracrossings were fixed for 2 minutes in 4% paraformaldehyde (PFA) and stained  
overnight, in the dark, at 37°C with 0.8 mg/ml X-gal in 3 mM K3Fe(CN)6/3 mM 
K4Fe(CN)6/1 mM MgCl2 in deionised phosphate-buffered saline (D-PBS), pH 7.4, to 
reveal β-galactosidase activity. Whole mount embryos were imaged with a Leica MZ16F 






TOPGAL embryos from the various intracrosses were paraffin-embedded, 
transversally sectioned at 5 μm (for E11.5-E12.5 embryos) or 6 μm (for E13.5-E14.5 
embryos) thickness and counterstained with Harris‘ Hematoxylin (Sigma-Aldrich) and 
Eosin Y (Sigma-Aldrich). Images were acquired with the Olympus BX61 upright 
microscope with the DP Controller software. For immunostainings, embryos were 
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harvested and fixed in methanol-Carnoy‘s (60% MeOH/30% CHCl3/10% HAc), paraffin-
embedded, and transversally sectioned at 5 μm or 6 μm thickness. 
 
 
3.3.4 Immunostaining of embryo sections 
 
For immunohistochemistry, embryo sections were rehydrated in xylene, 100% and 
95% ethanol, each for 2 minutes, and incubated in 1%H202/MeOH for 15 minutes to 
block endogenous peroxidase activity. This blocking step is omitted for 
immunofluorescence. Rehydration of the sections continues in 95%, 80%, and 70% 
ethanol, and finally in water. Antigen retrieval was done by incubating slides in boiling 
10  mM sodium citrate, pH 7.4 for 20 minutes. Slides were cooled on ice prior to primary 
antibody application. The following primary antibodies were used: rabbit anti-KRT5 
(1:1000, Covance), mouse anti-β-catenin (1:100, BD Transduction Labs), mouse 
anti-active β-catenin (1:100, Millipore), rabbit anti-PYGO2 (1:50, gift from Boan Li and 
Xing Dai). After an overnight incubation at 4°C, slides were washed 3 times in PBS/0.5% 
Tween-20, and incubated with goat anti-mouse HRP (1:100, Jackson) for 
immunohistochemistry, or for immunofluorescence, a fluorescent-tagged secondary 
antibody: goat anti-rabbit Alexa Fluor 594 (Invitrogen, 1:500), or goat anti-mouse Alexa 
Fluor 488 (Invitrogen, 1:500).  After a 1 hour incubation at 37°C or an overnight 
incubation at 4°C, slides were washed 3 times in PBS/0.5% Tween-20. For 
immunohistochemistry, diaminobenzidine was used as substrate to produce a brown 
precipitate. For immunofluorescence, sections were stained with 4',6-diamidino-2-
phenylindole (DAPI) or Hoechst-33342 (Sigma-Aldrich) to visualize cell nuclei and 
mounted in Vectashield (Vector Laboratories). Images were acquired with an Olympus 
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BX61 upright microscope with the DP Controller software or a Leica DM6000B 




3.3.5 MR dissection and RNA isolation  
 
Individual MRs, ectoderm and dermal mesenchyme were dissected in RNAlater 
(Ambion) from E13.5 embryos according to a protocol established by Sun et al., 
(submitted). In short, embryos in RNAlater were thawed on ice and transferred to a petri 
dish containing RNAlater at room temperature. The head and tail of embryos were cut 
off, after which the embryo was cut into half along the neural tube. Limb buds and 
internal organs were removed. Somitic mesoderm was peeled away until two flanks 
consisting of only ectoderm, including the MRs, and dermal mesenchyme were obtained. 
Such cleared flanks were transferred to 40% of RNAlater in PBS for partial rehydration. 
The MRs, ectoderm and the underlying mesenchyme could then be easily separated 
from each other using a pair of forceps.  
After pooling 6 to 12 MRs, small pieces of the ectoderm and mammary mesenchyme 
were dissected and collected. Tissues, aspirated with 2 μl to 5 μl of RNAlater were put 
into 100 μl RLT plus lysis buffer (Qiagen). Total RNA was extracted using the RNeasy 





The extracted RNA was reversed transcribed with First-Strand Synthesis System 
(Invitrogen) using oligo-dT primers according to manufacturer‘s instruction. The resulting 
cDNA was used as template for PCR with the following primers: HA-Ctnnb1Tg∆N57 
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forward: 5‘-TTA TGA CGT GCC TGA CTA TGC-3‘ and reverse: 5‘-CGT CAA ACT GCG 
TGG ATG-3‘ and β-actin forward: 5‘-CCT GAA CCC TAA GGC CAA CCG-3‘ and 




3.3.7 Immunofluorescence of whole mount ectoderm and MRs 
 
The ectoderm, with MRs attached, was peeled off from RNAlater-treated embryos 
(as described earlier) and spreaded and pinched on a polyethylene tissue culture 
coverslip (Sarstedt). The coverslips were rinsed and equilibrated in PBS. Samples were 
fixed with either 4% PFA or methanol-Carnoy‘s for 15 minutes. Ectoderm and attached 
MRs were then blocked for 1 hour at room temperature with 5% BSA/0.5% Tween-20 
and incubated with a primary antibody. The following antibodies were used:  mouse anti-
HA (1:100, Roche) and rat anti-HA (1:100, Roche) at 4°C overnight. After a wash with 
PBS/0.5% Tween-20, the ectoderm and attached MRs were incubated with goat anti-
mouse or anti-rat Alexa Fluor 488 overnight at 4°C. After 3 washing steps in PBS/0.5% 
Tween-20, sections were stained with Hoechst-33342 to visualize cell nuclei. The 





3.3.8 Carmine red staining 
 
E18.5 embryos were harvested and skins were dissected, flattened on microscope 
slides and fixed in methanol-Carnoys‘s overnight at room temperature. After 5 minute 
rehydration steps in 70% ethanol and water, the skins were stained in Carmine alum at 
4°C overnight. Skins were then washed in water and dehydrated progressively in 70%, 
80%, 90%, 100% ethanol and lastly xylene to clear the fat on the skins that may obscure 
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the visibility of the MRs. Images were acquired with a Leica MZ16F stereomicroscope 





3.4.1 Gli3Xt-J/Xt-J MRs display a loss or reduction of TOPGAL expression  
 
We and others have previously shown that Gli3Xt-J/Xt-J embryos fail to induce MR3 
(Veltmaat et al, 2006) and MR5 (Mailleux et al, 2002; Hatsell and Cowin, 2006). 
Moreover, Gli3Xt-J/Xt-J embryos show defective ML formation as seen by the expression 
pattern of TOPGAL (Veltmaat et al, 2006). While wild type embryos form a broad band 
of TOPGAL-positive cells from the forelimb to the hindlimb at E11.5, Gli3Xt-J/Xt-J embryos 
form a narrower ML with fewer, and more sparsely distributed TOPGAL-expressing cells 
(Fig. 3.1 A, B; (Veltmaat et al., 2006)). Histological analysis show that all TOPGAL-
positive cells are localized to the region of single-layered enlarged columnar cells or 
already multi-layered surface ectoderm (Fig. 3.1 A‘, B‘), i.e. to the ML (Veltmaat et al., 
2004; Veltmaat et al., 2006). Whole-mount analysis at E12.5 show a slightly smaller 
TOPGAL domain at the position of Gli3Xt-J/Xt-J MR2 (Fig. 3.1 D) while at E13.5, three 
phenotypes of Gli3Xt-J/Xt-J MR2, classified as mild hypoplasia (Fig. 3.1 F),  severe 
hypoplasia (Fig. 3.1 G) and absent (Fig. 3.1 H) are observed. As Gli3Xt-J/Xt-J MR2 is 
always observed at E12.5, the 30% (n=10 MR2) of absent Gli3Xt-J/Xt-J MR2 that are not 
discernable by TOPGAL expression or by histology (Fig 3.1 G, Table 3.1) indicates that 
MR2 is always induced but will regress in some embryos by E13.5 (Table 3.1). The 
absence of MR2 could be a genetic-background specific effect of the TOPGAL mice 
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strain (mixed CD1,  3 or 4 backcrosses with C57BL/6J mice) as it is never observed in 
Gli3Xt-J/Xt-J embryos of the pure C57BL/6J background at E13.5 (n=16 MR2). 
 
Fig. 3.1. Gli3Xt-J/Xt-J  embryos show loss or reduced TOPGAL expression.  
(A-G) Lateral view of mouse embryo flanks showing TOPGAL expression (blue). 
TOPGAL marks the mammary line (ML) at E11.5. Gli3Xt-J/Xt-J  embryos form a narrower 
mammary line with sparsely-distributed TOPGAL-expressing cells (B). (A’-B’) 
Histological sections showing the ML in wild type (A’)  and Gli3Xt-J/Xt-J  (B’) embryos and 
the localization of TOPGAL expressing cells in the ectoderm. TOPGAL expression along 
the ML becomes progressively restricted to the MRs at E12.5 (C) and E13.5 (E). At 
E13.5 in Gli3Xt-J/Xt-J embryos, the induced MRs are marked by a smaller TOPGAL domain 
(F, G), or absent at the region of MR2 (G). Note: MR2 in (F) is classified as mild 
hypoplasia (G) as severe hypoplasia and (H) as absent. Arrowheads in (E) indicate 
emerging hair follicles, which are absent in Gli3Xt-J/Xt-J  embryos (F, G, H). Scale bar in A-





Table 3.1: Frequency of MR2 phenotypes in Gli3Xt-J/Xt-J ;TOPGAL embryos 
Severity of MR2 
phenotype 
Frequency of phenotype (number of MR) 
E12.5 (n=24) E13.5 (n=10) E14.5 (n=4, fem.) 
Mild hypoplasia 67% (16) 40% (4) 0% (0) 
Severe hypoplasia 33% (8) 30% (3) 25% (1) 
Absent 0% (0) 30% (3) 75% (3) 
Note: Before E14.5, MR development proceeds similarly in male and female embryos. 
Thus, embryo genders were not determined for the E12.5 and E13.5 groups.  fem: 
female. 
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TOPGAL expression along the ML becomes progressively restricted to the MRs from 
E11.5 to E14.5. Histological analysis shows that with the exception of MR1, TOPGAL is 
expressed exclusively within the epithelial compartment of the MRs (Fig. 3.2). Gli3Xt-J/Xt-J  
MR1, MR2 and MR4 have a smaller domain of TOPGAL expression. Consistent with our 
previous finding (Chapter 2) Gli3Xt-J/Xt-J  MR2 fails to invaginate at E13.5 (Fig. 3.2 Q). At 
E14.5, 75% (n=4) of female Gli3Xt-J/Xt-J MR4 exhibit this morphogenetic defect (Fig. 3.2 
AC, Table 3.1).   
MR development diverges between the two sexes at E14.5. In wild type (wt) females, 
the bud enlarges and continues to develop inwardly into the mesenchyme. In wt males, 
action of androgens on the mesenchyme, which constricts the epithelium and halts 
further development (Durnberger and Kratochwil, 1980; Sakakura et al., 1982), causes 
the mammary epithelium to regress and form irregular shapes (Fig. 3.2 AE-AI). In 
addition, a subset of MRs develop outwardly (Fig. 3.2 AH, AI). Interestingly, the 
protruding phenotype of Gli3Xt-J/Xt-J MR2 at E13.5 and Gli3Xt-J/Xt-J MR4 at E14.5 is 
reminiscent of the morphology of MR4 in wt males at E14.5 (compare Fig. 3.2 Q and 3.2 
AH, AI), suggesting that MR development in Gli3Xt-J/Xt-J may proceed along the male 
developmental pathway (see also Chapter 5 for further discussion).  
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Fig. 3.2. Gli3Xt-J/Xt-J  embryos show MR-specific defects.  
(A-AI) Histological sections showing the central sections of MRs of wild type and 
Gli3Xt-J/Xt-J  embryos from E12.5 to E14.5. With exception of the mesenchymal TOPGAL 
expression near MR1, TOPGAL expression is confined to the mammary epithelium, and 
at E12.5 to an adjacent ectodermal ‗tail‘ as well. TOPGAL is first expressed in the 
ectoderm and mammary epithelium and becomes restricted to the MRs by E13.5 and 
E14.5 except for MR1 which have TOPGAL expression in the mesenchyme (K, L). 
Gli3Xt‐J/Xt‐J embryos have a smaller domain of TOPGAL expression (F-J, P-T, Z-AD), 
concurrent with the absence of MR3 (H, R, AB) and MR5 (J, T, AD), and the mild MR1 
(F, P, Z), to severe MR2 (G, Q, AA) and MR4 (I, S, AC) hypoplasia of MRs. (U-Y, AE-
AI) MR development diverges between the genders at E14.5. (U-Y) In females, the MR 
continues to enlarge and develop inwardly. In males, the MRs regress, form irregular 
shapes, and develop outwardly (AE-AI). Note the protrusions of Gli3Xt-J/Xt-J  MR2 at E13.5 
(Q) and Gli3Xt-J/Xt-J  MR4 at E14.5 (AC), which resemble a subset of male MRs at E14.5 
(AH, AI). Scale bar in A: 100 µm. 
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3.4.2 Misregulation of β-catenin, active β-catenin and PYGO2 expression in  
Gli3Xt-J/Xt-J MRs 
 
The smaller domain of TOPGAL expression suggests the misregulation of WNT 
pathway members. We therefore analyzed the expression of downstream pathway 
members, β-catenin and PYGO2. β-catenin and PYGO2 are transcriptional co-activators 
of WNT-target genes. At E12.5 and E13.5, endogenous β-catenin is predominantly 
localized to the cell membrane of the surface ectoderm and the mammary epithelium, as 
previously reported (Foley et al., 2001; Boras-Granic et al., 2006), with areas of higher 
expression in the latter compartment (Fig. 3.3 A-H). High β-catenin expression is also 
noted in the mammary mesenchyme (Fig. 3.3 A-H). Expression of β-catenin is not 
altered appreciably in the mammary epithelial compartment of Gli3Xt-J/Xt-J MRs. However, 
elevated levels of β-catenin are observed in the mesenchyme of Gli3Xt-J/Xt-J MR1, and to a 
greater extent in Gli3Xt-J/Xt-J MR2 (Fig. 3.3 G).  
As WNT signalling activity is dependent on transcriptionally active β-catenin we next 
asked if the levels of transcriptionally active β-catenin are affected in the Gli3Xt-J/Xt-J MRs. 
At E13.5, nuclear active β-catenin expression is observed in the mammary epithelium 
and mammary mesenchyme of wild type MR2 (Fig. 3.4 I). Preliminary data show that the 
levels of active β-catenin are downregulated in both the mammary epithelium and 
mesenchyme of Gli3Xt-J/Xt-J MR2 (Fig. 3.4 J). Thus, while total levels of β-catenin are not 
altered in the mammary epithelium of Gli3Xt-J/Xt-J MR2, the subset of β-catenin that is 
available for WNT signalling-mediated transcription is downregulated in this MR.  
 Pygopus (Pygo) was first identified through genetic screens for components of 
Drosophila wingless/WNT signalling (Belenkaya et al., 2002; Thompson et al., 2002). 
PYGO is required for high β-catenin levels during WNT signalling and increases the 
transcriptional activity of β-catenin in Drosophila embryos (Townsley et al., 2004) by the 
recruitment of chromatin remodelling complexes (reviewed in (MacDonald et al., 2009)). 
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Mammals have two Pygo homologs: Pygo1 and Pygo2 (Thompson et al., 2002; Li et al., 
2004). During mammary gland development, Pygo2 is required for MR-specific 
induction, growth and branching morphogenesis (Gu et al., 2009). 
PYGO2 is expressed within all MRs and at the basal layer of the ectoderm at E12.5 
and E13.5 in wild type (Fig. 3.3 K-O, data not shown). In Gli3Xt-J/Xt-J MR2, PYGO2 is 
highly expressed in the epithelial cells at the base of the bud, while the apex of the bud 
is devoid of PYGO2 expression, as if cells here have not fully differentiated (Fig 3.3 Q).  
In summary, the downregulation of transcriptionally active β-catenin and PYGO2 
suggests that the downregulation of WNT signalling in Gli3Xt-J/Xt-J embryos, is caused by 
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3.4.3 Ctnnb1Tg∆N57 rescues the induction of Gli3Xt-J/Xt-J MR3, but not MR5 
 
The downregulation of TOPGAL expression from E11.5 to E13.5 pointed to the 
potential involvement of WNT signalling for the induction of MR3 and MR5; the size 
regulation of MR1, MR2, and MR4; and the invagination of MR2 and MR4, downstream 
of Gli3. Thus, we hypothesized that these mammary phenotypes may be rescued by the 
reactivation of WNT signalling.  
To reintroduce WNT/β-catenin signalling, Gli3Xt/+;TOPGAL mice were crossed with 
Ctnnb1Tg∆N57 mice which carry a HA-tagged N-terminal truncated β-catenin transgene 
under the control of the Krt5 promoter (Teuliere et al., 2005). The truncated β-catenin 
transgene lacks the phosphorylation sites that are required for proteasome-mediated 
degradation. Ctnnb1Tg∆N57 would then be recruited for transcription of WNT-target genes.  
KRT5 is expressed in the ectoderm and mammary epithelium of wild type embryos (Fig. 
3.4 A-D) as well as Gli3Xt-J/Xt-J embryos at E12.5 and E13.5 (Fig. 3.4 E-G). MR5 was not 
analyzed. The Krt5 promoter would thus be expected to target expression of stabilized 
β-catenin to the ectoderm and MRs of wild type and Gli3Xt-J/Xt-J embryos. 
Transgene expression was detected by RT-PCR on RNA from cleared embryo flanks 
at E12.5 (data not shown) and dissected MRs at E13.5 (Fig. 3.4 H). The levels of 
transgene expression are relatively similar in all five MRs and in the ectoderm. 
Unexpectedly, we detected ectopic mesenchymal expression of the transgene as well 
(Fig. 3.4 H). Detection of transgene expression via immunostaining for the transgenic 
protein proved to be challenging. On one occasion, we detected the transgenic protein, 
seemingly localized to vesicular structures within a Ctnnb1Tg∆N57/Tg∆N57 embryo MR1 at 
E13.5 (Fig. 3.4 I), and a predominantly membrane-localized staining within another MR 
(Fig. 3.4 K). This may suggest that transgene expression is low and variable among 
embryos.   
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Fig. 3.4. Ctnnb1TgΔN57  is expressed in the MRs at E12.5 and E13.5.  
(A-G) Expression of endogenous keratin 5 (KRT5) in wild type and Gli3Xt‐J/Xt‐J MRs at 
E12.5 and E13.5. KRT5 is expressed at similar levels in all MRs. MR5 was omitted from 
the analysis. (H) RT-PCR of the Ctnnb1TgΔN57 transgene in Ctnnb1TgΔN57/TgΔN57 embryos, 
using primers targeted to the HA-tag. Transgene expression was detected at similar 
levels in the MRs, ectoderm and mesenchyme at E13.5. (I-L) Transgenic protein 
expression was detected at variable levels in E12.5 Ctnnb1TgΔN57/TgΔN57 MRs (I, K), either 
localized to vesicular structures (I) or localized predominantly at the membrane (K). 





We analysed the mammary phenotypes of Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/0 and 
Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 embryos from E11.5 to E13.5. At E11.5, the ML of 
Gli3+/+;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 is made up of TOPGAL-expressing cells extending 
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from the forelimb to hindlimb, in a similar pattern to Gli3+/+;TOPGAL embryos without the 
transgene (Fig. 3.1 B, 3.5 B). Thus, the ML of Gli3Xt-J/Xt-J;TOPGAL embryos is not altered 




Fig. 3.5. Ctnnb1TgΔN57 restores MR3 in Gli3Xt-J/Xt-J embryos and promotes 
supernumerary MR formation.  
(A-H) Lateral view of E11.5 to E13.5 mouse embryo flanks showing TOPGAL expression 
(blue) within the MRs. (A-B) The mammary lines in both wild type and Gli3Xt-J/Xt-J 
embryos are not altered appreciably with the Ctnnb1Tg∆N57 transgene (see also Fig. 3.1). 
However, Ctnnb1Tg∆N57 restores MR3 formation in a subset of Gli3Xt-J/Xt-J embryos (E, H).  
Moreover, in some control and Gli3Xt-J/Xt-J embryos, supernumerary MRs are formed at 
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As shown in Table 3.2, even in the absence of Ctnnb1Tg∆N57, 33% (n=9) of E13.5 
Gli3Xt-J/Xt-J;TOPGAL embryos of the CD1×C57BL/6J×DBA/2J background form MR3 
while Gli3Xt-J/Xt-J;TOPGAL embryos of the CD1×C57BL/6J genetic background never do 
(n=5).  Introduction of one allele of the Ctnnb1Tg∆N57 transgene does not increase this 
frequency of MR3 formation (Table 3.2). Together, this suggests that the DBA/2J genetic 
background may favour the formation of MR3 and that hemizygosity of the transgene 
does not confer any effect on MR development. However, homozygosity of the 
transgene augmented the frequency of rescue of MR3 to 44% (n=9) at E12.5 and 62% 
(n=13) at E13.5. Furthermore, while embryos without or with one allele of the 
Ctnnb1Tg∆N57 transgene form MR3 unilaterally only, two alleles of Ctnnb1Tg∆N57 increase 
the frequency of bilateral formation of MR3 in Gli3Xt-J/Xt-J;TOPGAL embryos at E12.5 and 
E13.5 (Table 3.3).  
8% (n=26) at  E12.5 and 10% (n=52)  at E13.5 of wild type and Gli3Xt-J/+ embryos 
homozygous for the Ctnnb1Tg∆N57 transgene show the formation of supernumerary MRs 
(Fig. 3.5 D and G; Table 3.4). These supernumerary MRs are always smaller than 
normal MRs and are formed either anterior or posterior to MR3. Notably, we also 
observed the formation of supernumerary MRs in the vicinity of MR3 in two 
Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57  embryos (MR3+ in Fig. 3.5 H). Whole-mount 
lateral view of embryo flanks show that the rescued MR3 may be formed at a position 
similar to the normal position of wild type (Fig. 3.5 E) or slightly displaced posteriorly 
MR3 (MR3+ in Fig. 3.5 G).  
Interestingly, although the expression of the transgene, as assessed by RT-PCR is 
similar in all 5 MRs, the lack of induction of MR5 was never rescued in 
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Table 3.2: Frequency of MR3 formation in Gli3Xt-J/Xt-J embryos with or without 
Ctnnb1TgΔN57 from E11.5 to E18.5  
Note: Before E14.5, MR development proceeds similarly in male and female embryos. Thus, 







Table 3.3: Ratio of MR3 unilateral to bilateral MR3 formation in Gli3Xt-J/Xt-J embryos 






Frequency of MR3 in Gli3
Xt-J/Xt-J
 embryos   
(% unilateral/% bilateral) 














































C57BL/6J ND ND 100%/0% ND ND 
 Note: Before E14.5, MR development proceeds similarly in male and female embryos. Thus, 
embryo genders were not determined for embryos in the E11.5-E13.5 groups. Only embryos that 
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Table 3.4: Frequency of supernumerary MR3 formation in control and Gli3Xt-J/Xt-J 
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Note: Before E14.5, MR development proceeds similarly in male and female embryos. Thus, 
embryo genders were not determined for embryos in the E11.5-E13.5 fem: female, ND: not 




3.4.3 Stabilized β-catenin partially rescues the maintenance of Gli3Xt-J/Xt-J MR2, 
attenuates the hypoplasia of Gli3Xt-J/Xt-J MR1, MR2, and MR4, but is insufficient to 
mediate the invagination of Gli3Xt-J/Xt-J MR2 and MR3  
 
As shown previously, while Gli3Xt-J/Xt-J MR2s are always induced, some will regress 
by E13.5. As the downregulation of WNT signalling in Lef1-/- embryos results in the 
failure of maintenance of some MRs beyond the bud stage ((Kratochwil, K. personal 
communication; (van Genderen et al., 1994; Boras-Granic et al., 2006)), we asked if the 
restoration of WNT signalling by Ctnnb1TgΔN57 can promote the maintenance of Gli3Xt-J/Xt-J 
MR2. Indeed, by whole-mount analysis, the introduction of Ctnnb1TgΔN57 decreased the 
frequency of MR2 regression in Gli3Xt-J/Xt-J embryos (compare Tables 3.1 with 3.5). 
Interestingly, the addition of Ctnnb1TgΔN57 shifts the phenotype of MR2 from severe to 
predominantly mild hypoplasia. Moreover, the percentage of Gli3Xt-J/Xt-J embryos with 
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absent MR2 is reduced from 30% to 4% with the introduction of Ctnnb1TgΔN57 (Table 3.1 
and 3.5). This indicates that homozygosity of Ctnnb1TgΔN57 sustains the development of 
Gli3Xt-J/Xt-J MR2 at least until the bud stage.  
 
 
Table 3.5: Frequency of MR2 phenotypes in Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57  
embryos 
Severity of MR2 
phenotype 
Frequency of phenotype (number of MR) 
E12.5 (n=18) E13.5 (n=26) E18.5 (n=7), fem. 
Mild hypoplasia 89% (16) 96% (25) ND 
Severe hypoplasia 11% (2) 0% (0) ND 
Absent 0% (0) 4% (1) 0% (7) 
Note: Before E14.5, MR development proceeds similarly in male and female embryos. 







In agreement with whole-mount analysis, histological analysis of 
Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 embryos show an increase in MR2 size compared 
to embryos without the CtnnbTg∆N57 transgene at E12.5 and E13.5 (Fig. 3.6). Moreover, 
the enlargement of MR size was also observed in Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57  
MR1 and MR4. As we have previously shown that Gli3Xt-J/Xt-J MR1, and in particular MR2 
and MR4 are hypoplastic (Chapter 2), the addition of Ctnnb1Tg∆N57/Tg∆N57 thus attenuates 
the hypoplasia of all Gli3Xt-J/Xt-J MRs. The extent of rescue is greatest in Gli3Xt-J/Xt-J MR4 
and perhaps MR2 which almost regain wild type MR size (compare Figs. 3.7 D with N; 
3.8 D with N). However, Gli3Xt-J/Xt-J MR2 remains protruded (Fig. 3.6 L, AA). In addition, 
wild type MRs with homozygosity of Ctnnb1Tg∆N57 are also larger in size (Fig. 3.6). The 
levels of Ctnnb1Tg∆N57 are crucial as the size increase was not observed in MRs with 
hemizygosity of Ctnnb1Tg∆N57 (data not shown).  
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In 33% (n=3) of Ctnnb1Tg∆N57/Tg∆N57 embryos (both Gli3+/+;TOPGAL and 
Gli3Xt-J/Xt-J;TOPGAL) at E12.5 and E13.5, TOPGAL expression is seen in the mammary 
mesenchyme of all rudiments (Fig.  3.6 F-O, U-AD), but never in Gli3Xt-J/Xt-J;TOPGAL 
MRs from E11.5 to E14.5 in the absence of Ctnnb1Tg∆N57 (Fig. 3.2). Thus the 
mesenchymal TOPGAL expression could be either an effect of the Ctnnb1Tg∆N57 
transgene in the mammary epithelium on the mesenchyme, or a result of ectopic 
transgene expression in the mesenchyme. This is also supported by the observation of 
transcript expression in the mammary mesenchyme (Fig. 3.4 H). 
While homozygosity of Ctnnb1Tg∆N57 rescued the induction defect of Gli3Xt-J/Xt-J MR3, 
histological analysis reveal that the rescued MR3 is hypoplastic and morphologically 
aberrant, as the bud protrudes outwardly (Fig. 3.6 M and AB) Also, mammary 
mesenchyme development seems to be impaired in the rescued MR3 as the 
condensation of the mesenchyme around the MR is less evident compared to wild type 
MRs (compare Figs. 3.6 C, R with 3.6 M, AB).  
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Fig. 3.6. Ctnnb1TgΔN57 restores MR3 formation, but not invagination in Gli3Xt-J/Xt-J 
embryos, and attenuates the hypoplasia of Gli3Xt-J/Xt-J MR2 and MR4. 
(A-O) Histological sections of E12.5 and (A-E, P-T) E13.5 MRs showing TOPGAL 
expression localized within the mammary epithelium of all MRs, as well as the 
mesenchyme of MR1 only. (F-O, U-AD) Homozygosity of the Ctnnb1Tg∆N57 transgene 
promotes the enlargement of all MRs. Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57  embryos 
form a hypoplastic and protruding MR3 (M, AB). Note TOPGAL expression in the 




3.4.4 Stabilized β-catenin does not rescue proper branching morphogenesis of 
Gli3Xt-J/Xt-J MRs and does not maintain the rescued Gli3Xt-J/Xt-J MR3 
 
We wanted to determine whether the morphologically defective Gli3Xt-J/Xt-J MRs are 
maintained beyond E13.5. By E18.5, the wild type MRs have branched out and adopted 
a rudimentary ductal tree structure (reviewed in (Veltmaat et al., 2003). Carmine red 
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stained E18.5 embryonic skins show that Gli3Xt-J/Xt-J MRs are maintained but have fewer 
branches emerging from the primary duct (Fig. 3.7 F-H). There is no effect of 
Ctnnb1Tg∆N57 on the branching morphogenesis of wild type and Gli3Xt-J/Xt-J  MRs (Fig. 3.7 
I-P). 
No MR3 was observed in Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57  embryos at E18.5 
(n=7 females). As KRT5 is still expressed in the epidermis up until this stage (Sun et al., 
2010), the absence of MR3 is likely not due to the absence of transgene expression at 
this stage, but rather to the insufficiency of Ctnnb1Tg∆N57 in mediating the maintenance of 
MR3 after E13.5.  
 
 
Fig. 3.7. Ctnnb1Tg∆N57 does not affect MR branching morphogenesis at E18.5. 
 (A-P) Carmine red–stained skin preparations showing MRs as branched structures 
connected to the nipple (outlined in A). Wild type MRs form a branched structure (A-E) 
and this is not altered with Ctnnb1Tg∆N57 expression (I-M).  Gli3Xt-J/Xt-J MRs (F-H) have 
fewer branches, and this is not changed with Ctnnb1Tg∆N57 expression (N-P). No rescued 
Gli3Xt-J/Xt-J;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 MR3 was ever observed at this stage (n=7 
females), suggesting that the rescued MR undergoes regression. Scale bar in A-P: 
0.5 mm. 
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3.4.5 Stabilized β-catenin does not rescue the mammary phenotype of Fgf10-/- 
and Fgfr2b-/- embryos 
 
Fgf10 and Fgfr2b are required for TOPGAL expression along the mammary line and 
the induction of all MRs with the exception of MR4 ((Veltmaat et al., 2006), Fig. 3.8 A-C). 
Gli3Xt-J/Xt-J embryos fail to form MR3 due to diminished Fgf10 expression in the somites 
(Veltmaat et al, 2006). As MR3 can be reinstated with the overexpression of 
Ctnnb1Tg∆N57 in Gli3Xt-J/Xt-J embryos, we asked whether overexpression of Ctnnb1Tg∆N57 
would be sufficient to induce MR3, and bypass the requirement for Fgf10 or its main 
receptor Fgfr2b as it does for Gli3.  
We generated Fgf10-/-;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 and 
Fgfr2b-/-;TOPGAL;Ctnnb1Tg∆N57/Tg∆N57 embryos between E11.5 and E13.5 (Fig. 3.8). At 
E11.5, formation of the mammary line by TOPGAL expression is impaired in both 
Fgf10-/- and Fgfr2b-/- mutants. TOPGAL is only expressed in a small streak of at the 
region where MR4 is formed (Fig. 3.8 B, C). Preliminary data shows that the addition of 
the Ctnnb1Tg∆N57 transgene slightly lengthens the TOPGAL expression domain at the 
level of MR4 (Fig. 3.8 E, F). In some cases, additional fragments at the level of MR3 in 
the Fgf10-/- embryo  are observed (Fig. 3.8 E).  
 At E12.5 and E13.5, MR4 is visible as a distinct domain of TOPGAL expression and 
histologically as a bud in Fgf10-/-;TOPGAL (Fig. 3.8 H, N) and Fgfr2b-/-;TOPGAL (Fig. I, 
O) embryos, and this is not altered with the addition of Ctnnb1Tg∆N57 (Table 3.6). Thus 
Ctnnb1Tg∆N57 is insufficient to mediate the induction of the ML, MR1, MR2, MR5 and in 
particular MR3 in the absence of Fgf10 and Fgf2b.  
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Fig. 3.8. Ctnnb1TgΔN57 does not rescue MR3 induction in Fgf10-/- and 
Fgfr2b-/- embryos.  
(Continued on next page) 
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(A-R) Mouse embryo flanks showing TOPGAL expression (blue). At E11.5, Fgf10-/-   (B) 
and Fgfr2b-/-  (C) embryos form a streak of TOPGAL-expressing cells at the level of MR4. 
The TOPGAL domain in these mutants is, in some cases, lengthened by the introduction 
of Ctnnb1TgΔN57 (E, F). Note the presence of TOPGAL-expressing cells at the thoracic 
region (denoted by arrowheads in (E)). At E12.5 and E13.5, Fgf10-/- and Fgfr2b-/-  
mutants form only MR4 (N, O) and this is not altered with Ctnnb1TgΔN57 (Q, R).  Note 
emerging hair follicle denoted by arrowheads in wild type embryos (P). The hair follicle 
defect in Fgf10-/- and Fgfr2b-/-  mutants is not rescued by Ctnnb1 TgΔN57/Tg∆N57  (K, L). Scale 





Table 3.6: Frequency of MR3 formation in Fgf10-/- and Fgfr2b-/- embryos with 







Frequency of MR3 in Fgf10-/-   and Fgfr2b-/- 
embryos   (n/total embryos) 
 


















Our previous observation of impaired mammary line formation in the Gli3Xt-J/Xt-J 
embryo associated with reduced TOPGAL expression (Veltmaat et al., 2006) suggested 
the downregulation of canonical WNT/β-catenin signalling in Gli3Xt-J/Xt-J embryos. This 
observation, and the known critical requirement of WNT/β-catenin signalling during 
embryonic mammary gland development (Chu et al, 2004), led us to hypothesize that 
the downregulation of canonical WNT/β-catenin signalling may be may be causal to the 
induction and morphological defects of Gli3Xt-J/Xt-J MRs. We therefore tested whether the 
MR phenotype of Gli3Xt-J/Xt-J embryos can be rescued by increasing the pool of stabilized 
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β-catenin. Overexpression of stabilized β-catenin rescues formation of MR3 in Gli3Xt-J/Xt-J 
embryos, even as late as E13.5. While the hypoplasia of the rescued MR3 could mean 
that the rudiment exhibits slower growth dynamics, and therefore is still too small for 
detection at earlier stages, a late induction may suggest that the embryonic ectoderm is 
still malleable and can adopt a mammary epithelium fate even at this stage of 
development. This has been seen previously in the paired-box homeobox Pax3ILZ/ILZ 
(null) mutant which show delayed formation of MR3 (Veltmaat et al., 2006). 
Gli3 is expressed in the somites at E11.5 (Veltmaat et al., 2006). The repressor form 
of GLI3 (GLI3R) is required for the induction of MR3 and MR5 (Hatsell and Cowin, 
2006). In wild type embryos, GLI3R is indirectly required to maintain high levels of Fgf10 
in the somites (Veltmaat et al, 2006). FGF10 signalling via FGFR2B, in turn is required 
for WNT/β-catenin signalling in the ectoderm and formation of MR3 (Fig. 3.9, Scenario 
1). However, in the absence of Fgf10 and Fgfr2b, downstream mediators of Gli3, 
(Veltmaat et al., 2006), stabilized β-catenin is not able to induce MR3.  
We present the following model of action of β-catenin to explain the differences in 
MR rescue between Gli3Xt-J/Xt-J, Fgf10-/- and Fgfr2b-/- embryos. This model is based on 
the observed differences in basal WNT signalling in these mutants, and the assumption 
that a certain threshold of WNT signalling must be exceeded for MR formation to occur. 
Indeed, hyperactivation of WNT signalling with the GSK3β inhibitor, LiCl, in embryo 
cultures promoted supernumerary MR induction (Chu et al., 2004). In this study, the 
addition of an allele of stabilized β-catenin transgene in wild type embryos minimally 
elevates WNT/β-catenin signalling activity, with no change in the induction of MRs 
(Scenario 2). In contrast, the addition of two alleles of the stabilized β-catenin transgene 
results in high WNT/β-catenin signalling activity and results in some cases, in the 
formation of supernumerary MRs in addition to, and in the vicinity of the normal MR3 
(Scenario 3).  
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In the absence of GLI3R, Fgf10 is present at low levels, resulting in low 
WNT/β-catenin signalling activity and the absence of MR3 (Scenario 4). Similar to wild 
type embryos, the addition of a single allele of stabilized β-catenin only minimally 
elevates WNT/β-catenin signalling and MR3 remains uninduced. However, the addition 
of two alleles of stabilized β-catenin significantly elevates WNT/β-catenin signalling, 
causing the induction of MR3, and occasionally supernumerary MRs (Scenario 6). In the 
absence of Fgf10, WNT/β-catenin signalling activity is absent in the ectoderm and MR3 
is not induced. The addition of a single allele (Scenario 7) or two alleles of stabilized 
β-catenin is not sufficient to elevate WNT/β-catenin signalling to critical levels required 








Fig. 3.9. Model of action of Ctnnb1Tg∆N57 downstream of GLI3R and FGF10 in the 
induction of MR3 during embryonic mammary gland development. 
 In the absence of GLI3R (R: Repressor), FGF10 expression is diminished, resulting in 
low WNT/β-catenin signalling activity in the ectoderm and the failure of MR3 induction 
(Scenario 5). With the introduction of Ctnnb1Tg∆N57, WNT/β-catenin signalling activity is 
elevated and is now sufficient to rescue the absence of MR3, and in some instances, 
even facilitate supernumerary MR formation (Scenario 6). In the absence of 
FGF10/FGFR2B signalling, WNT/β-catenin signalling activity is absent in the ectoderm 
and MR3 fails to form. Ctnnb1Tg∆N57 is not able to elevate WNT/β-catenin signalling 
activity to sufficiently high levels for MR3 induction (Scenarios 8, 9). Colour gradients 
indicate relative gene expression levels, cross in white boxes indicates no expression. 
As GLI3 is present as a transcriptional repressor, its transcriptional promoting effect on 
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While the preceding model proposes that Ctnnb1Tg∆N57 solely triggers WNT/β-catenin 
signalling downstream of Fgf10, it remains possible that the ectopically expressed 
Ctnnb1Tg∆N57 in the mesenchyme elevates WNT/β-catenin signalling that may perhaps be 
placed upstream of Fgf10. This situation would be reminiscent of that in the limb where 
WNT/β-catenin signalling determines the field of Fgf10 expression to guide limb initiation 
and apical ectodermal ridge induction (Kawakami et al, 2001). 
Several reports show that WNT signalling pathway members are MR inductive 
factors. A single nucleotide polymorphism located at the 3‘ end of the Lef1 gene has 
been shown to be highly correlated with the number of teats in pigs (Tetzlaff et al., 
2009). It remains unclear how the polymorphism may affect the function of LEF1 as a 
transcriptional co-activator of WNT-target genes. On the other hand, in a study of Pitt-
Hopkins Syndrome patients, harbouring missense mutations in the gene encoding 
TCF4, a transcriptional co-activator of the WNT signalling pathway, two out of four 
patients have been reported to develop supernumerary nipples (Amiel et al., 2007). The 
mutation on the TCF4 gene affects the DNA recognition domain of the protein, and may 
compromise its transcriptional activity. This suggests that the downregulation of WNT 
signalling may promote supernumerary nipple formation, in contrast to the MR inductive 
effect with the upregulation of WNT signalling shown here. This discrepancy may partly 
be explained by species-specific differences in the utilization of WNT signalling for MR 
induction.  
In addition to rescuing induction of MR3, stabilized β-catenin also attenuated the 
hypoplasia of Gli3Xt-J/Xt-J MR1, MR2 and MR4, similar to the in vitro effect of WNT3A on 
MR growth in embryonic flank cultures (Chu et al., 2004). This is also in line with the 
requirement of the WNT co-receptors Lrp5 or Lrp6 (Lindvall et al., 2006; Lindvall et al., 
2009) and the transcriptional co-activator Lef1 (Boras-Granic et al., 2006) to maintain 
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proper bud size, showing that WNT signalling pathway members are important in also 
regulating the growth of the MRs.  
The action of stabilized β-catenin on Gli3Xt-J/Xt-J MR3 is limited to induction and initial 
growth, but it is insufficient for maintenance of the MR to E18.5. As reciprocal epithelial-
mesenchymal interactions are crucial for MR induction and maintenance, the apparent 
absence or impaired differentiation of the mammary mesenchyme at E13.5 may perhaps 
cause the regression of the rescued MR3. This will be in accordance with the MR 
regression observed in Pthrp-/- embryos, caused by the failure of epithelial-mesenchymal 
signalling and the inability of the mesenchyme to differentiate (Foley et al., 2001). The 
regression of MR3 in Gli3Xt-J/Xt-J embryo is also reminiscent of Lef1-/- MR2 and MR3 which 
regress soon after induction, associated with deregulated epithelial-mesenchymal 
signalling ((Kratochwil, K. personal communication; (van Genderen et al., 1994; Boras-
Granic et al., 2006)). This phenocopy of  Gli3Xt-J/Xt-J MR3 with Lef1-/- MR2 and MR3  
opens up the enticing possibility that the loss of Gli3 may lead to the downregulation of 
LEF1, which results in the downregulation of WNT signalling activity, as observed by the 
reduction of TOPGAL expression at E11.5 (see also Chapter 5 for alternatives).  
Besides ensuring the maintenance of MRs, epithelial-mesenchymal interactions are 
also required for sexual dimorphism. At E14.5, MR development diverges between the 
two sexes. While in females, the bud enlarges and continues to develop inwardly into the 
mesenchyme, in males, the action of testosterone on the mesenchyme constricts the 
epithelium, causing the mammary epithelium to disconnect from the ectoderm and 
regress, or persist in a rudimentary form (Durnberger and Kratochwil, 1980; Sakakura et 
al., 1982). However, in some mouse strains, for example the C57BL/6J strain, inguinal 
buds grow outwardly (Fig. 3.2 AC, AD, (Veltmaat et al., 2003)). The outward growth of 
Gli3Xt-J/Xt-J MR2, MR3 and MR4, along with the absence or lack of differentiation of the 
mammary mesenchyme may thus suggest that these MRs develop along the male 
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developmental programme. This development along the male pathway may implicate 
Lef1, as timely expression of androgen receptor in the mammary mesenchyme, and 
invagination of the MRs are dependent on Lef1 (Boras-Granic et al., 2006). In addition, 
MR invagination may also involve Gli3 expression in the ectoderm and MRs at E12.5 
and E13.5 (Chapter  2 and Chapter 5).  
What cellular mechanisms does WNT/β-catenin signalling regulate in order to 
enlarge the MRs and promote the induction of MR3? We have previously shown that 
proliferative activity within the MRs is low during the first 3 days of mammogenesis and 
the influx of cells from the ectoderm to the mammary epithelium is the primary 
contributor of growth from E11.5 to E12.5. Growth of the MRs, contributed by the 
recruitment of cells into the MRs from the ectoderm, is complemented by cell 
hypertrophy from E12.5 to E13.5 (Chapter 2). WNT/β-catenin signalling has been shown 
to regulate both cell proliferation and migration in different contexts. For example, in  
Drosophila, WNT/β-catenin dependent cell proliferation underlies segmented lateral line 
morphogenesis (Aman et al., 2011) and de novo hair follicle formation via increased cell 
proliferation in the epidermis (Lo Celso et al., 2004). β-catenin can also be a  promoter of 
cell migration in vitro (Jeong et al., 2010). Thus, high levels of WNT/β-catenin signalling 
mediated by Ctnnb1Tg∆N57 may rescue MR3 formation by restoring the normal process of 
ectodermal migration, or by compensating the loss of influx by increasing cell 
proliferation. Future work will address these possibilities to delineate the cellular 
mechanisms regulated by Ctnnb1Tg∆N57.  
In conclusion, we have shown that WNT/β-catenin signalling acts downstream of Gli3 
and critical levels of this signalling are required for the formation of MR3 and growth of 
other MRs. While β-catenin induces MR3 and supernumerary MRs, supports the 
maintenance of MR2 and promotes the growth of all MRs, it does not rescue other 
aspects of MR morphogenesis such as invagination and branching morphogenesis. Our 
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data shows that development and morphogenesis of each MR is governed by different 
molecular players and reinforces the notion of the inherent uniqueness of each 
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Mammogenesis in the mouse begins in the embryo. At embryonic (E) day 10.5, three 
streaks of Wnt10b-positive ectodermal cells are formed along the two flanks of the 
embryo (Veltmaat et al, 2004). On each flank, these three streaks fuse by E11.5 to form 
a continuous, so-called mammary line (ML) (Veltmaat et al, 2004). On these MLs, five 
pairs of mammary rudiments (MRs) are formed in an asynchronous fashion, starting with 
MR3, followed by MR4, MR1, MR5 and finally MR2 (this thesis). 
The five pairs of mouse mammary glands are often regarded as repetitive structures 
as they are functionally and morphologically the same. Combining published literature 
data and data generated in our lab, we examine here if this notion holds true in terms of 










4.2.1 Differential mammogenic potential along the ML: MR4 is most resistant to 
altered gene expression levels, MR3 the most sensitive 
 
The understanding of the molecular mechanisms that regulate embryonic mammary 
gland development has increased with the insights gleaned from various mouse genetic 
models that have been recently developed ((reviewed in (Veltmaat et al., 2003; Hens 
and Wysolmerski, 2005; Cowin and Wysolmerski, 2010)). Our meta-analysis of the 
literature revealed that the five pairs of MRs in the mouse respond differentially to 
alterations of single gene expression levels. In 10 out of 19 mouse genetic mutants that 
exhibit an embryonic MR phenotype, MR4 is still induced and develops normally, in 
contrast to other MRs which either fail to form or exhibit growth defects (Table 4.1). 
(Note: the Msx1-/-;Msx2-/- mutant (Satokata et al., 2000) is not listed in Table 4.1 as only 
the MR4 phenotype was reported. The K14::Cre;Gata3f/f mutant (Asselin-Labat et al., 
2007) is also omitted as the individual mammary rudiment phenotype of this mutant is 
unclear.) Moreover, amongst these mutants, overexpression of Eda-A1 under the 
ectoderm specific keratin 14 (Krt14) promoter, resulted in supernumerary MR formation 
at the area between MR3 and MR4 (Mustonen et al., 2004). Similarly, the hypomorphic 
allele of Nrg3ska (Scaramanga) resulted in increased supernumerary MR formation 
adjacent to MR4 (Howard and Gusterson, 2000). In contrast, the induction of MR3 is 
compromised in 10 mouse genetic models (Table 4.1). Together, these observations 
indicate that the development of each mouse MR pair is governed by unique molecular 
mechanisms. Moreover, different mammogenic potential exists in different areas of the 
ectoderm, the highest at the area of MR4, and the weakest at MR3. 
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Table 4.1: Individual embryonic MR induction and morphogenesis in various 
mouse genetic models. The mouse models presented are clustered based on 
decreasing severity of the mammary rudiment phenotype 
Mouse model  
Age 
(E) 
MR1 MR2 MR3 MR4 MR5 References 
Krt5::rtTA, tetO-
Dkk1  






— — — — — 
(Mills et al., 1999; Yang 
et al., 1999)  
Tbx3
-/-  
 11.5 — — — — — (Davenport et al., 2003)  
Fgf10
-/-
  11.5 — — — +  — 
(Mailleux et al., 2002; 
Veltmaat et al., 2006) 
Fgfr2b
-/-
  11.5 — — — +  —  (Veltmaat et al., 2006) 
Gli3
Xt-J/Xt-J
 (null)  11.75 +/- +/- — +/- — 
(Hatsell and Cowin, 
2006; Veltmaat et al., 
2006; Lee et al., 2011)  
Pax3
ILZ/ILZ




11.5 + + — + + (Veltmaat et al., 2006)  
Pygo2
-/-
  11.5 +/- +/-- +/-- +/- +/- (Gu et al., 2009)  
Lrp6
-/-
  12.5 +/- +/- +/- +/- +/- (Lindvall et al., 2009)  
Lrp5
-/- 
 12.5 +/- +/- +/- +/- +/- (Lindvall et al., 2006)  
Hoxc6
-/-
  12.5 + or +/- + 
(Garcia-Gasca and 
Spyropoulos, 2000)  
Lef1
-/-
  11.5 + +/- +/- + + 




  12.5 + + or — + + + or — 
(Jerome-Majewska et 















12.5 + + + or — + or ++ + (Howard et al., 2005)  
Krt14::Eda-A1  11 + + ++++ + (Mustonen et al., 2004)  
 
Key:  
[+] Present and normal     [+/-(-)] Present but morphologically aberrant (hypoplasia 
and/or arrested development or reduced branching)  [++ (+)] Presence of supernumerary 
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4.2.2 Retained induction of MR4 in Fgfr2b-/-;Gli3Xt-J/Xt-J embryos 
 
It has been reported that Fgfr2b-/- embryos fail to induce all MRs except MR4 
(Mailleux et al., 2002; Veltmaat et al., 2006), while Gli3Xt-J/Xt-J (null) embryos fail to induce 
MR3 (Hatsell and Cowin, 2006; Veltmaat et al., 2006) and MR5 (Mailleux et al., 2002; 
Hatsell and Cowin, 2006). Given the apparent unique resistance of MR4 to loss of gene 
function, we asked if the combined loss of Fgfr2b and Gli3 would exert enough genetic 
pressure to inhibit the formation of MR4. To that end, we generated Fgfr2b-/-;Gli3Xt-J/Xt-J 
embryos on a TOPGAL background. TOPGAL is a lacZ reporter for LEF/TCF-mediated 
transcription (Das Gupta and Fuchs) and a marker of the MRs.  
At E11.5, MR4 is detectable as a local, TOPGAL-positive multilayering of the 
ectoderm in wild type embryos (Fig. 4.1 A‘). Gli3Xt-J/Xt-J and Fgfr2b+/-;Gli3+/Xt-J embryos 
show TOPGAL expression at the region of MR4 without any multilayering of the 
ectoderm at this stage (Fig. 4.1 B‘, C‘). However, the loss of both Gli3 alleles results in a 
smaller domain of TOPGAL expression and a more severe phenotype, compared to the 
loss of an allele each of Gli3 and Fgfr2b. In the Fgfr2b-/-;Gli3Xt-J/Xt-J embryo, only a slight 
enlargement of single-layered ectodermal cells was seen inguinally at the region of MR4, 
suggesting an attempt at inducing MR4 (Fig. 4.1 D) (Note: the histological section shown 
in Fig. 4.1 D is of an embryo without TOPGAL, as the embryo was generated from 
parents hemizygous for TOPGAL).  Thus the loss of Gli3 and Fgfr2b hampers, but not 
completely abrogates the induction of MR4. 
At E12.5, wild type MR4 adopts a hillock morphology, with a tail of TOPGAL-
expressing cells extending ventrally from the bud (Fig. 4.1 E). Homozygous deletion of 
either Gli3 or Fgfr2b results in a MR4 that is hypoplastic (Fig. 4.1 F, G) but still 
comprises multiple layers of TOPGAL-expressing cells (Fig. 4.1  F‘, G‘).  
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While a double heterozygous embryo has an almost normal MR4 at E12.5 (Fig. 4.1 
H, H‘), Fgfr2b-/- embryo that are heterozygous or homozygous-null for Gli3 display only a 
small dot or a faint streak of TOPGAL at the position of MR4. Histological analysis 
reveals that this TOPGAL-positive area corresponds to a single layer of TOPGAL-
positive cells that are perhaps enlarged. Thus, while the absence of Fgfr2b and Gli3 still 
allow induction of MR4, both genes are individually and cooperatively required for the 
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Fig. 4.1. Induction of MR4 is resistant to multiple gene deletions. 
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 (A-J) Lateral view of E11.5 (A-D) and E12.5 (E-J) embryo flanks showing TOPGAL 
expression (blue). Insets within each panel show magnified view of corresponding MR4, 
denoted by black arrowheads or the number ‗4‘.  (A’-J’) Histological sections of paraffin-
embedded E11.5 (A’-D’) and E12.5 (E’-J’) TOPGAL embryos. Gli3Xt-J/Xt-J;TOPGAL 
embryo induces MR4 but it is hypoplastic, as marked by a smaller domain of TOPGAL-
expressing cells (B, B’). Heterozygosity of Gli3 and Fgfr2b resulted in a slightly 
hypoplastic MR4 (C, C’). MR4 is induced in the Fgfr2b-/-;Gli3Xt-J/Xt-J embryo (non-
TOPGAL) but it is severely hypoplastic (D, D’). The green dotted line marks epithelium-
mesenchyme boundary. At E12.5, wild type MR4 forms an elongated bud, with a 
ventrally-extending TOPGAL tail (E). MR4 of Fgf10-/-;TOPGAL (F, F’), 
Gli3Xt-J/Xt-J;TOPGAL (G, G’), Fgfr2b+/-;Gli3+/Xt-J (H, H’), Fgfr2b-/-;Gli3+/Xt-J (I, I’), and 
Fgfr2b-/-;Gli3Xt-J/Xt-J (J, J’) develop hypoplastically.  Multilayering of the ectoderm is not 
evident in Fgfr2b-/-;Gli3+/Xt-J and Fgfr2b-/-;Gli3Xt-J/Xt-J  at this stage compared to embryos 
with either homozygous deletion of one gene, or heterozygosity for Fgfr2b and Gli3. 




4.2.3 Increased supernumerary MR formation near MR 4  
 
 
Supernumerary mammary glands have been reported in various inbred strains of 
mice. As their predominant position of formation varied with genetic background, 
supernumerary mammary glands were postulated to have a genetic basis (Little and 
McDonald, 1945). Could the resistance of the area of MR4 to the loss of induction in the 
context of gene mutation suggest that this area is particularly sensitized to form MRs 
and thus perhaps also form supernumerary MRs with greater ease than other areas 
along the ML? To test this, I scored the presence of supernumerary MRs in the area of 
all MRs of a variety of mouse strains of mixed genetic backgrounds. No supernumerary 
MRs were present near MR1 or MR5, but they appeared frequently between MR2, MR3 
and MR4. Typically, supernumerary MRs were formed along the mammary line, or 
slightly dorsally displaced and are smaller than wild type MRs (Fig. 4.2).  
I pooled data for supernumerary MR3 posterior to MR3 and between MR2 and MR3. 
While in these areas supernumerary MR3 occured in 0-15% of wild type and 
heterozygous embryos of various mutations and genetic background, the area of MR4 
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had a much higher frequency (36%-70%) of supernumerary MR induction (Table 4.2). 
Moreover, supernumerary MRs near MR4 appear bilaterally in a subset of embryos of all 
strains at E12.5 and E13.5 (Table 4.3), while this is never seen for supernumerary MR2 
and MR3 (Tables 4.3). Thus, along the ML, mammogenic potential is greatest in the 
area of MR4, followed by the area of MR2 and MR3, at least in a predominantly 
C57BL/6J background.  
In line with the observed hypoplasia or absence of MRs in homozygous-null embryos 
for either Fgf10, Fgfr2b or Gli3 (Chapter 3), none of these homozygous nulls have any 
supernumerary MR2, with the exception of one Fgfr2b-/- mutant that formed a bilateral 
supernumerary MR4 (Table 4.2 and 4.3). This supernumerary MR, being formed in the 
vicinity of MR4, underscores again the relative resistance of the mammogenic potential 
in this area to inhibitory gene mutations. 
What determines the position of the mammary glands? The MRs may be formed on 
any position along the mammary line in the embryo, and supernumerary MR formation 
has been attributed to the failure of certain areas along the mammary ridge to regress 
(Bland and Romrell, 1999). However, as shown in this study, not all positions along the 
mammary line are equally permissive for MR formation. In mouse embryos, the inguinal 
region, at the position of MR4, seems to harbour increased mammogenic potential by 
virtue of its resistance to gene deletions and propensity for supernumerary MR 
formation. Little and McDonald  also found a similar, specific distribution of 
supernumerary MRs in 10-day old mouse pups and lactating adult females, although in 
contrast with our data, all supernumerary MRs were found at the thoracic region (Little 
and McDonald, 1945). A possible explanation to resolve this discrepancy may lie in the 
maintenance of MR4. Although the area of MR4 is most potent in inducing MRs, the 
decline in the frequency of supernumerary MR4 from E12.5 to E13.5 suggests that the 
maintenance of the MR is compromised. Moreover, the slight increase in supernumerary 
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MR3 frequency at the same time in control embryos wild type or heterozygous for Gli3 
may suggest that these supernumerary MRs are induced at a later stage (see also 
Chapter 3) and more efficiently maintained (Table 4.2).   
 
Fig. 4.2. Supernumerary MR4 formation in wild type embryos.  
(A) Lateral view of a wild type embryo with the TOPGAL reporter. (B) Magnified view of 
MR4 and supernumerary MR4 (C, D). Histological sections of paraffin-embedded 
TOPGAL embryos showing MR4 (C) and a supernumerary MR formed in its vicinity (D). 
















Chapter 4: Differential mammogenic potential along the mammary line 
131 
 
Table 4.2: Frequency of supernumerary MR formation in mouse strains of various 
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Table 4.3: Frequency of unilateral and bilateral supernumerary MR formation in 
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57.1%/42.9% 0%/0% 100%/0% 0%/0% 






4.3.1 Differential mammogenic potential along the mammary line ─ a partial 
explanation for the diversity of mammary gland numbers and location amongst 
mammals? 
 
In mammals that only possess one or two pairs of mammary glands, the glands are 
usually located in the inguinal region (e.g. in hoofed animals - goat, sheep, horse, cattle 
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and others e.g. porpoises and whales) (Dehalt, 2011), which seem to support the notion 
of the greater mammogenic potential in the inguinal region shown in this chapter. 
Notable exceptions exist, for example in the elephant and certain primates such as the 
human, which have a single pair of mammary glands in the thoracic region. In addition to 
genetic factors, the different locations may be attributed to factors such as posture, 
anatomy and the way offsprings are nursed in each of these species. The inguinal region 
is usually the lowest part of the four-legged animal when that animal stands, and is 
therefore the most easily accessible area for the infant. Baby elephants have trunks, and 
so to nurse they have to get their trunk out of the way of their mouth and their mother‘s 
body. This makes thoracically placed nipples most convenient for the nursing of baby 
elephants (Greiner, 2003). Primates, having upright postures, will be best served by 
having thoracic mammary glands to facilitate nursing and the carrying of the infant.  
What are the implications of having an unequal distribution of mammogenic potential 
along the mammary line? The differential mammogenetic potential, combined with the 
different requirement of genes for the induction of different MR pairs, could ensure that 
the mammary glands are not all susceptible to the same genetic pressures, which may 




4.3.2 The resistance of the mouse MR4 to loss of gene function and increased 
inguinal mammogenic potential - considerations for its use as a model for the 
human breast 
 
As the mammary glands all function to produce milk for young offspring, the different 
mammary gland pairs are implicitly regarded as repetitive structures with no inherent 
differences. Many developmental biology or tumour studies typically use the postnatal 
murine mammary glands as models. In many of these studies, the mammary glands are 
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pooled and analysed, or the different mammary glands pairs may be compared with 
each other indiscriminately. If one pair of murine mammary glands is used, the murine 
mammary gland pair 4, being more experimentally accessible, is frequently used as a 
representative model of the human breast. 
However, by its anatomical position, this inguinal mammary gland pair 4 (Fig. 4.3 B) 
bears no similarity to the thoracically located human breasts (Fig. 4.3 D). The human 
breast, like the mouse MRs, starts to develop in the embryo. During the fourth week of 
gestation, mammary ridges or milk lines develop on the ventral surface of the human 
embryo and extend in a curvilinear fashion, convex towards the midline from the axilla to 
the medial thigh. Subsequently, these ridges disappear except at the level of the fourth 
intercostal space on the thorax, where the mammary gland subsequently develops 
((Gabriel, 2009), Fig. 4.3 C)). This position of the human breast almost coincides with 
the thoracic mammary gland pair 3 in the (compare Figs. 4.3 A and 4.3 C).  
As in this chapter I provide support for the likelihood for mammary gland induction at 
different postions along the ML, one can therefore question whether the extrapolation 
from results obrained with the murine mammary gland 4 to the human breast is justified. 
(besides other differences between mouse and human that are beyond the scope of this 
chapter).  
 




Fig. 4.3. The position of murine mammary gland 4 is different from the human 
breast. 
 (A) Lateral view of an E12 Fgf10+/mlcv embryo, containing a lacZ transgene that reports 
Fgf10 expression. The black arrowhead marks the fifth or sixth thoracic somite, which is 
the position where the murine MR3 develops. MR4 is situated approximately at the 
position of the 14th somite. (B) 3D magnetic resonance microscope image of a Carnegie 
stage 16 (37-42 days old) human embryo. Arrowhead indicate the approximate position 
on the mammary ridge where the breast will develop  (C) Ventral view of the maximum 
extent of the mammary system. The large black dots represent the nipples and the 
dotted areas the fat pads containing the mammary glands (MG)  (D) Cartoon of an adult 
female showing a pair of thoracically-located breasts. (B) Reproduced from the Kyoto 
Collection of Human Embryos, with permission from Dr Kohei Shiota. (C) Modified from 
(Murphy, 1966) (D) Modified from (Monkeypedia) Scale bar in A and C: 1 mm. 
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Importantly, the differences exhibited by the different MR pairs seen during 
embryonic life may persist later during postnatal life. For example, in E12.5 Hoxc6-/- 
embryos (Garcia-Gasca and Spyropoulos, 2000), all five MR pairs are present. However 
at E12.5, some thoracic MRs are smaller, while the inguinal glands develop normally. At 
birth, the thoracic glands of Hoxc6-/- females show reduced branching and defects in fat 
pad development. Furthermore, in 8 to 10 week old mice, major differences were noted 
between the thoracic and inguinal glands: while the mammary epithelium is normal in the 
inguinal glands, thoracic mammary fat pads were devoid of mammary epithelium. The 
observed phenotype is consistent with the expression of Hoxc6 normally in the anterior 
thoracic somites underlying the thoracic MRs, and the absence of Hoxc6 expression in 
the more posterior somites underlying the inguinal MRs. This mammary gland 
phenotype of the Hoxc6-/- mutant illustrates that differences observed during early 
mammogenesis may persist and exert effects during postnatal life. Moreover, along the 
mammary line, differential morphogenesis of the various mammary glands can occur 
postnatally as well.  
Differences in normal development amongst mammary glands are also mirrored 
during neoplastic transformation. Postnatal thoracic mammary glands form mammary 
tumours more frequently than inguinal glands (Sheldon et al., 1982; Minasian, 1983; 
Bolander, 1990). Assuming that the mammary epithelium to fat pad ratio is equal among 
all glands, it is hypothesized that the higher relative weight of the anterior glands, and 
therefore the presence of more epithelial tissue that can undergo neoplastic 
transformation, could explain in part the higher incidence of tumour formation (Vaage, 
1984). Another possible explanation for this unequal distribution of tumour formation is 
the asynchrony in differentiation between the thoracic and inguinal mammary glands, 
resulting in their differential susceptibility to 7,12-dimethylbenz(a)anthracene (DMBA)-
induced carcinogenesis (Russo and Russo, 1988). Notably, the increased presence of 
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less-differentiated structures such as terminal end buds in the thoracic glands was 
shown to correlate with increased susceptibility to tumour formation in these glands, 
compared to the inguinal glands.  Similar to the differential response of mammary glands 
to DMBA, it was shown that the postnatal thoracic glands require a smaller concentration 
of insulin, cortisol and prolactin for the production of α-lactalbumin than the abdominal 
glands (Bolander, 1990). It is conceivable that these physiological differences may, in 
part, be attributed to different molecular regulation amongst the mammary glands that 
has already been set in place since embryonic development, as reviewed in this chapter.  
Given the important differences amongst the individual mammary gland pairs during 
embryonic and postnatal stages of development, and even during pathological 
progression, it is very likely that experiments studying the mechanistic role of genes in 
mammary gland biology and neoplasia may yield different results and conclusions when 
performed in different pairs of glands. This cautions the use of MR4 as the sole model in 
any study. It may be worth considering the inclusion of all five MR pairs in a pilot study 
prior to the actual study to gauge if such differences exist.  
 
4.4 Concluding remarks 
 
The murine mammary glands are not merely repetitive structures, but each pair is 
unique in terms of the requirement for genes in their induction and morphogenesis. The 
unequal distribution of supernumerary MRs show that differential mammogenetic 
potential exist along the mammary line. These observations may partially explain the 
diversity of the positions of mammary glands in different mammals. Furthermore, this 
highlights the importance of mammary gland-specific comparisons in studies.  
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The aim of this thesis project is to understand the cellular and molecular 
mechanisms of action of Gli3 in embryonic mammary gland development. 
In this chapter, I will first discuss the cellular mechanisms that are regulated by Gli3 
and how these processes contribute to mammary rudiment (MR) induction and growth.  
The focus will then be shifted to the role of molecular mechanisms, and in particular 
WNT/β-catenin signalling downstream of Gli3. Based on accumulating literature 
suggesting that WNT-independent pathway molecules may interact with the lymphoid 
enhancer binding factor 1 (LEF1) I argue that TOPGAL, a LEF/TCF transcriptional 
reporter, may not report canonical WNT/β-catenin signalling exclusively. Furthermore, 
the interaction of WNT-independent pathway molecules with LEF1 is supported by the 
phenocopy of Gli3Xt-J/Xt-J MR2 by the Msx1-/-;Msx2-/- MR4.  
Next, I will discuss the finding of the unique nature of each MR pair by comparing it 
with other ectodermal appendages. Could the diversity in molecular regulation seen in 
the MRs imply that there is more diversity in terms of molecular regulation in seemingly 
―repetitive‖ structures such as hair follicles?  
Next, I will discuss the how our understanding of the molecular mechanisms that are 
misregulated in diseases such as cancer may be enhanced by the study of the 
mechanisms that regulate normal development. This alternative approach may aid in the 
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better understanding of the molecular basis of diseases, facilitate and perhaps 
accelerate the identification of novel targets for therapy.  
Lastly, I will sum up the implications and significance in terms of our understanding 
of Gli3 during embryonic mammary gland development, and what this means for future 
studies that use the murine mammary glands.  
 
5.2 Multi-faceted roles of Gli3 in embryonic mammary gland development 
 
5.2.1 Cellular mechanisms regulated by Gli3 
 
Prior to the onset of this project, the Veltmaat lab had reported that the Gli3Xt-J/Xt-J 
(null) mouse has a narrow mammary line (ML) with sparsely-distributed 
Wnt10b-expressing cells (Veltmaat et al, 2006). Out of the five pairs of mammary 
rudiments (MRs) present normally in the mouse, Gli3Xt-J/Xt-J embryos do not form MR3 
(Veltmaat et al., 2006) and MR5 (Mailleux et al., 2002; Hatsell and Cowin, 2006). The 
Gli3Xt-J/Xt-J mouse model is unique as the loss of a single gene results in differential 
mammary phenotypes among the different MRs.  
By histological analysis and MR volume estimation, it was determined that Gli3Xt-J/Xt-J 
MR1, MR2 and MR4 are hypoplastic (Chapter 2). In addition, MR2 and MR4 develop 
with an aberrant, protruding morphology. In order to understand the cause of the 
hypoplasia in Gli3Xt-J/Xt-J MRs, we first determined the largely unknown cellular 
mechanisms that regulate normal MR formation and growth. The MRs have low 
proliferative activity, showing that induction and growth are not mediated primarily by 
localized cell proliferation, as previously thought  (Raynaud, 1961). By analysing 
BrdU-labeled cells, which are present in the ectoderm five-times more than in the MRs 
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(2 hours post-labelling), and the observation that these cells accumulate in the MRs after 
24 hours, we show that cell migration is the primary mechanism for growth of all MRs 
during the first day of mammogenesis. Indeed, cell migration and cell proliferation are 
likely mutually exclusive events as both of these cellular mechanisms impinge on the 
same cytoskeletal machinery.  
In which direction are cells migrating towards the MRs? Balinsky proposed that cells 
migrate in a centripetal direction to form the MRs (Balinsky, 1949-1950). Based on 
studies in the rabbit embryo, Propper proposed that cells along the mammary ridge 
migrate along the antero-posterior axis to contribute to the formation of the MRs based 
on 3 lines of evidence: firstly, as the MRs are formed, the mammary ridge progressively 
diminishes. Secondly, cells along the mammary ridge have a spindle-like morphology, 
suggesting that these are migratory cells (Propper, 1978). Lastly, charcoal particles that 
are placed on the mammary ridge are incorporated into the MRs within 24 to 48 hours. 
However, charcoal particles deposited on the ectoderm adjacent to the mammary ridge 
are not incorporated into the MRs, showing that at least in the rabbit, cells migrating 
along the mammary ridge contribute exclusively towards MR formation (Propper, 1973). 
Moreover, the thick mammary ridge would harbour sufficient cells to form the MRs. This 
will negate the need for the involvement of cells from other areas of the ectoderm as 
suggested by Balinsky‘s centripetal migration.   
It is important to consider the differences in the ML of the rabbit and mouse at this 
time. While the ML in the rabbit is a thick, elevated ridge, the ML in the mouse is thinner 
and not elevated. This suggests that while cells along the ML may contribute to MR 
formation in the mouse, as in the rabbit, the number of cells may not be enough, thus 
requiring contribution from the adjacent ectoderm. This is in line with our previous 
hypothesis that during the first day of mammogenesis, ectodermal cells may migrate in 
the dorso-ventral direction in response to fibroblast growth factor 10- (FGF10) mediated 
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chemotaxis from the hypaxial buds of the underlying somites to form MR3 (Veltmaat et 
al., 2006). As the growth of the somites halt, cells from the ectoderm may be attracted 
towards the hypaxial buds from all directions, in line with Balinksy‘s hypothesis of 
centripetal cell migration. While the above situation is plausible for MR3, the direction of 
cell migration in the formation of MR1, MR2, MR4 and MR5, which do not seem to 
implicate the involvement of the somites, remains to be determined.  
Interestingly, while the MRs continue to grow and by E13.5 had increased their size 
by 1.5 to 2 times from the previous day, similar to the 1.5 to 2.5 size increase from 
E11.75 to E12.5, the ratio and number of BrdU+ve cells that are present within the MRs at 
E13.5, 24 hours post-labelling is much lower compared to the ratio and number of 
BrdU+ve cells observed at E12.5, 24 hours post-labelling. While cells from the ectoderm, 
having five-fold more BrdU+ve cells than the MRs contribute to the induction and growth 
of the MRs during the first day of mammogenesis, the source of cells for MR growth on 
the second day may, at least partly, originate from the ML. This is an attractive possibility 
given that the ML consists of predominantly BrdU-ve cells, as observed 2 hours 
post-labelling.  Thus, the mechanism of MR growth during the second day of 
mammogenesis would be reminiscent of the mechanism of the formation of MRs in the 
rabbit proposed by Propper where cells from the mammary ridge contribute to MR 
growth (Propper, 1978). In short, during the first day of mammogenesis, cells may 
migrate along the dorso-ventral axis to form the ML, as proposed previously (Veltmaat et 
al., 2006), and then along the ML towards the MRs during the second day of 
mammogenesis. To determine this, the challenge would be to accurately identify and 
label a small number of presumptive mammary epithelial cells adjacent to the mammary 
line in order to facilitate the observation of cell migration in ―real‖ time. A fluorescent-
tagged marker of these cells would be envisioned to overcome the difficulties associated 
with the identification and labelling. In addition, a whole embryo or embryonic flank 
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culture protocol that is stable enough to prevent or minimize the loss of optical focus of 
the embryos would be required to observe the migration of cells leading to the formation 
of the MRs. 
In addition to cell migration, growth of the MRs during the second day of 
mammogenesis is mediated by the hypertrophy of peripheral cells in the MRs. In 
Gli3Xt-J/Xt-J MR2 and MR4, migration of cells and the hypertrophy of peripheral cells within 
the MRs is perturbed, leading to the observed hypoplasia. These observations are in line 
with reports of Gli family members having migration promoting effects on enteric nerves, 
pancreatic stellar cells, endothelial cells (Fu et al., 2004; Shinozaki et al., 2008; Renault 
et al., 2009), and the role of Gli3 in regulating chondrocyte hypertrophy (Koziel et al., 
2005).  
A question that remains to be answered is the identity of the ectodermal cell layer 
that contributes to MR formation. Clearly, the approach of BrdU-labeling cells to visualize 
cell migration cannot address this question sufficiently. Are the MRs derived from a 
particular cell layer, or do both the periderm and basal cell layers contribute equally to 
MR formation? The MRs expression of basal markers such as keratin 5 (Krt5) and Krt14,  
may suggest that cells that form the MRs originate from ectodermal progenitors of the 
basal layer, as opposed to the periderm which does not express these markers. 
However, the accumulation of BrdU+ve cells at the apex of MRs at E13.5, 24 hours post-
labelling (Chapter 2, Fig. 2.4 F‘-J‘) may suggest that cells from the periderm, which 
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5.2.2 Cell differentiation regulated by Gli3 in the embryonic MRs 
 
The lack of hypertrophy in the basal cells in MR2 and MR4 indicates that the 
differentiation of these cells is affected. In support of this, the expression of p63, a 
transcription factor and a marker of epithelial progenitor cells is downregulated in the 
mammary epithelial cells of Gli3Xt-J/Xt-J MR2 at E13.5 (Fig. 5.1 B).  
What factors regulate differentiation? One important determinant of efficient 
differentiation is the establishment and maintenance of cell polarity. The ventricular 
neuroepithelium of the dorsal telencephalon of Gli3Xt-J/Xt-J mutants is characterized by the 
loss of several apically-localized cell adhesion molecules such as zona occludens 1 
(ZO-1), partitioning-defective 3 (PAR3), filamentous actin (F-actin) and numb, indicating 
a loss of cell polarity in these cells (Theil, 2005). In addition, the disruption of the apical-
basal cell polarity of neuroepithelial cells in the basal forebrain has been shown to exert 
profound effects on cell proliferation and differentiation (Klezovitch et al., 2004). 
Given the importance of cell polarity, and the link between cell adhesion and 
collective cell migration, we examined the expression of E-cadherin in Gli3Xt-J/Xt-J MRs. 
Preliminary data show that E-cadherin may be expressed in variable levels in Gli3Xt-J/Xt-J 
MR2. In one instance, E-cadherin levels seem to be normal and localized to cell-cell 
contacts in the mammary epithelium and ectoderm (Fig. 5.1 E), while in another 
instance, E-cadherin expression was severely downregulated in Gli3Xt-J/Xt-J MR2 (Fig. 5.1 
D). Furthermore, the domain of E-cadherin expression was restricted to the intermediate 
layer and periderm of the ectoderm (Fig. 5.1 D), suggesting that Gli3 may be crucial in 
the maturation of the ectoderm to become epidermis. The loss of E-cadherin may form 
the basis for the lack of cell migration, leading to the hypoplasia of Gli3Xt-J/Xt-J MR2. This 
is in line with a recent finding showing that the levels of N-cadherin must be properly 
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regulated in order to maintain cell polarity to allow for proper neural crest migration and 
chemotaxis (Theveneau et al., 2010).  
Canonical WNT signalling activity, which is required for the formation of the MRs 
(Chu et al., 2004) and cadherin-mediated cell adhesion are dependent on the same pool 
of β-catenin. Both LEF1 and E-cadherin form mutually exclusive complexes with 
β-catenin required for WNT signalling and cell adhesion respectively (Orsulic et al., 
1999). Interestingly, despite the downregulation of E-cadherin in Gli3Xt-J/Xt-J MR2, 
β-catenin is expressed at similar levels in cell-cell junctions in the mammary epithelium 
and ectoderm Gli3Xt-J/Xt-J MR2 compared to wild type MR2 at E13.5 (Chapter 3, Fig. 3.3), 
suggesting the presence of another binding partner of  β-catenin at the cell membrane. 
Moreover, preliminary data suggests that nuclear β-catenin is downregulated in 
Gli3Xt-J/Xt-J MR2, leading to the downregulation of WNT signalling. Future studies 
addressing how β-catenin alternates between its adhesive and transcriptional function 
may provide new insights into the molecular basis of cell migration and morphogenesis 
of the embryonic MRs.  
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Fig. 5.1. Gli3 regulates cell differentiation in MR2.  
(A, B) P63 expression in wild type and Gli3Xt-J/Xt-J MR2. P63 is expressed in the ectoderm 
and MR in wild type MR2, but is downregulated in the MR with the loss of Gli3. (C, D) 
E-cadherin expression in wild type and Gli3Xt-J/Xt-J MR2. Similar to P63, E-cadherin is 
expressed in the ectoderm and MR of wild type MR2. In one Gli3Xt-J/Xt-J MR2 E-cadherin 
is expressed normally in cell-cell junctions in the mammary epithelium and ectoderm (D). 
In another MR, E-cadherin expression is downregulated in both compartments 
Moreover, E-cadherin expression is restricted to the periderm, and absent in the 
mammary epithelium of Gli3Xt-J/Xt-J MR2 (E). Scale bar in A-E: 50 µm.  
 
 
5.3 Why only partial rescue of the mammary phenotype of Gli3Xt-J/Xt-J 
embryos by stabilized β-catenin? - Some considerations 
 
The Veltmaat lab had previously shown that the number of cells expressing Wnt10b 
and TOPGAL is lower in the ML of Gli3Xt-J/Xt-J embryos (Veltmaat et al., 2006).  TOPGAL 
is a lacZ reporter of LEF/TCF-mediated transcription which is the outcome of canonical 
WNT signalling. Therefore, the observation of fewer TOPGAL-expressing cells suggests 
that WNT signalling is downregulated in Gli3Xt-J/Xt-J embryos during MR induction. To test 
this, we attempted to rescue the mammary phenotype of Gli3Xt-J/Xt-J by the tissue-specific 
overexpression of a stabilized form of β-catenin (Ctnnb1TgΔN57) (Teuliere et al., 2005). 
β-catenin partially rescues various aspects of the phenotype of Gli3Xt-J/Xt-J embryos 
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namely the induction of MR3, but not of MR5. However, MR3 develops with an 
abnormal, protruding morphology similar to Gli3Xt-J/Xt-J MR2.  
What could account for the rescue of MR3 but not MR5? As TOPGAL is widely-
known as a faithful reporter of WNT/β-catenin signalling, the lack of rescue of MR5 may 
suggest that the levels of β-catenin provided by the transgene are still insufficient to 
result in MR5 induction. This is supported by the subtle to non-detectable increase in 
TOPGAL-positive cells forming the ML in both wildtype and Gli3Xt-J/Xt-J embryos with the 
stabilized β-catenin transgene (Fig. 3.5). As transgene expression is approximately 
equal in MR3 and MR5 (see also Chapter 3), this implies that MR5 may require a higher 
level of WNT/β-catenin signalling for its induction than MR3. Alternatively, it is possible 
that the expression of other genes that are known to be crucial for the induction of MR5 
such as p63, Fgf10, and Fgfr2b are downregulated in the absence of Gli3. The 
reconstitution of these genes, either with or independently of β-catenin, may then induce 
MR5. 
Still other possibilities exist that may explain for the lack of induction of MR5. In 
recent times, it is recognized that LEF/TCFs are context-dependent regulators that may 
cooperate with factors to regulate transcription independent of WNT signaling (reviewed 
in Arce et al, 2006). Thus, TOPGAL may read-out other signalling pathways that act via 
LEF1, other than the WNT signalling pathway. For example, in Drosophila, LEF1 
depends on localized decapentaplegic (dpp, Drosophila homolog of BMPs) expression 
to stimulate gene transcription in the midgut, suggesting that DPP signalling may 
cooperate with LEF1 to mediate transcription (Riese et al., 1997). Importantly, the 
interaction between DPP and LEF1 does not depend on wingless/WNT signalling 
activity. Moreover, LEF1 has been shown to mediate gene transcription through a 
physical interaction with SMAD3 and SMAD4, downstream mediators of the TGFβ 
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signalling pathway instead of β-catenin (Labbe et al., 2000). The interaction of SMAD 
and LEF1 is dependent on the presence of SMAD-binding elements (SBEs) which are 
absent in the TOPGAL transgene. However, read-out of the BMP and TGFβ signalling 
pathways may still be possible if TOPGAL is integrated in areas of the genome where 
SBEs are present.  
The question then becomes whether the TOPGAL expression in the mammary 
region could actually represent active BMP or TGFβ signalling. Of interest, the 
expression of Bmp4 as a broad domain in the ventral region of the embryo at E10.5 
suggests that the BMP pathway is turned on. Indeed, Bmp4 is required at this stage of 
development to specify the dorso-ventral boundary on which the mammary line forms 
(Cho et al., 2006). At the same time, Lef1 is expressed as a broad domain along the 
flank (Cho et al., 2006). Thus, activation of BMP signalling and its downstream SMADS 
may elevate LEF1 transcriptional activity to a critical level, resulting in TOPGAL 
expression along the ML. The regulation of Lef1 expression by Bmp4 (Cho et al., 2006) 
may continue into the bud stage of development as BMP signalling remains activated 
and epithelial LEF1 expression expands into the mammary mesenchyme at around 
E13.5 (Foley et al., 2001). Furthermore, preliminary data showing the presence of 
phosphorylated SMADS 2 and 3 in the ectoderm and MRs at E12.5 suggests that TGFβ 
signalling is activated during embryonic mammary gland development as well (M. Y. 
Lee, and J.M. Veltmaat, unpublished observations). Similarly, these SMADS may act in 
concert with LEF1 to mediate TOPGAL expression. 
It is of interest then to determine the status of BMP and TGFβ signalling pathways in 
the Gli3Xt-J/Xt-J mutants, specifically if these signalling pathways are downregulated in the 
absence of Gli3. If these pathways are downregulated, it would be possible that their 
restoration would rescue the induction of Gli3Xt-J/Xt-J MR5.  
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The arguments discussed above may also explain why stabilized β-catenin does not 




Fig. 5.2. Multiple molecules may modulate LEF1-mediated transcription.  
(A) Summary of various studies showing signalling molecules that may interact with 
LEF1 and guide LEF1-mediated transcription. LEF1/TCF/β-catenin-mediated 
transcription is mostly known as the outcome of WNT signalling. In the Xenopus, 
SMAD3 and SMAD4 associate with LEF1 to synergistically mediate the transcription of 
target genes (Labbe et al., 2000) decapentaplegic (DPP), the Drosophila homolog of 
BMP, can regulate LEF1 transcriptional activity (Riese et al., 1997).  (B) A hypothetical 
model during embryonic mammary gland development showing possible convergence of 
molecules on LEF1. PTHrP regulates BMP signalling by regulating phosphorylated 
SMADs 1, 5, 8 levels. In parallel, PTHrP regulates Msx2 expression (Hens et al., 2007), 
which in turn regulates Lef1 expression (Satokata et al., 2000). Note that the interactions 
depicted here are a compilation of known interactions that may not happen 
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5.4  Molecular mechanisms regulated by Gli3 in the embryonic MRs 
 
5.4.1 GLI3 in the embryonic MRs ─ a choice between GLI3 activator (GLI3A) and 
GLI3 repressor (GLI3R) 
 
GLI3 functions as a bifunctional mediator of the Hedgehog (HH) pathway, either 
activating or repressing the transcription of downstream genes depending on the status 
of HH signalling (see also Chapter 1).  
HH ligands such as sonic hedgehog (Shh) and Indian hedgehog (Ihh) are expressed 
in the MRs at E12.5, suggesting that Hh signalling may be activated in the MRs. 
However, Shh is not required for the development of the MRs as Shh-/- embryos continue 
to develop 5 pairs of MRs that branch normally at E16.5 (Michno et al., 2003). Moreover, 
transplantation of Shh-/- and Ihh-/- MRs into wild type cleared fat pads resulted in normal 
ductal morphogenesis, showing that epithelial Shh and Ihh is not required for ductal 
branching (Gallego et al., 2002). 
The status of HH signalling within the MRs may also be determined by the 
transcription of HH-target genes. Gli1 is a direct transcriptional target of positive HH 
signalling, and its expression is strictly dependent on Hh signals transduced by either 
Gli2 or Gli3 activators (Dai et al., 1999). Thus Gli1 is a reliable read-out of activated HH 
signalling. Gli1 expression is not detected in the somites underlying MR3 at E11.5, 
whereas Gli2 and more prominently, Gli3, are expressed. From E11.5 to E14.5, Gli1 
expression is absent in the MRs, indicating that HH signalling is inactive (Fig. 5. 4  A-G;  
(Hatsell and Cowin, 2006)). The upregulation of Gli1 and to a lesser extent, Gli2 
expression in Gli3Xt-J/Xt-J MRs is further indicative that during normal MR development, 
Gli1 expression is suppressed by Gli3. In other words, GLI3 is present in the GLI3R form 
in the MRs. Furthermore, phenocopy of the lack of induction of Gli3Xt-J/Xt-J MR3 and MR5 
can be achieved by the expression of Gli1 under the Gli2 promoter in combination with 
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heterozygosity for Gli3, showing that HH activity has to remain in the off-state for MR 
induction to proceed (Hatsell and Cowin, 2006).  
Is Gli3 functioning cell autonomously to guide mammary gland morphogenesis? Gli3 
is expressed in the somites at E10.5 (Veltmaat et al., 2006). At E12.5 and E13.5, Gli3 is 
also expressed in the ectoderm and mammary epithelium (Fig. 5.4). Thus, the mammary 
phenotype of the Gli3Xt-J/Xt-J MRs observed at E12.5 and E13.5 could be secondary to the 
non-cell autonomous function of Gli3 in the somites, the cell autonomous function of Gli3 
in the ectoderm and MRs, or a combination of the two. Whether correct morphogenesis 
is determined by somitic Gli3, mammary epithelial or mesenchymal, or a combination of 
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5.4.2 GLI3R and WNT signalling interactions in the embryonic MRs — some 
possibilities 
 
The close links between Gli3 and the WNT signalling pathway during embryonic 
mammary gland development raise the possibility of direct interactions between the two 
pathways. This is an attractive possibility given that the WNT and HH signalling 
pathways have several pathway members in common. In particular, the degradation 
complex that regulates proteolysis in both WNT and HH signalling utilize glycogen 
synthase kinase (GSK3), casein kinase 1 (CK1), and the E3 ubiquitin ligase, β-TrCP. 
Importantly, these common players play critical roles in determining the levels of the 
downstream transcription activators, the GLI proteins and β-catenin, and therefore have 
profound implications on the transcriptional regulation of HH- and WNT-target genes.   
As discussed previously, GLI3, in its repressor form, is present in the somites at 
E11.5, while at this time TOPGAL is expressed in the ectoderm. Thus, the interaction 
between GLI3R and WNT signalling may be non-cell autonomous by nature at this point. 
As Gli3 expression transits to the ectoderm and mammary epithelium, and mammary 
mesenchyme at E12.5 and E13.5, the interaction between Gli3 and WNT signalling may 
then be cell autonomous. A possible cell autonomous interaction between HH and WNT 
signalling has been shown in the neural tube of the mouse embryo. In E9.5 Shh-/- mouse 
embryos, the expression of the WNT-target gene Axin2 is decreased in the neural tube, 
indicating that HH signalling inhibits canonical WNT signalling. The point of interaction 
between these 2 pathways seems to be at the level of GLI3R, as GLI3R was sufficient to 
decrease the response of neural cells to WNT3A, using TOPFLASH as read-out. 
Furthermore, transcriptional activity of β-catenin is compromised in the presence of 
GLI3R. This interaction between β-catenin and Gli3R is direct, as revealed by 
immunoprecipitation assays (Ulloa et al., 2007). However, the preceding scenario is in 
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opposition to the observations in the MRs where GLI3R positively correlates with WNT 
signalling activity, suggesting that other nodes of interactions may exist between these 2 
pathways in different contexts.  
A genome-wide in silico study has predicted a large number of mammalian 
enhancers harbouring both GLI and TCF binding sites  (Hallikas et al., 2006), suggesting 
that shared enhancer elements may also represent a common mechanism integrating 
HH and WNT signalling. 
 
 
5.4.3 A role for non-canonical WNT signalling during embryonic mammary gland 
development? 
 
Canonical WNT/β-catenin signalling has been shown to be critically required for the 
induction of the MRs, in part due to the observation of the failure of MR induction in 
embryos overexpressing the secreted WNT inhibitor, dickkopf 1 (Dkk1) under the Krt14 
promoter. DKK1 blocks WNT signalling by binding to the LDL receptor-related protein 5 
or 6 (LRP5 or LRP6) — WNT co-receptors, thereby inhibiting the formation of WNT-
induced FZD–LRP5 or FZD-LRP6 complexes. The overexpression of Dkk1 under the 
Krt14 promoter blocks the expression of TOPGAL in the mammary region (Chu et al., 
2004). 
However, several studies challenge the notion that DKK1 exerts its effects 
exclusively on the canonical WNT signalling pathway. Dkk1 and β-catenin double- 
depleted Xenopus embryos did not fully phenocopy the convergent extension 
movements at the equatorial zone of solely β-catenin-depleted embryos, suggesting that 
Dkk1 may also affect other non-WNT/β-catenin signalling pathways. Moreover, in the 
absence of Dkk1, an increased in JNK activity a key component of the non-canonical 
WNT signalling pathway was detected in the equatorial zone (Cha et al., 2008). A similar 
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situation was demonstrated in vitro where Dkk1 expression has been shown to suppress 
cell growth and induces apoptotic cell death in β-catenin-deficient mesothelioma cell 
lines through a JNK dependent pathway (Lee et al., 2004). Together, this suggests that 
in addition to the canonical WNT pathway Dkk1 may inhibit the non-canonical WNT 
pathway as well. 
WNT ligands that activate the non-canonical pathway such as Wnt5a and Wnt11 are 
expressed in the MRs at E12.5 and E15.5, although Wnt5a-/- embryos induce all MR 
pairs normally (Chu et al., 2004). Whether or not Wnt5a acts redundantly with Wnt11 
remains to be determined. The role of the non-canonical pathway in cell migration 
(reviewed in (Komiya and Habas, 2008)), the main cell mechanism of induction and 
growth of the MRs in the first day of mammogenesis (Chapter 2) is further suggestive of 
the involvement of the non-canonical pathway.  
 
5.5 A possible molecular basis for the protrusion of Gli3Xt-J/Xt-J MR2  
 
As phenocopies of the Gli3Xt-J/Xt-J MR2 phenotype exist in other mouse models, I may 
speculate on a possible genetic hierarchy that governs invagination. Lef1-/- MRs are 
hypoplastic and protrude outwardly at E13.5 (Boras-Granic et al., 2006). Msx1-/-;Msx2-/- 
MR4 is hypoplastic and is slightly elevated at E15.5 (Satokata et al., 2000). Interestingly, 
the phenotype of Msx1-/-;Msx2-/- MR4 bud is also associated with the loss of mammary 
epithelial and mesenchymal Lef1 expression, suggesting that Msx1, Msx2 and Lef1 may 
act in the same genetic hierarchy to mediate invagination.  
We therefore propose a genetic hierarchy governing invagination that places 
Msx2/Msx1 upstream of Lef1. Where may Gli3 be placed in this genetic hierarchy? 
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Preliminary data shows that LEF1 expression is downregulated in Gli3Xt-J/Xt-J MR2 (Fig. 
5.4 B), suggesting that GLI3 may be placed upstream of LEF1 (Fig.  5.4 E).  
In addition, the protrusion of Gli3Xt-J/Xt-J MR2 and MR4 is also reminiscent of a subset 
of male MRs, such as MR4 and MR5, at E14.5 (Chapter 3, reviewed in (Veltmaat et al., 
2003)), which may suggest that the MRs are developing along the male pathway. At 
E14.5, development of the MRs diverges between the genders. In males, under the 
influence of testosterone, the mammary mesenchyme, expressing androgen receptors 
(AR), constricts around the mammary epithelium thereby causing the mammary 
epithelium to regress. The expression of AR is dependent on epithelial-mesenchymal 
interactions mediated at least in part by PTHrP-PTHR1 signalling (Dunbar et al., 1999), 
and epithelial, mesenchymal or both of these sources of Lef1. In Lef1-/- embryos, AR is 
expressed in a narrower domain in the mesenchyme, suggesting that mammary 
mesenchyme differentiation is perturbed. Moreover, as described previously, the MR 
protrudes outwardly and regresses over time, as in male MRs (Kratochwil K. personal 
communication; (van Genderen et al., 1994; Boras-Granic et al., 2006)). In a similar 
fashion, epithelial-mesenchymal interactions may also be impaired in Gli3Xt-J/Xt-J embryos. 
While androgen receptor seems to be expressed at normal levels in Gli3Xt-J/Xt-J MR2 and 
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  Fig. 5.4. A highly speculative molecular basis for the protrusion of Gli3Xt-J/Xt-J MR2.  
(A-B) Immunohistochemistry of LEF1 in wild type and Gli3Xt-J/Xt-J MR2 at E13.5. LEF1 is 
expressed predominantly in the mammary epithelium, and to a lesser extend in the 
ectoderm and mammary epithelium. Expression of Lef1 is downregulated in Gli3Xt-J/Xt-J 
MR2. (C-D) Immunohistochemistry of androgen receptor (AR) in wild type and Gli3Xt-J/Xt-J 
MR2 at E13.5. AR is expressed in the mammary mesenchyme at similar levels in wild 
type and Gli3Xt-J/Xt-J MR2. (E) A speculative genetic hierarchy for invagination based on 
the phenocopy of Gli3Xt-J/Xt-J MR2 in Msx1-/-;Msx2-/-  and Lef1-/- MRs. Refer also to text for 




5.6 Many roads lead to Rome: multiple signalling networks govern the 
development of each MR pair 
 
5.6.1 The unique nature of each mammary gland pair - implications for research 
 
Does developmental history affect or have a bearing on postnatal development? It is 
conceivable that development of during the embryonic phase may lay the foundation for 
growth and morphogenesis during the postnatal phase.   
In Hoxc6-/- mice (Garcia-Gasca and Spyropoulos, 2000), all five MR    pairs are 
induced, although at E12.5, some thoracic buds are smaller and may have a protruding 
morphology. In Hoxc6-/- newborn females, thoracic glands show reduced branching and 
defects in fat pad development. In 8-10 weeks old mice, while the mammary epithelium 
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is normal in the inguinal glands, thoracic mammary fat pads were devoid of mammary 
epithelium. Thus, differences observe during early mammogenesis may persist and 
exert effects during postnatal life. Furthermore, along the mammary line, differential 
morphogenesis of the mammary glands can occur in the adult, as in the embryo.  
The differences amongst mammary glands seen in their normal development are 
also mirrored during neoplastic transformation. Studies have shown that the postnatal 
thoracic mammary glands form mammary tumours more frequently than inguinal glands 
(Sheldon et al., 1982; Minasian, 1983; Bolander, 1990). Assuming that the mammary 
epithelium to fat pad ratio is equal across all glands, it is hypothesized that the higher 
relative weight, and therefore the presence of more epithelial tissue that can undergo 
neoplastic transformation of the anterior glands could explain in part the higher incidence 
of tumour formation (Vaage, 1984). Another explanation for this unequal distribution of 
tumour formation is the asynchrony in differentiation between the thoracic and inguinal 
mammary glands, resulting in their differential susceptibility to 7,12-
dimethylbenz(a)anthracene (DMBA)-induced carcinogenesis (Russo and Russo, 1988). 
Notably, the increased presence of less-differentiated structures such as the terminal 
end buds in the thoracic glands was shown to be correlated with increased susceptibility 
to tumour formation. In line with the differential response of mammary glands to DMBA, 
it was shown that the postnatal thoracic glands require a smaller concentration of insulin, 
cortisol and prolactin for the production of α-lactalbumin than the inguinal glands 
(Bolander, 1990). These physiological differences could, in part, be attributed to different 
molecular regulation amongst the mammary glands that has already been set in place 
since embryonic development.  
Considering the variation amongst the mammary glands, it may be prudent to make 
MR-specific comparison for research. In addition, a pilot study that utilizes all 5 MR pairs 
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may be included to determine whether important differences exist amongst the MR pairs 




5.6.2 More diversity than uniformity in other ―repetitive‖ structures? 
 
One of the conclusions drawn from this thesis is that each of the 5 pairs of MRs has 
its own unique dynamics of cellular mechanisms and unique molecular mechanisms for 
its formation. This challenges the long-standing assumption that the 5 pairs of mammary 
glands, though functionally identical in the adult, may therefore be considered identical, 
repetitive structures. What may be the advantage of using varying developmental 
mechanisms? Though it may be simpler to engage the same mechanisms or 
developmental programs, the utilization of different mechanisms may be an ingenious 
way of protecting at least a subset of mammary glands in the event of an inhibitory 
mutation. This is a safety net to safeguard the survival of offsprings which are highly 
dependent on the mammary glands to provide for their nourishment. 
Could the diversity of the 5 pairs of MRs suggest that such diversity may also exist in 
other seemingly repetitive structures? Hair follicles and other ectodermal appendages 
such as whisker follicles, feathers and teeth are examples of such seemingly repetitive 
structures, analogous to the mammary glands. In general, all hair follicles are similar in 
terms of their morphology, function and early development. Like the MRs, initiation of 
hair follicle development is marked by the appearance of a local epithelial thickening, a 
placode, and a bud. Moreover, like the MRs, the epithelial–mesenchymal crosstalk is 
mediated by signalling pathways including the WNT, FGF, TGF, and TNF signalling 
pathways (reviewed in (Mikkola, 2007; Widelitz et al., 2007)). Strikingly, ablation of the 
WNT signalling with the overexpression of the secreted WNT inhibitor Dkk1 results in the 
loss of all hair follicles, MRs and teeth in mouse embryos (Chu et al., 2004). The loss of 
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Gli3 results in a severe mammary gland phenotype, defective hair follicles growth as well 
as defective whisker follicles patterning and growth (Chapter 3, Fig. 3.1, and data not 
shown). Fgf10-/- and Fgfr2b-/- mutants show, in addition to a severe mammary gland 
defect, defects in hair and whisker follicle development (Chapter 3, Fig. 3.8 and data not 
shown). Thus, by similarities in terms of their early anatomy, function and dependence 
on certain molecular regulators, ectodermal appendages such as the teeth, hair, and 
whisker follicles may be considered, separately, as groups of identical and repetitive 
structures.  
However, the formation of hair follicles in different regions of the body may suggest 
that different hair follicles are exposed to vastly different molecular milieus. Like the 
MRs, position-specific molecular regulators may be at play in the induction and 
development of each hair follicle. Such positional information may be conferred by 
molecular regulators such as the homeobox transcription factors, HOX. Indeed, Hox3.1 
is expressed differentially in different skin regions – higher expression was detected in 
the posterior skin than the anterior skin (Bieberich et al., 1991). Such region-specific 
expression patterns have also been demonstrated for the Hoxc8 gene, which is 
expressed in gradients along the antero-posterior and dorso-ventral axes (Kanzler et al., 
1994). These differential gene expression patterns establish more subtle characteristics 
in hair follicles such as length, texture, and pigmentation. In particular, differences in 
dorsal and ventral pigmentation, caused by the regional and temporal-specific 
expression of the agouti gene induces melanocytes within hair follicles to switch from the 
synthesis of black pigment granules (eumelanosomes) to yellow pigment granules 
(phaeomelanosomes), which will then be incorporated into the growing hair.     
Thus, the apparent uniformity in the embryonic MRs and structures such as hair 
follicles obscures the underlying diversity in molecular regulation. When examined 
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closely enough, we may find more diversity that is required for more sophisticated and 
fine regulation, which eventually translates into a variety of phenotypes.  
 
5.7 The murine mammary glands as models for development and pathology 
 
5.7.1 Making in-roads from biology into pathology 
 
The murine mammary glands are excellent models for understanding normal 
developmental mechanisms: ectodermal patterning, specification, cellular and molecular 
mechanisms that underlie morphogenesis, amongst many other aspects.  
The understanding of developmental mechanisms paves the way for understanding 
various pathological conditions. There is considerable overlap between molecular factors 
that play important roles during development, and those that are misregulated during 
cancer. Aberrant reactivation of latent developmental signalling pathways and 
transcription factors in tumour cells has been associated with and shown to play causal 
roles in advanced-stage, invasive cancers. An example of this is the embryonic 
transcription cofactor limb-bud and heart (LBH), a direct target of the WNT pathway in 
epithelial development. At high levels, LBH suppresses mammary epithelial cell 
differentiation. LBH is also expressed in the postnatal mammary gland and is 
overexpressed in the basal subtype of breast carcinoma cells (Rieger et al., 2010). 
Furthermore, the approach of understanding pathological conditions such as cancer 
from studying normal development has yielded new insights into the origin of cancer – 
since transcription factors that normal control gene expression in embryonic stem or 
progenitor cells are the same ones that are deregulated in breast tumours, this suggests 
that breast cancer cells may have a stem cell origin (reviewed in (Briegel, 2006)).  
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Another example of a recurring player in normal development and pathology is the 
T-box transcription factor. Tbx genes, specifically Tbx2 and Tbx3, play important roles in 
embryonic mammary gland development. No MRs were detectable in Tbx3-/- embryos at 
E11.5 by Lef1 and Wnt10b expression, and only a minority of mutants develop MR2 at 
E13.5, indicating that Tbx3 is an important MR induction factor (Davenport et al., 2003).  
Although induction was not affected in Tbx2+/-;Tbx3+/- mutants, the thoracic glands in 
these mutants frequently fail to form nipples and ductal trees (Jerome-Majewska et al., 
2005). Interestingly, TBX2 is found in a region of amplification chromosome 17q23 in 
breast tumours and is amplified in about 8.6% of human breast cancers (Sinclair et al., 
2003). In addition, TBX2 overexpression has been correlated with hereditary BRCA1/2-
associated breast cancers, which are characteristically more aggressive than sporadic 
breast cancers, and with advanced tumour stages. The preceding example shows that 
misregulation of genes which are important regulators during normal development 
frequently occur in pathological conditions. The identification and understanding of the 
mechanisms mediated by these factors during early development may pave the way for 
a deeper understanding of various human diseases. Furthermore, the embryonic MR is 
an easier and cleaner structure to work with compared to human or mouse mammary 
gland tumours which are generally heterogenous in cell composition: tumours are 
architecturally complex, differing regionally in vasculature, host infiltrates and connective 
tissue components ((Heppner, 1984) and reviewed in (Campbell and Polyak, 2007)). 
This heterogeneity could complicate gene expression profiling and obscure the 
identification of molecular regulators that induce and drive tumour formation. Moreover, 
an added dimension of genetic heterogeneity is present within human tumour samples 
as unlike most mouse models, humans are not inbred. 
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5.7.2 A case in point: Gli in breast cancer 
 
Similar to the above-mentioned Lbh and Tbx genes, the Gli genes play important 
roles during normal development and are often misregulated during tumour progression.  
 Since the identification of GLI1 as an amplifed gene in a human glioblastoma, GLI1 
has also been found to be amplified in a variety of cancers (Kinzler et al., 1987; Roberts 
et al., 1989). For example, Gli1 expression in estrogen receptor (ER) α negative and 
triple negative breast cancers is predictive of a poor prognosis (Souzaki et al., 2011). In 
addition, Gli1 promotes the growth, survival, migration, invasion and metastasis of ERα 
negative breast cancer cell lines. The actions of Gli1 in promoting migration and invasion 
may be mediated by matrix metalloproteinase 11 (MMP11), which is upregulated by Gli1 
(Kwon et al., 2011). Overexpression of the HH ligand in the epithelium and GLI1 in the 
stroma are predictors of poor outcome in breast cancer and breast cancer-specific death 
(O'Toole et al., 2011).  
While Gli3 is not known to be misregulated in breast cancer, in a bioinformatics 
analysis of gene expression profile datasets, GLI3 was identified as a putative 
interacting partner of TBX3. TBX3 is commonly over-expressed in breast cancer tissues 
and cell lines. Further sequence-based and chromatin immunoprecipitation analysis 
uncovered Gli3 as a direct transcriptional target of TBX3 (Mosca et al., 2009).  
To further complicate matters, while the GLI proteins are mostly known to be 
downstream mediators responding to HH activity within the cell, it is becoming clear that 
the GLI code may be modulated by non-HH signalling pathways. GLI proteins may 
integrate signals from EGFR-MEK/ERK (Kasper et al., 2006), RAS/AKT (Stecca et al., 
2007), TGFβ (Dennler et al., 2007) signalling pathways, all of which are widely known as 
oncogenic signalling pathways.  
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The HH pathway and GLI proteins are currently being explored as new therapeutic 
targets for breast cancer patients. There is evidence that this may prove to be a good 
strategy as exposure to cyclopamine, a steroidal alkaloid that blocks the HH pathway, 
suppresses expression of Gli1 and the growth of HH pathway-activated breast 
carcinoma cells (Kubo et al., 2004).  
 
5.8 Significance and implications 
 
The study of the role of Gli3 in embryonic mammary gland development has 
uncovered MR-specific roles of Gli3. The dynamics of cellular and molecular 
mechanisms are regulated differentially by Gli3 in the different MRs. Thus each MR pair 
has different requirements for Gli3 in various processes. The Gli3Xt-J/Xt-J and other mouse 
genetic models show that the embryonic mammary glands are unique in their 
requirement for molecules to regulate development, an unexpected notion given that 
they are functionally-identical organs in the adult. As early development has been shown 
to affect postnatal development of the mammary glands, this highlights the importance of 
using mammary gland-specific comparisons during research.  
  
 
CHAPTER 6  
Conclusions and Future Perspectives 
 
6.1 Main conclusions 
 
 The GLI-Krupple family member 3 (Gli3) regulates various cellular mechanisms 
differentially among the different mammary rudiment pairs.  
 
 Despite being functionally-uniform in the postnatal stage as milk-producing 
organs, the mammary glands are distinct entities in terms of their dynamics of 
growth, morphology, and differential requirement of molecular regulators for 
induction, growth and morphogenesis in the embryonic phase of development. 
 
 High levels of canonical WNT/β-catenin signalling are crucial for MR induction 
and growth, but insufficient to mediate proper morphogenesis and maintenance 
of MR3 in the absence of Gli3.  
 
 The unique nature of each mammary gland pair ensures that they are not 
susceptible to the same genetic pressures, which may lead to the compromised 
survival of the species.  
 
 As development of the mammary glands during the embryonic phase have a 
bearing on postnatal development and even disease progression of the 
Chapter 6: Conclusions and Future Perspectives 
167 
 
mammary gland, it is important that mammary gland-specific comparisons be 
made in research. 
 
 Accumulating evidence show that many pathways that are important for normal 
development are reactivated or misregulated during tumour progression. This 
suggests that the study of normal development may provide a new avenue for 
the identification of new molecular regulators that would aid in the understanding 
of disease progression and the identification of potential targets for therapeutic 
intervention.  
 
6.2 Recommendations for future work 
 
Via what cellular mechanism does β-catenin regulate to increase MR size? The 
MRs have very low proliferative activity during the first 3 days of mammogenesis. The 
influx of cells from the ectoderm to the mammary epithelium is the primary contributor of 
growth during from E11.5 to E12.5, and further complemented by cell hypertrophy from 
E12.5 to E13.5 (Chapter 2). WNT/β-catenin signalling can regulate multiple cellular 
mechanisms including cell proliferation, cell migration that may be implicated in 
reforming MR3 in the absence of Gli3 and in enlarging MR size. Future work will address 
these possibilities to delineate the cellular mechanisms regulated by stabilized β-catenin. 
  
What are the downstream effectors of Gli3?  We have dissected MRs of wild type 
and Gli3Xt-J/Xt-J MRs and subjected them to MR-specific micro-array analysis. In 
collaboration with a bioinformatician, we plan to extract information regarding differential 
regulation of genes in each MR, downstream of Gli3.  
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Compartment-specific roles of Gli3. Gli3 is expressed in the somites at E10.5. At 
E12.5 and E13.5, Gli3 expression is expands to the ectoderm and mammary epithelium. 
Thus, the mammary phenotype of the Gli3Xt-J/Xt-J MRs observed at E12.5 and E13.5 could 
be secondary to the loss of Gli3 in the somites, the direct effect of loss in the ectoderm 
and MRs, or a combination of the two. The source of Gli3 that is crucial for 
morphogenesis of the MRs could be determined by tissue recombinations of Gli3Xt-J/Xt-J 
ectoderm with wild type mesenchyme (and vice-versa), and observing the growth of the 
MR in culture. Tissue-specific deletion of Gli3 using an ectoderm- or mesenchyme-
specific promoter could also be used to determine the contributions of different sources 















Table A.1: List of primers
Gene Name of primer Tm, (°C) Sequence (5’-3’) Reference 
Gli3Xt-J 
Xtfwd-C 58 GGC CCA AAC ATC TAC CAA CAC ATA G 
(Maynard et al., 
2002) 
Xtrev-C 58 GTT GGC TGC TGC ATG AAG ACT GAC 
Xtfwd-580 58 TAC CCC AGC AGG AGA CTC AGA TTA G 
Xtrev-580 58 AAA CCC GTG GCT CAG GAC AAG 
Ctnnb1Tg∆N57 
Dnbcat-5s 58 ATCCTTATGACGTGCCTGAC (Teuliere et al., 
2005) Dnbcat-111as 58 GCCCGTCAATATCAGCTACT 
Dnbcat-200s 58 TTA TGA CGT GCC TGA CTA TGC 
This thesis 
Dnbcat-200as 58 CGT CAA ACT GCG TGG ATG 
XY 
Zfx-5-2 60 AGA AAG CCA TAG AAT GCG ATG AGT GC 
(Nagamine et al., 
1989) 
Zfy-5-11 60 CGA ATG TGA TGA CTG TAG GAA GAA TC 
Zfxya-3 60 AGC TGT TTC ATA GTC ACA GAA CTT AC 
Actin 
Actin-fwd 56 CCT GAA CCC TAA GGC CAA CCG 
(Veltmaat, 2001) 
Actin-rev 56 GCT CAT AGC TCT TCT CCA GGG 
Fgf10 
Fgf10-S 65 CTT CCA GTA TGT TCC TTC TGA TGA GAC 
(Sekine et al., 
1999) 
Fgf10-AS 65 GTA CGG ACA GTC TTC ATT CTT GGT CCC 
Neo-S 65 ACG ACG GGC GTT CCT TGC GCA GCT GTG 
Neo-AS 65 TCA GAA GAA CTC GTC AAG AAGGCG ATA 
Fgfr2b 




Wt-FloxR (P2) 55 CTC AAC AGG CAT GCA AAT GCA AGG TC 
Mut-P3 55 GGC AGT AAA TAC GGG CCT G 
MutP4 55 CGT AAA CTC CTC TTC AGA CC 
lacZ 
lacZ-F 63 GCA TCG AGC TGG GTA ATA AGC GTT GGC AAT Robert Kelly, 
personal 
communication 







Table A.2: List of antibodies 
 
Abbreviations: mc: monoclonal; pc: polyclonal; HRP: horse-radish peroxidase; IHC: Immunohistochemistry; IF: Immunofluorescence 
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